Published on

Ophthalmology – Refractive Error (Myopia, Hyperopia, Astigmatism)

Basics

Description

A refractive error exists when light entering the unaccommodated eye does not focus precisely on the retina.

The refractive state depends mainly on the relationship between:

  • Corneal power
  • Crystalline lens power
  • Anterior chamber depth
  • Axial length

The three major refractive errors are:

  • Myopia
  • Hyperopia
  • Astigmatism


Emmetropia

In an emmetropic eye, parallel rays from a distant object focus:

On the retina without accommodation.

Emmetropization during childhood coordinates:

  • Axial growth
  • Corneal curvature
  • Lens power

so that refractive error tends toward a relatively narrow range.


Myopia

Myopia occurs when parallel rays focus:

In front of the retina

with accommodation relaxed.

It is corrected with:

Minus lenses

which diverge incoming light.


Hyperopia

Hyperopia occurs when parallel rays would focus:

Behind the retina

with accommodation relaxed.

It is corrected with:

Plus lenses

which converge incoming light.


Astigmatism

In astigmatism, optical power differs between meridians, so light does not converge to a single point focus.

Instead, two principal focal lines are formed.

Astigmatism may be:

  • Regular
  • Irregular


Regular Astigmatism

In regular astigmatism:

  • The two principal meridians are approximately perpendicular

Common forms include:

  • With-the-rule
  • Against-the-rule
  • Oblique astigmatism


With-the-Rule Astigmatism

The vertical meridian is relatively steeper.

In minus-cylinder notation, the cylinder axis is typically near:

180°


Against-the-Rule Astigmatism

The horizontal meridian is relatively steeper.

In minus-cylinder notation, the cylinder axis is typically near:

90°


Oblique Astigmatism

Principal meridians lie away from the usual vertical/horizontal axes, often around:

  • 45°
  • 135°

Oblique astigmatism may be especially noticeable symptomatically because adaptation can be more difficult.


Irregular Astigmatism

In irregular astigmatism, the optical surface cannot be described adequately by two perpendicular principal meridians.

Causes include:

  • Keratoconus
  • Corneal scar
  • Corneal ectasia
  • Pterygium
  • Post-surgical irregularity
  • Corneal degeneration

Irregular astigmatism often cannot be fully corrected with spectacles.


Epidemiology

Refractive error is one of the most common causes of reduced vision worldwide.

Its prevalence varies by:

  • Age
  • Ethnicity
  • Geography
  • Education
  • Environmental exposure

Myopia is particularly common in:

  • East and Southeast Asia
  • Urbanized populations
  • Highly educated populations

and its prevalence has risen substantially over recent decades.


Genetics

Refractive error has a strong heritable component.

Myopia, hyperopia, and astigmatism are influenced by:

  • Multiple genes
  • Ocular biometric traits
  • Environmental exposures

Most common refractive error is:

Polygenic and multifactorial

rather than caused by a single gene.


Myopia – Pathophysiology

Most clinically important myopia is:

Axial myopia

in which the eye is too long for its optical power.

A relatively small increase in axial length can produce substantial refractive change.


Axial Length

A rough clinical principle:

~1 mm of axial elongation produces approximately 2.5–3 D of myopia

although the exact relationship varies.

High myopia usually reflects:

  • Excessive axial elongation

rather than simply excessive corneal curvature.


Refractive Myopia

Less commonly, myopia results from excessive optical power rather than axial elongation.

Examples include:

  • Increased corneal curvature
  • Lenticular myopia
  • Nuclear sclerosis
  • Lens swelling


Myopic Shift in Cataract

Nuclear sclerosis may increase the refractive index of the lens and produce:

A myopic shift

sometimes called:

Second sight

because an older hyperopic or presbyopic patient may temporarily read without glasses again.


Myopia Risk Factors

Important risk factors include:

  • Family history
  • Limited outdoor time
  • Greater near-work/educational exposure
  • Urban environment
  • East Asian ancestry
  • Earlier age of onset


Outdoor Time

One of the best-supported environmental protective factors against childhood myopia onset is:

More time spent outdoors

Outdoor exposure appears to reduce the risk of developing myopia, although it is less certain how strongly it slows progression once myopia is established.


Near Work

Near work is associated with myopia development, particularly:

  • Prolonged uninterrupted near tasks
  • Very short working distance

The relationship is weaker than the protective effect of outdoor time.


Hyperopia – Pathophysiology

Hyperopia is commonly caused by:

Axial length that is too short for the optical power of the eye

Other contributors include:

  • Flat cornea
  • Reduced lens power
  • Aphakia


Accommodation and Hyperopia

Young hyperopes may compensate using:

Accommodation

Therefore they may have:

  • Clear distance vision
  • Clear near vision
  • No symptoms

despite measurable hyperopia.


Manifest Hyperopia

The portion of hyperopia detected without cycloplegia is:

Manifest hyperopia


Latent Hyperopia

Additional hyperopia uncovered after cycloplegia is:

Latent hyperopia

It is particularly important in:

  • Children
  • Young adults
  • Accommodative esotropia


Total Hyperopia

Total hyperopia is approximately:

Manifest + latent hyperopia

and is best estimated with adequate cycloplegia.


Hyperopia and Age

Hyperopia itself does not necessarily increase dramatically with age, but symptoms often worsen because:

Accommodation progressively decreases

As presbyopia develops, previously compensated hyperopia becomes clinically apparent.


Hyperopia and Angle Closure

Hyperopic eyes often have:

  • Shorter axial length
  • Shallower anterior chamber
  • Narrower angles

and therefore have increased risk for:

Primary angle-closure disease

especially with aging.


Astigmatism – Optical Basis

Astigmatism may arise from:

  • Cornea
  • Crystalline lens
  • Posterior corneal surface

The anterior cornea contributes most of the clinically measured astigmatism.


Corneal vs Refractive Astigmatism

Keratometry measures primarily:

Anterior corneal curvature

whereas manifest refraction measures:

Total refractive astigmatism

which includes:

  • Anterior cornea
  • Posterior cornea
  • Lens

This difference is important in:

  • Toric IOL planning
  • Refractive surgery
  • Contact lens fitting


Symptoms

Symptoms depend on:

  • Magnitude
  • Type of refractive error
  • Age
  • Accommodation
  • Visual demand


Myopia Symptoms

Typical complaints include:

  • Blurred distance vision
  • Squinting
  • Sitting close to television or screen
  • Difficulty seeing classroom board or road signs

Near vision may remain clear without correction.


Hyperopia Symptoms

Possible symptoms include:

  • Near blur
  • Eyestrain
  • Frontal headache
  • Fatigue with reading
  • Intermittent blur
  • Difficulty sustaining near work

Young patients may remain asymptomatic because of accommodation.


Astigmatism Symptoms

Symptoms may include:

  • Blur at distance and near
  • Ghosting
  • Distortion
  • Headache
  • Eyestrain
  • Difficulty with fine detail
  • Night-driving glare


Asthenopia

Refractive error may contribute to:

Asthenopia

including:

  • Frontal headache
  • Eye fatigue
  • Brow ache
  • Difficulty sustaining near work

However, headache should not automatically be attributed to refractive error without appropriate clinical evaluation.


Pediatric Importance

Uncorrected significant refractive error can cause:

Amblyopia

particularly:

  • High bilateral ametropia
  • Anisometropia
  • High astigmatism
  • Hyperopia associated with esotropia


Anisometropia

Anisometropia is unequal refractive error between the two eyes.

It may cause:

  • Unequal retinal image quality
  • Suppression
  • Amblyopia
  • Reduced stereopsis

in children.


Aniseikonia

Spectacle correction of large anisometropia can produce different retinal image sizes:

Aniseikonia

This may cause:

  • Eyestrain
  • Diplopia
  • Reduced stereopsis
  • Poor spectacle tolerance

Contact lenses often reduce this problem.


Accommodative Esotropia

Significant hyperopia may cause excessive accommodative effort.

Because accommodation is linked to convergence:

Accommodation → convergence

some children develop:

Accommodative esotropia


Hyperopic Correction in Accommodative Esotropia

Children with accommodative esotropia generally receive:

Full cycloplegic hyperopic correction initially

to reduce accommodative convergence.


Diagnosis

Diagnosis requires measurement of refractive state and assessment of ocular health.

Core components include:

  • Distance visual acuity
  • Near visual acuity
  • Pinhole acuity
  • Objective refraction
  • Subjective refraction
  • Cycloplegic refraction when indicated


Pinhole Test

Improvement in visual acuity through a pinhole suggests that decreased vision is at least partly:

Optical/refractive

because the pinhole reduces the blur circle.

However, lack of pinhole improvement does not completely exclude refractive error.


Objective Refraction

Objective techniques include:

  • Retinoscopy
  • Autorefraction

These provide a starting estimate without requiring subjective responses.


Retinoscopy

Retinoscopy is especially valuable in:

  • Children
  • Nonverbal patients
  • Developmental delay
  • Poor subjective responders
  • Irregular reflexes

It remains a fundamental method for objective refraction.


Autorefraction

Autorefraction is useful for:

  • Rapid screening
  • Starting subjective refraction

but should generally not replace:

Clinical refinement

especially in:

  • Young patients
  • High accommodation
  • Irregular corneas


Manifest Refraction

Manifest refraction is performed without cycloplegia.

It reflects the patient’s functional refractive state but can be influenced by:

Accommodation

Young patients may be:

  • Over-minused
  • Under-plussed

if accommodation is not controlled.


Cycloplegic Refraction

Cycloplegic refraction temporarily eliminates accommodation.

It is particularly important in:

  • Children
  • Suspected hyperopia
  • Accommodative esotropia
  • Unexplained reduced vision
  • Suspected accommodative spasm
  • Large discrepancy between objective and subjective refraction


Cycloplegic Agents

Common agents include:

  • Cyclopentolate
  • Tropicamide in selected situations
  • Atropine for stronger/prolonged cycloplegia when clinically required

Cyclopentolate is commonly used for routine pediatric cycloplegic refraction.


Important Modern Correction

There is no universal rule that a fixed amount such as:

−0.25 D

must automatically be added after every cycloplegic refraction.

Final prescribing should be based on:

  • Age
  • Symptoms
  • Alignment
  • Accommodation
  • Visual acuity
  • Refractive findings


Keratometry

Keratometry measures:

  • Central corneal curvature

and estimates:

  • Corneal astigmatism

It is useful for:

  • Contact lenses
  • Cataract surgery
  • Toric IOL planning
  • Corneal disease screening


Corneal Topography and Tomography

These are important when astigmatism is:

  • High
  • Irregular
  • Progressive
  • Asymmetric

They help diagnose:

  • Keratoconus
  • Corneal ectasia
  • Pellucid marginal degeneration
  • Post-surgical ectasia


Jackson Cross Cylinder

The JCC is used during subjective refraction to refine:

  • Cylinder axis
  • Cylinder power

It is particularly useful in regular astigmatism.


Spherical Equivalent

The spherical equivalent is:

Sphere + ½ cylinder

It is useful for:

  • Comparing prescriptions
  • Research
  • Some prescribing adjustments

but does not fully describe the optical effect of astigmatism.


Treatment Principles

Refractive error can be corrected with:

  • Spectacles
  • Contact lenses
  • Refractive surgery
  • Intraocular lens-based procedures

Choice depends on:

  • Age
  • Refractive magnitude
  • Corneal anatomy
  • Ocular health
  • Lifestyle
  • Patient preference


Spectacles

Spectacles are:

The simplest and safest form of optical correction

and can correct:

  • Myopia
  • Hyperopia
  • Regular astigmatism
  • Presbyopia


Correcting Myopia

A practical goal is:

Full or appropriate distance correction without unnecessary over-minus

Over-minus can:

  • Stimulate accommodation
  • Cause eyestrain
  • Distort binocular balance

especially in young patients.


Myopic Undercorrection

An important modern correction:

Deliberately undercorrecting childhood myopia does not prevent progression and may worsen progression in some patients.

Children should generally receive:

Appropriate full distance correction

unless there is a specific clinical reason not to.


Correcting Hyperopia

Correction depends on:

  • Age
  • Symptoms
  • Magnitude
  • Accommodation
  • Binocular alignment
  • Presence of amblyopia

Asymptomatic low hyperopia in a young patient may not require full correction.


Hyperopia in Children

Full or near-full correction is especially important when there is:

  • Accommodative esotropia
  • Amblyopia
  • Significant high hyperopia
  • Reduced visual function


Correcting Astigmatism

Significant astigmatism should be corrected in children to prevent:

Meridional amblyopia

Children generally adapt better than adults to:

  • Large cylinder corrections
  • Changes in axis


Adult Astigmatic Adaptation

Adults receiving a new large cylinder or major axis change may experience:

  • Floor tilt
  • Spatial distortion
  • Dizziness
  • Headache

Gradual adaptation often occurs over:

  • Days to weeks

Large unnecessary reductions in accurate cylinder should not be routine, but modification may occasionally improve tolerance.


Contact Lenses

Contact lenses can correct:

  • Myopia
  • Hyperopia
  • Astigmatism
  • Anisometropia

Advantages include:

  • Wider visual field
  • Less spectacle magnification/minification
  • Better optical quality in high refractive error


Contact Lenses in High Myopia

Compared with spectacles, contact lenses reduce:

  • Minification
  • Peripheral distortion
  • Prism effects

and may provide better visual quality.


Contact Lenses in High Hyperopia

Contact lenses reduce:

  • Spectacle magnification
  • Ring scotoma
  • Peripheral distortion

and may be especially beneficial in:

  • Aphakia
  • High anisometropia


Toric Contact Lenses

Regular astigmatism may be corrected with:

  • Soft toric lenses
  • Rigid gas-permeable lenses


Rigid Lenses for Irregular Astigmatism

Rigid gas-permeable or scleral lenses may provide major improvement in:

  • Keratoconus
  • Corneal scars
  • Irregular astigmatism

by creating a more regular anterior refractive surface.


Myopia Control in Children

A major modern development is active treatment to slow:

Childhood myopia progression and axial elongation.

This is particularly important because higher lifetime myopia increases risk of:

  • Retinal detachment
  • Myopic maculopathy
  • Glaucoma
  • Cataract


Myopia-Control Options

Evidence-based options include:

  • Low-dose atropine
  • Orthokeratology
  • Dual-focus/multifocal soft contact lenses
  • Specialized myopia-control spectacle lenses
  • Increased outdoor time

The most appropriate strategy depends on:

  • Age
  • Rate of progression
  • Axial length
  • Refractive error
  • Patient preference
  • Local availability


Low-Dose Atropine

Low-concentration atropine may slow myopia progression.

Commonly studied concentrations include:

  • 0.01%
  • 0.025%
  • 0.05%

Higher low-dose concentrations tend to have:

  • Greater efficacy
  • More photophobia
  • More near blur

Exact concentration should be individualized.


Orthokeratology

Orthokeratology uses overnight rigid lenses to temporarily flatten central cornea.

It can:

  • Correct daytime myopia
  • Slow axial elongation in many children

Risks include:

  • Microbial keratitis
  • Corneal staining
  • Lens-related complications

Strict hygiene is essential.


Multifocal / Dual-Focus Contact Lenses

Specialized soft contact lenses can create:

  • Central distance correction
  • Peripheral or simultaneous myopic defocus

and can reduce myopia progression in selected children.


Myopia-Control Spectacle Lenses

Newer designs use peripheral optical strategies to create myopic defocus while maintaining central clarity.

These can slow:

  • Refractive progression
  • Axial elongation

without contact lens risks.


Outdoor Time Recommendation

For children, encouraging approximately:

2 hours or more outdoors daily when practical

is commonly recommended as part of myopia prevention strategies.

This should complement—not replace—optical or pharmacologic treatment in progressing myopia.


High Myopia

Definitions vary, but high myopia is commonly considered approximately:

≤ −6.00 D

and/or excessive axial elongation.

The important distinction is whether there is associated structural damage.


Pathologic Myopia

Pathologic myopia refers to myopia associated with degenerative structural changes such as:

  • Posterior staphyloma
  • Myopic maculopathy
  • Lacquer cracks
  • Patchy/chorioretinal atrophy
  • Myopic CNV

High refractive error alone does not automatically equal pathologic myopia.


Complications of High Myopia

High axial myopia increases risk of:

  • Retinal tear/detachment
  • Posterior vitreous detachment
  • Lattice degeneration
  • Myopic macular degeneration
  • Myopic CNV
  • Foveoschisis
  • Macular hole
  • Open-angle glaucoma
  • Earlier cataract


Hyperopia Complications

Significant hyperopia is associated with:

  • Accommodative esotropia
  • Amblyopia
  • Anisometropia
  • Narrow angles
  • Angle-closure disease


Astigmatism Complications

Astigmatism itself does not cause keratoconus.

Instead:

Increasing or irregular astigmatism may be a sign of keratoconus.

This distinction is important.


Keratoconus Red Flags

Consider corneal tomography when there is:

  • Increasing cylinder
  • New oblique astigmatism
  • Reduced BCVA despite refraction
  • Scissoring retinoscopic reflex
  • Progressive asymmetry
  • Family history of keratoconus
  • Frequent eye rubbing


Refractive Surgery

Corneal refractive surgery can correct selected cases of:

  • Myopia
  • Hyperopia
  • Astigmatism

Options include:

  • LASIK
  • PRK
  • SMILE for selected refractive ranges
  • Other laser platforms depending on region


LASIK

LASIK reshapes the corneal stroma using an excimer laser beneath a flap.

Advantages:

  • Rapid visual recovery
  • Minimal discomfort

Potential complications include:

  • Dry eye
  • Flap complications
  • Ectasia
  • Night-vision symptoms
  • Residual refractive error


PRK

PRK removes corneal epithelium before stromal ablation.

Advantages:

  • No flap
  • May be preferred with thinner corneas or certain occupational considerations

Disadvantages:

  • More postoperative discomfort
  • Slower recovery
  • Haze risk


SMILE

Small-incision lenticule extraction is primarily used for:

  • Myopia
  • Myopic astigmatism

depending on regulatory approval and platform.

Potential advantages include:

  • No large corneal flap
  • Less early corneal nerve disruption than LASIK in some cases


Refractive Surgery Limits

Older fixed rules such as:

  • “LASIK corrects up to 10 D myopia”
  • “6 D hyperopia”
  • “4 D astigmatism”

are oversimplified.

Eligibility depends on:

  • Corneal thickness
  • Tomography
  • Optical zone
  • Residual stromal bed
  • Age
  • Stability
  • Dry eye
  • Pupil size
  • Device approval


Phakic Intraocular Lens

Phakic IOLs are useful for selected patients with:

  • High myopia
  • Thin corneas
  • Refractive errors outside comfortable laser ranges

Advantages include:

  • Excellent optical quality
  • Preservation of accommodation

Potential risks include:

  • Cataract
  • Endothelial cell loss
  • IOP elevation
  • Intraocular inflammation
  • Infection


Clear Lens Extraction

Refractive lens exchange may be considered in selected adults with:

  • Very high hyperopia
  • Presbyopia
  • Lens-related anatomy unsuitable for corneal surgery

However, it sacrifices:

Natural accommodation

and carries intraocular surgical risks.


High Myopia and Lens Extraction

In younger highly myopic patients, refractive lens exchange deserves caution because of:

Retinal detachment risk

and loss of accommodation.

Phakic IOLs are often preferable when anatomy permits.


Intrastromal Corneal Ring Segments

Corneal ring segments are not routinely used simply to correct ordinary low myopia anymore.

Their modern role is primarily in selected cases of:

  • Keratoconus
  • Corneal ectasia

to regularize corneal shape.


Follow-Up in Children

Children with significant refractive error should be monitored for:

  • Visual acuity
  • Amblyopia
  • Strabismus
  • Refractive progression

Children with progressing myopia may also benefit from:

Serial axial length measurement

when available.


Follow-Up in High Myopia

Patients with high myopia require attention to:

  • Peripheral retina
  • Macula
  • Optic nerve
  • IOP

New:

  • Flashes
  • Floaters
  • Curtain/shadow
  • Sudden visual decline

require urgent retinal evaluation.


Age-Related Changes

Myopia

Childhood myopia often progresses through:

  • School years
  • Adolescence

and may continue into early adulthood.

Progression is not guaranteed to stop at age 18.


Hyperopia

Children often undergo:

Partial emmetropization

with decreasing hyperopia during early development.

Later symptoms may increase as accommodation declines.


Astigmatism With Aging

An important correction:

The typical age-related trend is often a shift from:

With-the-rule astigmatism in younger adults → against-the-rule astigmatism in older adults

rather than increasing with-the-rule astigmatism with age.


Spectacle Intolerance

If new spectacles are not tolerated, check:

  • Prescription accuracy
  • Pupillary distance
  • Optical centers
  • Cylinder axis
  • Lens fabrication
  • Frame fit
  • Vertex distance
  • Pantoscopic tilt
  • Face-form wrap

Also compare with the patient’s:

  • Habitual prescription


Large Prescription Changes

Rapid large changes in:

  • Sphere
  • Cylinder
  • Axis

may be difficult to adapt to.

Before arbitrarily reducing the prescription, confirm:

  • Refraction accuracy
  • Ocular pathology
  • Corneal shape


Anisometropia and Spectacle Tolerance

There is no absolute rule that adults cannot tolerate more than:

2 D of anisometropia

Some patients tolerate more, while others tolerate less.

Tolerance depends on:

  • Optical magnification differences
  • Age
  • Duration
  • Binocular function
  • Lens type

Contact lenses substantially reduce spectacle-induced aniseikonia.


Prognosis

Most refractive errors can be corrected to:

Normal or near-normal visual acuity

provided there is no:

  • Amblyopia
  • Corneal disease
  • Retinal disease
  • Optic nerve disease

The major long-term concern is not refractive blur itself but associated structural disease, especially in:

High axial myopia.


Ophthalmology Pearls

  • Myopia focuses distant light in front of the retina, hyperopia behind the retina, and astigmatism produces different focal powers in different meridians.
  • Most clinically important high myopia is caused by excessive axial elongation.
  • Young hyperopes may hide substantial refractive error through accommodation, making cycloplegic refraction especially important.
  • Cycloplegic refraction is essential in children with significant hyperopia, accommodative esotropia, unexplained reduced vision, or suspected accommodative spasm.
  • Children with accommodative esotropia generally require full cycloplegic hyperopic correction initially.
  • Significant anisometropia and astigmatism in children can cause amblyopia even when neither eye has obvious structural disease.
  • Deliberately undercorrecting childhood myopia is not an evidence-based myopia-control strategy and may worsen progression.
  • Modern childhood myopia control includes low-dose atropine, orthokeratology, dual-focus/multifocal contact lenses, specialized spectacle lenses, and increased outdoor time.
  • Increasing outdoor exposure is one of the best-supported strategies for reducing the risk of myopia onset.
  • High myopia increases risk of retinal detachment, myopic maculopathy, CNV, glaucoma, cataract, and tractional macular disease.
  • High myopia and pathologic myopia are not synonymous; pathologic myopia implies structural degenerative change.
  • Hyperopia is associated with accommodative esotropia, amblyopia, and increased angle-closure risk.
  • Irregular or progressively increasing astigmatism should raise suspicion for keratoconus or corneal ectasia.
  • Astigmatism generally shifts with age from with-the-rule toward against-the-rule.
  • Rigid or scleral contact lenses are particularly useful for irregular astigmatism, because they create a regular refractive surface.
  • Modern refractive surgery candidacy cannot be defined by simple fixed diopter limits; it depends on corneal tomography, thickness, ocular surface, refractive stability, and platform-specific parameters.
  • Phakic IOLs are an important option for high refractive errors with otherwise healthy phakic eyes, particularly when corneal laser surgery is unsuitable.
  • Large anisometropia is often better tolerated with contact lenses than spectacles because contact lenses reduce magnification/minification differences.


Emmetropia In an emmetropic eye, parallel rays from a distant object focus: On the retina without accommodation. Emmetropization during childhood coordinates:  Axial growth Corneal curvature Lens power  so that refractive error tends toward a relatively narrow range.

Myopia Myopia occurs when parallel rays focus: In front of the retina with accommodation relaxed. It is corrected with: Minus lenses which diverge incoming light.

Hyperopia Hyperopia occurs when parallel rays would focus: Behind the retina with accommodation relaxed. It is corrected with: Plus lenses which converge incoming light.

Astigmatism In astigmatism, optical power differs between meridians, so light does not converge to a single point focus. Instead, two principal focal lines are formed. Astigmatism may be:  Regular Irregular

Regular Astigmatism In regular astigmatism:  The two principal meridians are approximately perpendicular  Common forms include:  With-the-rule Against-the-rule Oblique astigmatism

With-the-Rule Astigmatism The vertical meridian is relatively steeper. In minus-cylinder notation, the cylinder axis is typically near: 180°

Against-the-Rule Astigmatism The horizontal meridian is relatively steeper. In minus-cylinder notation, the cylinder axis is typically near: 90°

Oblique Astigmatism Principal meridians lie away from the usual vertical/horizontal axes, often around:  45° 135°  Oblique astigmatism may be especially noticeable symptomatically because adaptation can be more difficult.

Irregular Astigmatism In irregular astigmatism, the optical surface cannot be described adequately by two perpendicular principal meridians. Causes include:  Keratoconus Corneal scar Corneal ectasia Pterygium Post-surgical irregularity Corneal degeneration  Irregular astigmatism often cannot be fully corrected with spectacles.

Epidemiology Refractive error is one of the most common causes of reduced vision worldwide. Its prevalence varies by:  Age Ethnicity Geography Education Environmental exposure  Myopia is particularly common in:  East and Southeast Asia Urbanized populations Highly educated populations  and its prevalence has risen substantially over recent decades.

Genetics Refractive error has a strong heritable component. Myopia, hyperopia, and astigmatism are influenced by:  Multiple genes Ocular biometric traits Environmental exposures  Most common refractive error is: Polygenic and multifactorial rather than caused by a single gene.

Myopia – Pathophysiology Most clinically important myopia is: Axial myopia in which the eye is too long for its optical power. A relatively small increase in axial length can produce substantial refractive change.

Axial Length A rough clinical principle: ~1 mm of axial elongation produces approximately 2.5–3 D of myopia although the exact relationship varies. High myopia usually reflects:  Excessive axial elongation  rather than simply excessive corneal curvature.

Refractive Myopia Less commonly, myopia results from excessive optical power rather than axial elongation. Examples include:  Increased corneal curvature Lenticular myopia Nuclear sclerosis Lens swelling

Myopic Shift in Cataract Nuclear sclerosis may increase the refractive index of the lens and produce: A myopic shift sometimes called: Second sight because an older hyperopic or presbyopic patient may temporarily read without glasses again.

Myopia Risk Factors Important risk factors include:  Family history Limited outdoor time Greater near-work/educational exposure Urban environment East Asian ancestry Earlier age of onset

Outdoor Time One of the best-supported environmental protective factors against childhood myopia onset is: More time spent outdoors Outdoor exposure appears to reduce the risk of developing myopia, although it is less certain how strongly it slows progression once myopia is established.

Near Work Near work is associated with myopia development, particularly:  Prolonged uninterrupted near tasks Very short working distance  The relationship is weaker than the protective effect of outdoor time.

Hyperopia – Pathophysiology Hyperopia is commonly caused by: Axial length that is too short for the optical power of the eye Other contributors include:  Flat cornea Reduced lens power Aphakia

Accommodation and Hyperopia Young hyperopes may compensate using: Accommodation Therefore they may have:  Clear distance vision Clear near vision No symptoms  despite measurable hyperopia.

Manifest Hyperopia The portion of hyperopia detected without cycloplegia is: Manifest hyperopia

Latent Hyperopia Additional hyperopia uncovered after cycloplegia is: Latent hyperopia It is particularly important in:  Children Young adults Accommodative esotropia

Total Hyperopia Total hyperopia is approximately: Manifest + latent hyperopia and is best estimated with adequate cycloplegia.

Hyperopia and Age Hyperopia itself does not necessarily increase dramatically with age, but symptoms often worsen because: Accommodation progressively decreases As presbyopia develops, previously compensated hyperopia becomes clinically apparent.

Hyperopia and Angle Closure Hyperopic eyes often have:  Shorter axial length Shallower anterior chamber Narrower angles  and therefore have increased risk for: Primary angle-closure disease especially with aging.

Astigmatism – Optical Basis Astigmatism may arise from:  Cornea Crystalline lens Posterior corneal surface  The anterior cornea contributes most of the clinically measured astigmatism.

Corneal vs Refractive Astigmatism Keratometry measures primarily: Anterior corneal curvature whereas manifest refraction measures: Total refractive astigmatism which includes:  Anterior cornea Posterior cornea Lens  This difference is important in:  Toric IOL planning Refractive surgery Contact lens fitting

Symptoms Symptoms depend on:  Magnitude Type of refractive error Age Accommodation Visual demand

Myopia Symptoms Typical complaints include:  Blurred distance vision Squinting Sitting close to television or screen Difficulty seeing classroom board or road signs  Near vision may remain clear without correction.

Hyperopia Symptoms Possible symptoms include:  Near blur Eyestrain Frontal headache Fatigue with reading Intermittent blur Difficulty sustaining near work  Young patients may remain asymptomatic because of accommodation.

Astigmatism Symptoms Symptoms may include:  Blur at distance and near Ghosting Distortion Headache Eyestrain Difficulty with fine detail Night-driving glare

Asthenopia Refractive error may contribute to: Asthenopia including:  Frontal headache Eye fatigue Brow ache Difficulty sustaining near work  However, headache should not automatically be attributed to refractive error without appropriate clinical evaluation.

Pediatric Importance Uncorrected significant refractive error can cause: Amblyopia particularly:  High bilateral ametropia Anisometropia High astigmatism Hyperopia associated with esotropia

Anisometropia Anisometropia is unequal refractive error between the two eyes. It may cause:  Unequal retinal image quality Suppression Amblyopia Reduced stereopsis  in children.

Aniseikonia Spectacle correction of large anisometropia can produce different retinal image sizes: Aniseikonia This may cause:  Eyestrain Diplopia Reduced stereopsis Poor spectacle tolerance  Contact lenses often reduce this problem.

Accommodative Esotropia Significant hyperopia may cause excessive accommodative effort. Because accommodation is linked to convergence: Accommodation → convergence some children develop: Accommodative esotropia

Hyperopic Correction in Accommodative Esotropia Children with accommodative esotropia generally receive: Full cycloplegic hyperopic correction initially to reduce accommodative convergence.

Diagnosis Diagnosis requires measurement of refractive state and assessment of ocular health. Core components include:  Distance visual acuity Near visual acuity Pinhole acuity Objective refraction Subjective refraction Cycloplegic refraction when indicated

Pinhole Test Improvement in visual acuity through a pinhole suggests that decreased vision is at least partly: Optical/refractive because the pinhole reduces the blur circle. However, lack of pinhole improvement does not completely exclude refractive error.

Objective Refraction Objective techniques include:  Retinoscopy Autorefraction  These provide a starting estimate without requiring subjective responses.

Retinoscopy Retinoscopy is especially valuable in:  Children Nonverbal patients Developmental delay Poor subjective responders Irregular reflexes  It remains a fundamental method for objective refraction.

Autorefraction Autorefraction is useful for:  Rapid screening Starting subjective refraction  but should generally not replace: Clinical refinement especially in:  Young patients High accommodation Irregular corneas

Manifest Refraction Manifest refraction is performed without cycloplegia. It reflects the patient’s functional refractive state but can be influenced by: Accommodation Young patients may be:  Over-minused Under-plussed  if accommodation is not controlled.

Cycloplegic Refraction Cycloplegic refraction temporarily eliminates accommodation. It is particularly important in:  Children Suspected hyperopia Accommodative esotropia Unexplained reduced vision Suspected accommodative spasm Large discrepancy between objective and subjective refraction

Cycloplegic Agents Common agents include:  Cyclopentolate Tropicamide in selected situations Atropine for stronger/prolonged cycloplegia when clinically required  Cyclopentolate is commonly used for routine pediatric cycloplegic refraction.

Important Modern Correction There is no universal rule that a fixed amount such as: −0.25 D must automatically be added after every cycloplegic refraction. Final prescribing should be based on:  Age Symptoms Alignment Accommodation Visual acuity Refractive findings

Keratometry Keratometry measures:  Central corneal curvature  and estimates:  Corneal astigmatism  It is useful for:  Contact lenses Cataract surgery Toric IOL planning Corneal disease screening

Corneal Topography and Tomography These are important when astigmatism is:  High Irregular Progressive Asymmetric  They help diagnose:  Keratoconus Corneal ectasia Pellucid marginal degeneration Post-surgical ectasia

Jackson Cross Cylinder The JCC is used during subjective refraction to refine:  Cylinder axis Cylinder power  It is particularly useful in regular astigmatism.

Spherical Equivalent The spherical equivalent is: Sphere + ½ cylinder It is useful for:  Comparing prescriptions Research Some prescribing adjustments  but does not fully describe the optical effect of astigmatism.

Treatment Principles Refractive error can be corrected with:  Spectacles Contact lenses Refractive surgery Intraocular lens-based procedures  Choice depends on:  Age Refractive magnitude Corneal anatomy Ocular health Lifestyle Patient preference

Spectacles Spectacles are: The simplest and safest form of optical correction and can correct:  Myopia Hyperopia Regular astigmatism Presbyopia

Correcting Myopia A practical goal is: Full or appropriate distance correction without unnecessary over-minus Over-minus can:  Stimulate accommodation Cause eyestrain Distort binocular balance  especially in young patients.

Myopic Undercorrection An important modern correction: Deliberately undercorrecting childhood myopia does not prevent progression and may worsen progression in some patients. Children should generally receive: Appropriate full distance correction unless there is a specific clinical reason not to.

Correcting Hyperopia Correction depends on:  Age Symptoms Magnitude Accommodation Binocular alignment Presence of amblyopia  Asymptomatic low hyperopia in a young patient may not require full correction.

Hyperopia in Children Full or near-full correction is especially important when there is:  Accommodative esotropia Amblyopia Significant high hyperopia Reduced visual function

Correcting Astigmatism Significant astigmatism should be corrected in children to prevent: Meridional amblyopia Children generally adapt better than adults to:  Large cylinder corrections Changes in axis

Adult Astigmatic Adaptation Adults receiving a new large cylinder or major axis change may experience:  Floor tilt Spatial distortion Dizziness Headache  Gradual adaptation often occurs over:  Days to weeks  Large unnecessary reductions in accurate cylinder should not be routine, but modification may occasionally improve tolerance.

Contact Lenses Contact lenses can correct:  Myopia Hyperopia Astigmatism Anisometropia  Advantages include:  Wider visual field Less spectacle magnification/minification Better optical quality in high refractive error

Contact Lenses in High Myopia Compared with spectacles, contact lenses reduce:  Minification Peripheral distortion Prism effects  and may provide better visual quality.

Contact Lenses in High Hyperopia Contact lenses reduce:  Spectacle magnification Ring scotoma Peripheral distortion  and may be especially beneficial in:  Aphakia High anisometropia

Toric Contact Lenses Regular astigmatism may be corrected with:  Soft toric lenses Rigid gas-permeable lenses

Rigid Lenses for Irregular Astigmatism Rigid gas-permeable or scleral lenses may provide major improvement in:  Keratoconus Corneal scars Irregular astigmatism  by creating a more regular anterior refractive surface.

Myopia Control in Children A major modern development is active treatment to slow: Childhood myopia progression and axial elongation. This is particularly important because higher lifetime myopia increases risk of:  Retinal detachment Myopic maculopathy Glaucoma Cataract

Myopia-Control Options Evidence-based options include:  Low-dose atropine Orthokeratology Dual-focus/multifocal soft contact lenses Specialized myopia-control spectacle lenses Increased outdoor time  The most appropriate strategy depends on:  Age Rate of progression Axial length Refractive error Patient preference Local availability

Low-Dose Atropine Low-concentration atropine may slow myopia progression. Commonly studied concentrations include:  0.01% 0.025% 0.05%  Higher low-dose concentrations tend to have:  Greater efficacy More photophobia More near blur  Exact concentration should be individualized.

Orthokeratology Orthokeratology uses overnight rigid lenses to temporarily flatten central cornea. It can:  Correct daytime myopia Slow axial elongation in many children  Risks include:  Microbial keratitis Corneal staining Lens-related complications  Strict hygiene is essential.

Multifocal / Dual-Focus Contact Lenses Specialized soft contact lenses can create:  Central distance correction Peripheral or simultaneous myopic defocus  and can reduce myopia progression in selected children.

Myopia-Control Spectacle Lenses Newer designs use peripheral optical strategies to create myopic defocus while maintaining central clarity. These can slow:  Refractive progression Axial elongation  without contact lens risks.

Outdoor Time Recommendation For children, encouraging approximately: 2 hours or more outdoors daily when practical is commonly recommended as part of myopia prevention strategies. This should complement—not replace—optical or pharmacologic treatment in progressing myopia.

High Myopia Definitions vary, but high myopia is commonly considered approximately: ≤ −6.00 D and/or excessive axial elongation. The important distinction is whether there is associated structural damage.

Pathologic Myopia Pathologic myopia refers to myopia associated with degenerative structural changes such as:  Posterior staphyloma Myopic maculopathy Lacquer cracks Patchy/chorioretinal atrophy Myopic CNV  High refractive error alone does not automatically equal pathologic myopia.

Complications of High Myopia High axial myopia increases risk of:  Retinal tear/detachment Posterior vitreous detachment Lattice degeneration Myopic macular degeneration Myopic CNV Foveoschisis Macular hole Open-angle glaucoma Earlier cataract

Hyperopia Complications Significant hyperopia is associated with:  Accommodative esotropia Amblyopia Anisometropia Narrow angles Angle-closure disease

Astigmatism Complications Astigmatism itself does not cause keratoconus. Instead: Increasing or irregular astigmatism may be a sign of keratoconus. This distinction is important.

Keratoconus Red Flags Consider corneal tomography when there is:  Increasing cylinder New oblique astigmatism Reduced BCVA despite refraction Scissoring retinoscopic reflex Progressive asymmetry Family history of keratoconus Frequent eye rubbing

Refractive Surgery Corneal refractive surgery can correct selected cases of:  Myopia Hyperopia Astigmatism  Options include:  LASIK PRK SMILE for selected refractive ranges Other laser platforms depending on region

LASIK LASIK reshapes the corneal stroma using an excimer laser beneath a flap. Advantages:  Rapid visual recovery Minimal discomfort  Potential complications include:  Dry eye Flap complications Ectasia Night-vision symptoms Residual refractive error

PRK PRK removes corneal epithelium before stromal ablation. Advantages:  No flap May be preferred with thinner corneas or certain occupational considerations  Disadvantages:  More postoperative discomfort Slower recovery Haze risk

SMILE Small-incision lenticule extraction is primarily used for:  Myopia Myopic astigmatism  depending on regulatory approval and platform. Potential advantages include:  No large corneal flap Less early corneal nerve disruption than LASIK in some cases

Refractive Surgery Limits Older fixed rules such as:  “LASIK corrects up to 10 D myopia” “6 D hyperopia” “4 D astigmatism”  are oversimplified. Eligibility depends on:  Corneal thickness Tomography Optical zone Residual stromal bed Age Stability Dry eye Pupil size Device approval

Phakic Intraocular Lens Phakic IOLs are useful for selected patients with:  High myopia Thin corneas Refractive errors outside comfortable laser ranges  Advantages include:  Excellent optical quality Preservation of accommodation  Potential risks include:  Cataract Endothelial cell loss IOP elevation Intraocular inflammation Infection

Clear Lens Extraction Refractive lens exchange may be considered in selected adults with:  Very high hyperopia Presbyopia Lens-related anatomy unsuitable for corneal surgery  However, it sacrifices: Natural accommodation and carries intraocular surgical risks.

High Myopia and Lens Extraction In younger highly myopic patients, refractive lens exchange deserves caution because of: Retinal detachment risk and loss of accommodation. Phakic IOLs are often preferable when anatomy permits.

Intrastromal Corneal Ring Segments Corneal ring segments are not routinely used simply to correct ordinary low myopia anymore. Their modern role is primarily in selected cases of:  Keratoconus Corneal ectasia  to regularize corneal shape.

Follow-Up in Children Children with significant refractive error should be monitored for:  Visual acuity Amblyopia Strabismus Refractive progression  Children with progressing myopia may also benefit from: Serial axial length measurement when available.

Follow-Up in High Myopia Patients with high myopia require attention to:  Peripheral retina Macula Optic nerve IOP  New:  Flashes Floaters Curtain/shadow Sudden visual decline  require urgent retinal evaluation.

Age-Related Changes Myopia Childhood myopia often progresses through:  School years Adolescence  and may continue into early adulthood. Progression is not guaranteed to stop at age 18.

Hyperopia Children often undergo: Partial emmetropization with decreasing hyperopia during early development. Later symptoms may increase as accommodation declines.

Astigmatism With Aging An important correction: The typical age-related trend is often a shift from: With-the-rule astigmatism in younger adults → against-the-rule astigmatism in older adults rather than increasing with-the-rule astigmatism with age.

Spectacle Intolerance If new spectacles are not tolerated, check:  Prescription accuracy Pupillary distance Optical centers Cylinder axis Lens fabrication Frame fit Vertex distance Pantoscopic tilt Face-form wrap  Also compare with the patient’s:  Habitual prescription

Large Prescription Changes Rapid large changes in:  Sphere Cylinder Axis  may be difficult to adapt to. Before arbitrarily reducing the prescription, confirm:  Refraction accuracy Ocular pathology Corneal shape

Anisometropia and Spectacle Tolerance There is no absolute rule that adults cannot tolerate more than: 2 D of anisometropia Some patients tolerate more, while others tolerate less. Tolerance depends on:  Optical magnification differences Age Duration Binocular function Lens type  Contact lenses substantially reduce spectacle-induced aniseikonia.

Prognosis Most refractive errors can be corrected to: Normal or near-normal visual acuity provided there is no:  Amblyopia Corneal disease Retinal disease Optic nerve disease  The major long-term concern is not refractive blur itself but associated structural disease, especially in: High axial myopia.

Ophthalmology Pearls  Myopia focuses distant light in front of the retina, hyperopia behind the retina, and astigmatism produces different focal powers in different meridians. Most clinically important high myopia is caused by excessive axial elongation. Young hyperopes may hide substantial refractive error through accommodation, making cycloplegic refraction especially important. Cycloplegic refraction is essential in children with significant hyperopia, accommodative esotropia, unexplained reduced vision, or suspected accommodative spasm. Children with accommodative esotropia generally require full cycloplegic hyperopic correction initially. Significant anisometropia and astigmatism in children can cause amblyopia even when neither eye has obvious structural disease. Deliberately undercorrecting childhood myopia is not an evidence-based myopia-control strategy and may worsen progression. Modern childhood myopia control includes low-dose atropine, orthokeratology, dual-focus/multifocal contact lenses, specialized spectacle lenses, and increased outdoor time. Increasing outdoor exposure is one of the best-supported strategies for reducing the risk of myopia onset. High myopia increases risk of retinal detachment, myopic maculopathy, CNV, glaucoma, cataract, and tractional macular disease. High myopia and pathologic myopia are not synonymous; pathologic myopia implies structural degenerative change. Hyperopia is associated with accommodative esotropia, amblyopia, and increased angle-closure risk. Irregular or progressively increasing astigmatism should raise suspicion for keratoconus or corneal ectasia. Astigmatism generally shifts with age from with-the-rule toward against-the-rule. Rigid or scleral contact lenses are particularly useful for irregular astigmatism, because they create a regular refractive surface. Modern refractive surgery candidacy cannot be defined by simple fixed diopter limits; it depends on corneal tomography, thickness, ocular surface, refractive stability, and platform-specific parameters. Phakic IOLs are an important option for high refractive errors with otherwise healthy phakic eyes, particularly when corneal laser surgery is unsuitable. Large anisometropia is often better tolerated with contact lenses than spectacles because contact lenses reduce magnification/minification differences.

Image description
Published on

Ophthalmology – Recurrent Corneal Erosion Syndrome

Basics

Description

Recurrent corneal erosion syndrome (RCES) is characterized by repeated episodes of spontaneous breakdown of corneal epithelium caused by abnormal epithelial adhesion to the underlying basement membrane/Bowman layer.

The classic presentation is:

Sudden severe unilateral eye pain on awakening or with the first eye opening in the morning

associated with:

  • Tearing
  • Photophobia
  • Foreign-body sensation
  • Redness
  • Blurred vision

RCES may be:

  • Traumatic
  • Associated with epithelial basement membrane dystrophy (EBMD)
  • Less commonly associated with other corneal dystrophies or ocular-surface disorders


Key Clinical Concept

The fundamental abnormality is:

Failure of the corneal epithelium to form stable adhesion complexes with the underlying basement membrane

During sleep:

  • Tear production falls
  • Eyelid and corneal epithelium become relatively adherent
  • Sudden lid opening creates shearing force

resulting in:

Avulsion of poorly adherent epithelium


Epidemiology

The true incidence is unknown because:

  • Mild episodes may never reach medical attention
  • Symptoms may be misdiagnosed as dry eye or abrasion

RCES typically affects:

  • Young to middle-aged adults

It is usually:

  • Unilateral after trauma
  • More likely bilateral when associated with EBMD


Etiology

The two major causes are:

  1. Previous corneal trauma
  2. Epithelial basement membrane dystrophy


Traumatic RCES

Previous trauma is one of the most common causes.

Typical injuries include:

  • Fingernail scratch
  • Paper edge
  • Tree branch
  • Leaf
  • Other organic material

The original injury may have occurred:

Weeks, months, or even years earlier

and the patient may initially forget it.

Traumatic erosions usually recur:

At the same corneal location.


Epithelial Basement Membrane Dystrophy

EBMD, also called:

  • Map-dot-fingerprint dystrophy
  • Anterior basement membrane dystrophy

is the most common corneal dystrophy associated with RCES.

Characteristic findings include:

  • Map-like lines
  • Dot-like epithelial microcysts
  • Fingerprint lines
  • Negative fluorescein staining
  • Loose epithelium

EBMD is often:

  • Bilateral
  • Asymmetric


Other Corneal Dystrophies

RCES may occasionally occur with:

  • Reis-Bücklers corneal dystrophy
  • Thiel-Behnke corneal dystrophy
  • Lattice corneal dystrophy
  • Granular corneal dystrophy
  • Meesmann epithelial corneal dystrophy


Risk Factors

Factors associated with RCES include:

  • Previous corneal trauma
  • EBMD
  • Dry eye disease
  • Meibomian gland dysfunction
  • Blepharitis
  • Ocular rosacea
  • Diabetes mellitus
  • Nocturnal lagophthalmos
  • Prior corneal refractive surgery
  • Exposure keratopathy


Pathophysiology

Normal corneal epithelium adheres to the underlying basement membrane through:

  • Hemidesmosomes
  • Anchoring filaments
  • Anchoring fibrils

In RCES these structures may be:

  • Reduced
  • Abnormal
  • Poorly organized

resulting in unstable epithelial attachment.


Basement Membrane Abnormality

In EBMD, abnormal basement membrane may extend:

Anteriorly into the epithelial layer

and trap epithelial cells.

This produces:

  • Microcysts
  • Maps
  • Fingerprint lines
  • Poor epithelial adhesion


Matrix Metalloproteinases

Increased activity of:

  • MMP-2
  • MMP-9

has been implicated in degradation of epithelial adhesion structures.

This provides the rationale for using:

Oral tetracyclines such as doxycycline

in selected recurrent or refractory cases.


Why Episodes Occur on Awakening

During sleep:

  • Tear secretion decreases
  • The ocular surface becomes relatively dry
  • The upper lid may adhere to unstable corneal epithelium

When the patient opens the eye:

The lid pulls the weakly attached epithelium away from Bowman membrane

causing abrupt pain and epithelial breakdown.


Clinical Presentation

Symptoms include:

  • Severe sharp pain
  • Foreign-body sensation
  • Tearing
  • Photophobia
  • Redness
  • Blepharospasm
  • Blurred vision

Episodes may last:

  • Minutes
  • Hours
  • Occasionally several days


Characteristic History

The classic patient reports:

“My eye is extremely painful when I first open it in the morning.”

The recurrent nature and morning timing are highly suggestive.


Frequency

Episodes may occur:

  • Rarely
  • Every few months
  • Weekly
  • Repeatedly within short periods

The severity may vary substantially between episodes.


Examination During an Acute Episode

Findings may include:

  • Conjunctival injection
  • Lid edema
  • Tearing
  • Blepharospasm
  • Reduced visual acuity

Corneal findings range from subtle epithelial irregularity to a large epithelial defect.


Microform Erosion

A microform erosion may show:

  • Punctate epithelial disturbance
  • Small area of fluorescein staining
  • Loose or irregular epithelium

Symptoms may nevertheless be severe.


Macroform Erosion

A macroform erosion causes:

  • Large epithelial defect
  • Positive fluorescein staining
  • Loose surrounding epithelium
  • Occasionally an epithelial flap or tag


Negative Fluorescein Staining

An important sign is:

Negative fluorescein staining

This occurs when elevated or abnormal epithelium disrupts the normal tear film, producing a dark area against surrounding fluorescent tear film.

It may identify:

  • EBMD
  • Loose epithelium
  • Microcysts

The abnormal epithelial area may extend well beyond the obvious positive-staining defect.


Slit-Lamp Examination Between Episodes

The cornea may appear:

Almost normal

between attacks.

Careful examination should look for:

  • Map lines
  • Fingerprint lines
  • Epithelial dots
  • Microcysts
  • Subtle loose epithelium

Use:

  • Retroillumination
  • Oblique illumination
  • Broad-beam fluorescein examination


Location

Traumatic RCES typically recurs at:

The original injury site

EBMD-related erosions may occur at:

  • Different corneal locations
  • Either eye

The lower central cornea is commonly involved.


Diagnosis

Diagnosis is primarily:

Clinical

based on:

  • Typical history
  • Recurrent morning pain
  • Slit-lamp evidence of unstable epithelium
  • Previous trauma or EBMD

Routine laboratory or imaging studies are not required.


Corneal Sensation

Check corneal sensation when the course is atypical.

Reduced sensation raises concern for:

  • Herpes simplex keratitis
  • Neurotrophic keratopathy
  • Trigeminal dysfunction


Anterior Segment OCT

AS-OCT is not routinely required.

It may occasionally help demonstrate:

  • Irregular epithelium
  • Basement membrane abnormalities

but diagnosis remains clinical.


In Vivo Confocal Microscopy

Confocal microscopy may demonstrate:

  • Epithelial microcysts
  • Abnormal basement membrane
  • Altered subbasal nerves
  • Anterior stromal changes

However:

These findings are not sufficiently specific to diagnose RCES routinely.


Differential Diagnosis

Important differentials include:

  • Acute corneal abrasion
  • Herpes simplex epithelial keratitis
  • Infectious keratitis
  • Dry eye disease
  • Exposure keratopathy
  • Neurotrophic keratopathy
  • Meesmann dystrophy
  • Bullous keratopathy
  • Band keratopathy
  • Salzmann nodular degeneration
  • Trichiasis
  • Subtarsal foreign body
  • Recurrent foreign-body exposure
  • Contact lens-related epithelial disease


RCES vs Herpes Simplex Keratitis

HSV epithelial keratitis may produce:

  • Recurrent pain/redness
  • Dendritic epithelial ulcer
  • Reduced corneal sensation

RCES usually produces:

  • Mechanical epithelial defect
  • No true dendritic branching pattern
  • Normal sensation unless another disorder coexists

Steroids should not be started casually if HSV is possible.


RCES vs Infectious Keratitis

Infectious keratitis is suggested by:

  • Stromal infiltrate
  • Purulent discharge
  • Significant anterior chamber reaction
  • Progressive focal ulceration
  • Contact lens-related risk

A simple epithelial defect without infiltrate favors RCES.


Treatment Principles

Management has two goals:

  1. Heal the acute epithelial defect
  2. Prevent recurrence by improving epithelial adhesion

Treatment progresses from:

  • Conservative therapy

to:

  • Bandage contact lens

to:

  • Procedural treatment for refractory disease


Acute Episode – Lubrication

Initial therapy usually includes:

  • Frequent preservative-free artificial tears
  • Lubricating ointment

Ointment is particularly useful:

At bedtime

to reduce friction during eyelid opening.


Hypertonic Saline

Hypertonic sodium chloride may improve epithelial adhesion by reducing epithelial edema.

Options include:

  • Hypertonic drops during daytime
  • 5% sodium chloride ointment at bedtime

It is commonly continued for:

Several months after the acute erosion heals

in recurrent disease.


Analgesia

Pain management may include:

  • Oral acetaminophen
  • Oral NSAIDs when appropriate
  • Cycloplegic drops for significant photophobia or ciliary spasm


Topical Anesthetic Warning

Topical anesthetic may be used during examination but should generally:

Never be supplied for repeated unsupervised home use

because abuse can cause:

  • Severe epithelial toxicity
  • Nonhealing ulceration
  • Stromal melt
  • Infection


Topical Antibiotics

When a significant epithelial defect is present, a topical antibiotic may be used until re-epithelialization.

Common choices include:

  • Antibiotic ointment
  • Preservative-free antibiotic drops when appropriate

The purpose is:

Secondary infection prevention, not treatment of the underlying RCES.


Eye Patching

Routine pressure patching is:

No longer generally recommended

for RCES or uncomplicated corneal abrasions.

It provides little proven benefit and can:

  • Delay assessment
  • Increase infection concerns


Long-Term Lubrication

After epithelial healing, preventive therapy often consists of:

  • Preservative-free tears during the day
  • Lubricating or hypertonic ointment before sleep

for weeks to months.

This is first-line prevention for mild disease.


Treat Associated Ocular Surface Disease

Correct contributing factors such as:

  • Blepharitis
  • Meibomian gland dysfunction
  • Dry eye
  • Ocular rosacea
  • Nocturnal lagophthalmos

This may substantially reduce recurrence.


Eyelid Hygiene

For associated MGD/blepharitis:

  • Warm compresses
  • Lid hygiene

may improve tear-film quality and reduce epithelial stress.


Bandage Contact Lens

For recurrent disease not controlled by lubrication, a:

Bandage soft contact lens (BCL)

may protect the epithelium from eyelid shear while adhesion complexes reform.

It may be used for:

  • Several weeks

depending on severity and response.


BCL Advantages

A bandage lens can:

  • Reduce pain
  • Protect epithelium
  • Promote healing
  • Reduce mechanical trauma during blinking


BCL Safety

Because extended lens wear increases risk of:

Microbial keratitis

patients require:

  • Close follow-up
  • Strict hygiene
  • Appropriate topical antibiotic prophylaxis while a significant epithelial defect is present or according to specialist protocol

Patients should return urgently for:

  • Increased pain
  • Increasing redness
  • Discharge
  • Reduced vision


Doxycycline

Oral doxycycline can be useful in recurrent or refractory RCES, particularly with:

  • MGD
  • Rosacea
  • Chronic inflammation

Its benefit may reflect:

  • MMP inhibition
  • Anti-inflammatory action

rather than simply antimicrobial activity.


Doxycycline + Topical Steroid

A commonly used approach in recalcitrant RCES is:

Oral doxycycline + a short course of topical corticosteroid

to suppress:

  • MMP activity
  • Ocular surface inflammation

This is especially useful in patients with:

  • MGD
  • Rosacea

Treatment should be supervised because topical steroids can:

  • Raise IOP
  • Delay epithelial healing
  • Worsen infection or HSV


Tetracycline Precautions

Doxycycline is generally avoided in:

  • Pregnancy
  • Patients with important tetracycline contraindications

Pediatric use depends on:

  • Age
  • Dose
  • Clinical context


Autologous Serum Tears

For difficult recurrent disease, autologous serum tears may provide:

  • Lubrication
  • Growth factors
  • Epitheliotrophic support

They can be useful in:

  • Refractory epithelial instability
  • Persistent epithelial defects


When to Consider a Procedure

Procedural treatment is appropriate when:

  • Frequent recurrences persist despite lubrication
  • BCL therapy fails
  • Symptoms are severe
  • Quality of life is significantly affected

Choice depends strongly on whether the abnormal epithelium is:

  • Central
  • Peripheral


Epithelial Debridement

Loose epithelium may be mechanically removed.

Simple debridement alone can relieve an acute episode, but:

Recurrence rates are relatively high if the abnormal basement membrane is not also treated.

Therefore it is often combined with:

  • Diamond-burr polishing
  • Other adhesion-promoting procedures


Diamond-Burr Superficial Keratectomy

Epithelial debridement with diamond-burr polishing of Bowman layer is one of the most effective procedures for recurrent RCES, particularly when:

  • EBMD is present
  • Lesions involve the visual axis

The procedure:

  • Removes loose epithelium
  • Smooths abnormal basement membrane/Bowman surface
  • Promotes formation of stronger adhesion complexes


Diamond-Burr Advantages

Advantages include:

  • High success rate
  • Relatively low recurrence
  • Can be used for central disease

Potential complications include:

  • Transient haze
  • Pain during healing
  • Infection
  • Refractive change


Anterior Stromal Puncture

Anterior stromal puncture (ASP) creates small scars that anchor epithelium more firmly to Bowman layer/anterior stroma.

It is best suited for:

Peripheral erosions outside the visual axis.


Why ASP Is Avoided Centrally

ASP can produce:

  • Permanent punctate stromal scars
  • Glare
  • Reduced visual quality

Therefore it should generally:

Not be performed over the central visual axis.


Phototherapeutic Keratectomy

Phototherapeutic keratectomy (PTK) uses an excimer laser to remove abnormal:

  • Epithelium
  • Superficial Bowman layer

It is particularly useful for:

  • Central recurrent erosions
  • EBMD
  • Disease refractory to simpler procedures


PTK Advantages

PTK provides:

  • Precise superficial ablation
  • Smooth optical surface
  • Good recurrence control


PTK Risks

Potential complications include:

  • Corneal haze
  • Hyperopic shift
  • Astigmatic change
  • Recurrence
  • Rare infection

The refractive effect depends on:

  • Ablation depth
  • Treatment diameter


Alcohol Delamination

Alcohol delamination uses dilute ethanol to loosen and remove abnormal epithelium.

It may:

  • Remove diseased epithelium cleanly
  • Allow regeneration of a more normal epithelial basement membrane

It remains a reasonable option in selected specialist practice, although diamond-burr polishing and PTK are more commonly emphasized in many modern treatment algorithms.


Post-Procedural Care

After debridement, diamond burr, PTK, or alcohol delamination:

  • Bandage contact lens
  • Topical antibiotic
  • Preservative-free lubrication

are commonly used until epithelial healing.

A topical steroid may be used selectively after epithelial closure depending on:

  • Procedure
  • Haze
  • Inflammation


Nocturnal Lagophthalmos

If episodes are associated with incomplete eyelid closure during sleep, management may include:

  • Nighttime ointment
  • Moisture chamber
  • Eyelid taping in selected cases
  • Treatment of underlying exposure disease


Prevention

Protective eyewear should be used for activities with risk of:

  • Fingernail injury
  • Plant/branch trauma
  • Occupational debris

Prevention of the original epithelial injury can reduce traumatic RCES.


Follow-Up

During an acute large erosion, follow-up depends on:

  • Defect size
  • Pain
  • Infection risk
  • BCL use

Patients with a bandage contact lens or large defect often require review within:

24–48 hours

initially.


Long-Term Monitoring

Monitor for:

  • Recurrence frequency
  • Epithelial healing
  • Stromal haze
  • Infection
  • Underlying EBMD
  • Dry eye/MGD

Treatment response can be assessed by documenting:

  • Frequency of attacks
  • Duration
  • Severity


Prognosis

The overall prognosis is:

Very good

Most patients eventually achieve substantial reduction or complete cessation of episodes with:

  • Lubrication
  • Ocular surface optimization
  • BCL
  • Procedural therapy when necessary


Recurrence

Recurrence remains possible after any treatment, particularly with:

  • Diffuse EBMD
  • Persistent dry eye
  • MGD
  • Continued ocular surface trauma

Repeat treatment is occasionally necessary.


Complications

Potential complications include:

  • Infectious keratitis
  • Corneal stromal haze
  • Corneal scar
  • Persistent epithelial defect
  • Reduced vision
  • Rare stromal thinning

The risk of infectious keratitis is increased with:

  • Bandage contact lens use
  • Topical steroid misuse
  • Poor follow-up


Ophthalmology Pearls

  • RCES causes recurrent breakdown of poorly adherent corneal epithelium, classically producing severe pain when the eye is first opened after sleep.
  • The two major causes are previous corneal trauma and epithelial basement membrane dystrophy (EBMD).
  • Traumatic erosions usually recur at the same site, whereas EBMD-related erosions may occur at multiple sites and may be bilateral.
  • Look carefully for map-dot-fingerprint changes, microcysts, loose epithelium, and negative fluorescein staining.
  • RCES results from abnormal epithelial adhesion involving hemidesmosomes, basement membrane, and anchoring fibrils.
  • Increased MMP-2 and MMP-9 activity provides a rationale for doxycycline therapy in selected refractory cases.
  • First-line prevention is preservative-free lubrication with nighttime ointment, often supplemented by hypertonic sodium chloride.
  • Routine pressure patching is not generally recommended.
  • Never provide topical anesthetic drops for repeated unsupervised home use because abuse can cause severe toxic keratopathy and corneal melt.
  • A bandage contact lens can be highly effective for persistent disease but requires close follow-up because of microbial keratitis risk.
  • Doxycycline plus a short topical steroid course can be useful in recalcitrant RCES, especially when MGD or rosacea is present.
  • For persistent disease, diamond-burr superficial keratectomy is highly effective and can be used for central EBMD-related erosions.
  • Anterior stromal puncture is best reserved for peripheral lesions outside the visual axis because it leaves small scars.
  • PTK is an effective option for central or refractory disease but may cause haze or refractive shift.
  • Simple epithelial debridement alone has a higher recurrence rate than procedures that also address the abnormal basement membrane/Bowman surface.
  • Always reconsider HSV keratitis or infectious keratitis when an erosion behaves atypically or fails to heal as expected.
  • Most patients ultimately achieve excellent symptom control with appropriately escalated therapy.


Image description
Published on

Ophthalmology – Radiation Retinopathy

Basics

Description

Radiation retinopathy is a delayed, progressive occlusive retinal microangiopathy caused by previous therapeutic radiation involving the eye, orbit, or adjacent head and neck structures.

It may follow:

  • Plaque brachytherapy
  • Proton-beam therapy
  • External-beam radiotherapy
  • Stereotactic radiotherapy
  • Other radiation delivered sufficiently close to the retina

The disorder resembles diabetic retinopathy because radiation damages the retinal capillary circulation, producing:

  • Microaneurysms
  • Retinal hemorrhages
  • Cotton-wool spots
  • Capillary nonperfusion
  • Radiation macular edema
  • Retinal neovascularization
  • Vitreous hemorrhage
  • Neovascular glaucoma

The major cause of vision loss is usually:

Radiation maculopathy with macular edema and/or macular ischemia.


Clinical Importance

Radiation retinopathy may remain asymptomatic until:

  • Macular edema develops
  • Macular ischemia becomes significant
  • Neovascular complications occur

Modern management is centered largely on:

Intravitreal anti-VEGF therapy

for radiation maculopathy and retinal neovascularization.

This is a major change from older treatment paradigms that relied primarily on focal/grid laser.


Terminology

Radiation Retinopathy

Refers broadly to radiation-induced retinal microvascular disease.

Radiation Maculopathy

Refers specifically to radiation-induced vascular injury involving the macula, often causing:

  • Macular edema
  • Ischemia
  • Hemorrhage
  • Exudation

Radiation maculopathy is the most common vision-threatening manifestation.


Epidemiology

Incidence depends on:

  • Total radiation dose
  • Dose per fraction
  • Radiation modality
  • Volume of retina exposed
  • Macular dose
  • Optic disc dose
  • Follow-up duration
  • Patient vascular risk factors

Because onset may be delayed by years, prevalence increases with longer follow-up.


Latency

Radiation retinopathy generally appears:

Months to years after treatment

A common interval is approximately:

1–3 years

but onset may be:

  • Earlier after high-dose exposure
  • Delayed for many years

Therefore a remote history of ocular or orbital radiotherapy remains clinically relevant.


Risk Factors

Important risk factors include:

  • Higher retinal radiation dose
  • Larger dose per fraction
  • Greater macular exposure
  • Greater optic disc exposure
  • Larger irradiated retinal volume
  • Diabetes mellitus
  • Hypertension
  • Concurrent chemotherapy
  • Preexisting retinal vascular disease
  • Previous vascular compromise


Diabetes

Diabetes substantially increases susceptibility because both:

  • Diabetes
  • Radiation

damage the retinal microcirculation.

Patients with diabetes may develop:

  • Earlier disease
  • More severe macular edema
  • More extensive ischemia

after a comparable radiation exposure.


Radiation Dose

With conventional fractionated radiotherapy, retinal toxicity becomes increasingly likely as cumulative retinal dose rises, particularly beyond approximately:

45–50 Gy

Risk is also influenced heavily by:

  • Fraction size
  • Exact retinal volume irradiated

There is no single completely “safe” retinal dose.


Brachytherapy

Radiation retinopathy is an important delayed complication of plaque treatment for:

  • Choroidal melanoma
  • Other selected intraocular tumors

Risk increases when the tumor lies close to:

  • Fovea
  • Optic disc

because these structures receive higher radiation doses.


Pathophysiology

Radiation causes:

Direct DNA injury + free-radical formation + microvascular endothelial damage

The retinal capillary endothelium is particularly vulnerable.


Capillary Injury

Radiation damages:

  • Endothelial cells
  • Pericytes
  • Capillary basement membrane

leading to:

  • Capillary incompetence
  • Microaneurysm formation
  • Vascular leakage
  • Capillary closure


Retinal Ischemia

Progressive capillary occlusion produces:

Retinal nonperfusion

which drives expression of:

  • VEGF
  • Other angiogenic mediators

This may eventually cause:

  • Retinal neovascularization
  • NVD
  • NVE
  • NVI
  • Neovascular glaucoma


Blood-Retinal Barrier Breakdown

Endothelial dysfunction produces:

  • Leakage
  • Intraretinal fluid
  • Lipid exudation
  • Cystoid macular edema

This is the basis of:

Radiation macular edema

and explains the effectiveness of VEGF inhibition.


Clinical Presentation

Patients may initially be:

Asymptomatic

Symptoms depend on the retinal region involved.

Possible complaints include:

  • Blurred central vision
  • Metamorphopsia
  • Central scotoma
  • Reduced contrast sensitivity
  • New floaters
  • Sudden visual loss from vitreous hemorrhage


Visual Loss

Vision may decline from:

  • Macular edema
  • Macular ischemia
  • Foveal atrophy
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • Neovascular glaucoma
  • Concurrent radiation optic neuropathy


Fundus Findings

Early findings may include:

  • Microaneurysms
  • Telangiectatic capillaries
  • Dot-blot hemorrhages
  • Cotton-wool spots
  • Hard exudates

Later findings include:

  • Capillary nonperfusion
  • Macular edema
  • Vascular sheathing
  • Retinal neovascularization
  • Optic disc neovascularization
  • Vitreous hemorrhage


Microaneurysms

Microaneurysms are often among the earliest visible abnormalities.

They may appear:

  • Around the macula
  • Near irradiated tumor margins
  • Within regions of vascular injury


Cotton-Wool Spots

Cotton-wool spots represent:

Focal retinal nerve fiber layer ischemia

and indicate significant microvascular compromise.


Retinal Hemorrhages

Hemorrhages may be:

  • Dot-blot
  • Flame-shaped
  • Preretinal in proliferative disease

The overall pattern can closely mimic diabetic retinopathy.


Hard Exudates

Hard exudates result from chronic vascular leakage and may accumulate:

  • Around microaneurysms
  • Around the fovea

forming circinate patterns.


Radiation Macular Edema

Macular edema is a major cause of reduced central vision.

OCT may show:

  • Intraretinal cysts
  • Diffuse retinal thickening
  • Subretinal fluid in selected cases
  • Hyperreflective exudates


Macular Ischemia

Capillary closure involving the foveal circulation may produce:

  • Enlarged or irregular FAZ
  • Reduced capillary density
  • Permanent central visual loss

Unlike edema:

Established macular ischemia has no proven restorative treatment.


Proliferative Radiation Retinopathy

Severe ischemia may result in:

  • NVD
  • NVE
  • Preretinal hemorrhage
  • Vitreous hemorrhage

This represents the proliferative stage.


Anterior Segment Neovascularization

Extensive retinal ischemia may cause:

  • Neovascularization of the iris
  • Neovascularization of the angle

leading to:

Neovascular glaucoma


Radiation Retinopathy vs Radiation Optic Neuropathy

Both may occur after ocular radiation.

Radiation Retinopathy

Primarily affects:

  • Retinal microvasculature

Findings include:

  • Microaneurysms
  • Hemorrhages
  • Exudates
  • Macular edema
  • Nonperfusion

Radiation Optic Neuropathy

Primarily affects:

  • Optic nerve
  • Chiasm

and produces:

  • Dyschromatopsia
  • RAPD
  • Visual field loss
  • Optic atrophy

Both disorders may coexist.


Diagnosis

Diagnosis is based on:

  • Prior radiation exposure
  • Compatible retinal examination
  • Characteristic multimodal imaging
  • Exclusion of competing vascular causes


History

Important questions include:

  • Original tumor diagnosis
  • Radiation modality
  • Total dose
  • Fractionation
  • Date of treatment
  • Plaque location if brachytherapy
  • Tumor distance from fovea and disc
  • Diabetes
  • Hypertension
  • Chemotherapy
  • Previous retinal disease

Radiation oncology records are very useful when available.


Slit-Lamp Examination

Assess for:

  • NVI
  • Hyphema
  • Cataract
  • Radiation-related ocular surface disease


Intraocular Pressure

Measure IOP because severe ischemic disease may progress to:

Neovascular glaucoma


Gonioscopy

Perform gonioscopy when:

  • NVI is present
  • IOP is elevated
  • Neovascular glaucoma is suspected

Look for:

  • NVA
  • PAS
  • Angle closure


Dilated Fundus Examination

Evaluate:

  • Macula
  • Posterior pole
  • Peripheral retina
  • Optic nerve
  • Neovascularization

Look specifically for:

  • Hemorrhages
  • Cotton-wool spots
  • Microaneurysms
  • Exudates
  • Vascular attenuation
  • NVD/NVE


Optical Coherence Tomography

OCT is the principal test for detecting and monitoring radiation maculopathy.

It demonstrates:

  • Intraretinal fluid
  • Cystoid spaces
  • Subretinal fluid
  • Retinal thickness
  • Outer retinal damage
  • Atrophy

Serial OCT is central to anti-VEGF treatment decisions.


OCT Angiography

OCTA can demonstrate:

  • Capillary dropout
  • Enlarged FAZ
  • Superficial plexus abnormalities
  • Deep capillary plexus abnormalities
  • Neovascular complexes

It is especially useful for:

Early microvascular disease before dramatic funduscopic changes develop.


Fluorescein Angiography

FA may demonstrate:

  • Microaneurysms
  • Telangiectasia
  • Capillary nonperfusion
  • Enlarged FAZ
  • Macular leakage
  • NVD/NVE leakage

Wide-field FA can be particularly useful for quantifying:

Peripheral retinal ischemia.


Fundus Photography

Fundus photography is useful for documenting:

  • Hemorrhage
  • Exudation
  • Neovascularization
  • Evolution over time


Differential Diagnosis

Important differentials include:

  • Diabetic retinopathy
  • Retinal vein occlusion
  • Hypertensive retinopathy
  • Ocular ischemic syndrome
  • Retinal artery occlusive disease
  • Sickle cell retinopathy
  • Retinal vasculitis
  • Purtscher-like retinopathy
  • Other ischemic retinopathies


Radiation Retinopathy vs Diabetic Retinopathy

The retinal appearance can be nearly identical.

Radiation retinopathy is favored by:

  • Previous radiation exposure
  • Distribution matching radiation field
  • Unilateral/asymmetric disease after unilateral treatment
  • Lack of comparable systemic diabetic retinal disease

A diabetic patient can, of course, have:

Both conditions simultaneously.


Radiation Retinopathy vs Retinal Vein Occlusion

Vein occlusion typically produces:

  • Venous dilation/tortuosity
  • Sectoral or diffuse hemorrhage pattern
  • Corresponding venous drainage distribution

Radiation retinopathy tends to produce a more chronic microangiopathic pattern related to the irradiated retina.


Treatment Principles

Treatment is aimed at:

  • Controlling macular edema
  • Suppressing neovascularization
  • Preventing vitreous hemorrhage
  • Preventing neovascular glaucoma

Damage from established retinal nonperfusion itself is:

Usually irreversible.


Anti-VEGF Therapy

The modern first-line treatment for vision-threatening radiation maculopathy is:

Intravitreal anti-VEGF therapy

Common agents include:

  • Bevacizumab
  • Ranibizumab
  • Aflibercept
  • Other VEGF-inhibiting agents depending on availability


Anti-VEGF Effects

Anti-VEGF therapy may:

  • Reduce macular edema
  • Improve retinal thickness
  • Stabilize visual acuity
  • Improve vision in some patients
  • Suppress retinal/iris neovascularization


Chronic Treatment Requirement

Radiation maculopathy is usually a:

Chronic disease

and anti-VEGF benefit frequently requires:

  • Repeated injections
  • Long-term surveillance

Stopping treatment may lead to:

  • Recurrent edema
  • Progressive vascular damage
  • Visual decline


Treatment Regimens

Common approaches include:

  • Fixed interval dosing
  • PRN dosing
  • Treat-and-extend strategies

Treatment is guided by:

  • OCT fluid
  • Visual acuity
  • Hemorrhage
  • Disease recurrence


Important Treatment Principle

Radiation maculopathy may require:

More persistent anti-VEGF treatment than many patients initially expect.

The goal is often:

Preservation of vision, rather than permanent cure.


Prophylactic Anti-VEGF

In patients receiving plaque brachytherapy for uveal melanoma, some centers use prophylactic intravitreal anti-VEGF injections before clinically apparent radiation maculopathy develops.

This strategy may:

  • Delay macular edema
  • Reduce severity of radiation maculopathy
  • Improve long-term visual preservation

However:

Prophylactic anti-VEGF is not universally required or standardized for every irradiated eye.

Use depends on:

  • Tumor location
  • Macular radiation dose
  • Patient risk
  • Institutional protocol


Intravitreal Corticosteroids

Steroids may be useful for:

  • Persistent radiation macular edema
  • Incomplete anti-VEGF response

Options include:

  • Dexamethasone implant
  • Other intravitreal steroid approaches


Steroid Risks

Potential complications include:

  • IOP elevation
  • Cataract
  • Infection

Therefore steroids are generally used selectively.


Focal/Grid Laser

Focal or grid laser was historically a major treatment for radiation macular edema.

Its role is now:

Much more limited

because anti-VEGF therapy generally provides better control of center-involving edema.

Laser may still have a role in selected:

  • Non-center-involving focal leakage
  • Chronic cases not suitable for injections


Panretinal Photocoagulation

PRP is indicated for significant proliferative radiation retinopathy, particularly when there is:

  • NVD
  • NVE
  • Extensive ischemia with neovascular complications

Its purpose is to reduce:

Retinal ischemic VEGF drive


Anti-VEGF + PRP

For active neovascularization:

  • Anti-VEGF produces rapid regression
  • PRP provides more durable ischemia control

The combination is especially useful with:

  • NVI
  • NVA
  • Neovascular glaucoma


Neovascular Glaucoma

Management includes:

  • Intravitreal anti-VEGF
  • PRP
  • Aqueous suppressant medications
  • Glaucoma surgery when necessary

Anti-VEGF alone is temporary because it does not eliminate the underlying retinal ischemia.


Vitrectomy

Pars plana vitrectomy may be required for:

  • Nonclearing vitreous hemorrhage
  • Recurrent vitreous hemorrhage
  • Tractional retinal detachment
  • Combined tractional/rhegmatogenous detachment
  • Epiretinal traction in selected cases


Macular Ischemia

No established treatment restores retinal tissue lost from:

Macular capillary nonperfusion

Anti-VEGF may reduce coexisting edema but cannot reliably reverse established foveal ischemia.


Systemic Risk-Factor Control

Optimize:

  • Diabetes
  • Hypertension
  • Dyslipidemia
  • Smoking status
  • Other vascular risk factors

This does not reverse radiation damage but may reduce additive microvascular stress.


Prevention

The most important preventive strategy is:

Minimizing unnecessary radiation exposure to the retina and macula during treatment planning.

Techniques include:

  • Careful dosimetry
  • Conformal radiation planning
  • Shielding when feasible
  • Plaque placement optimization
  • Proton-beam targeting
  • Fractionation where appropriate


Post-Radiation Surveillance

Patients receiving significant retinal radiation exposure should undergo:

Long-term ophthalmic surveillance

because disease may appear years after treatment.


Follow-Up

Frequency depends on:

  • Radiation dose
  • Tumor location
  • Macular involvement
  • Current retinal findings
  • Active treatment

Stable high-risk patients may be examined every:

3–6 months

while active macular edema or neovascular disease often requires much closer follow-up.


Monitoring

Assess:

  • Visual acuity
  • IOP
  • Slit-lamp examination
  • NVI
  • Gonioscopy when indicated
  • Dilated fundus examination
  • OCT

Use FA/OCTA when:

  • Ischemia needs characterization
  • Neovascularization is uncertain


Prognosis

Radiation retinopathy is:

Chronic and potentially progressive

Visual prognosis depends heavily on:

  • Macular radiation dose
  • Degree of macular ischemia
  • Optic nerve involvement
  • Time to treatment
  • Response to anti-VEGF
  • Development of neovascular complications


Early Treatment

Modern anti-VEGF therapy has substantially improved visual outcomes compared with historical observation or laser-only treatment.

Best outcomes occur when:

Macular edema is detected and treated before severe irreversible ischemic or structural damage develops.


Poor Prognostic Features

Poor visual prognosis is associated with:

  • Severe macular ischemia
  • Extensive capillary nonperfusion
  • Chronic untreated edema
  • Foveal atrophy
  • Radiation optic neuropathy
  • Vitreous hemorrhage
  • Neovascular glaucoma
  • Retinal detachment


Complications

Important complications include:

  • Radiation macular edema
  • Macular ischemia
  • Retinal neovascularization
  • NVD/NVE
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • NVI/NVA
  • Neovascular glaucoma
  • Permanent central visual loss
  • Concurrent radiation optic neuropathy


Ophthalmology Pearls

  • Radiation retinopathy is a delayed occlusive retinal microangiopathy after radiation involving the eye, orbit, or adjacent head and neck structures.
  • The pathology resembles diabetic retinopathy because radiation produces endothelial injury, capillary leakage, and progressive nonperfusion.
  • Typical findings include microaneurysms, cotton-wool spots, retinal hemorrhages, hard exudates, macular edema, and later neovascularization.
  • Radiation maculopathy is the major cause of visual loss, particularly through macular edema and ischemia.
  • Disease most commonly appears 1–3 years after radiation, but substantially later onset is possible.
  • Risk increases with higher retinal dose, larger fraction size, macular/optic-disc exposure, diabetes, hypertension, and chemotherapy.
  • OCT is the key modern test for radiation macular edema, while FA and OCTA demonstrate capillary nonperfusion and vascular abnormalities.
  • Intravitreal anti-VEGF is now first-line treatment for vision-threatening radiation maculopathy, replacing focal/grid laser as the mainstay for center-involving edema.
  • Anti-VEGF treatment is often chronic and repeated; interruption may lead to recurrent edema and visual deterioration.
  • Intravitreal corticosteroids may help selected anti-VEGF–refractory cases but carry risks of IOP elevation and cataract.
  • Prophylactic anti-VEGF after plaque brachytherapy is used in selected high-risk eyes and may delay radiation maculopathy, but it is not a universal requirement.
  • PRP remains important for proliferative radiation retinopathy and retinal ischemia producing neovascularization.
  • NVI/NVA should be managed with rapid anti-VEGF plus definitive retinal ischemia treatment with PRP, along with glaucoma therapy.
  • Vitrectomy is reserved for complications such as nonclearing vitreous hemorrhage and tractional retinal detachment.
  • Established macular ischemia is generally irreversible, so early detection of edema and vascular injury is critical.
  • Patients require long-term surveillance, because radiation retinopathy may develop years after apparently successful cancer treatment.


Image description
Published on

Ophthalmology – Radiation Optic Neuropathy

Basics

Description

Radiation-induced optic neuropathy (RION) is a delayed, usually severe optic neuropathy caused by previous radiation exposure to the:

  • Optic nerve
  • Optic chiasm
  • Occasionally optic tract

It most often occurs after radiotherapy for tumors involving or adjacent to the anterior visual pathway, including:

  • Orbit
  • Paranasal sinuses
  • Skull base
  • Sella/parasellar region
  • Nasopharynx
  • Intracranial tumors near the optic apparatus

The typical presentation is:

Sudden or rapidly progressive, painless visual loss months to years after radiotherapy

RION is usually irreversible and must be distinguished urgently from:

Recurrent or progressive tumor, which may require specific treatment.


Clinical Importance

New visual loss in a patient with previous radiation near the optic pathways should prompt urgent evaluation for:

  • Radiation-induced optic neuropathy
  • Recurrent/compressive tumor
  • Tumor infiltration
  • Optic neuritis
  • Ischemic optic neuropathy
  • Meningeal carcinomatosis
  • Radiation retinopathy

The diagnosis should not be assumed solely because of a history of radiotherapy.


Epidemiology

RION is uncommon with modern radiation planning but remains a serious delayed complication.

Risk is strongly related to:

  • Total radiation dose
  • Dose per fraction
  • Volume of optic nerve/chiasm irradiated
  • Radiation technique
  • Patient-specific vascular susceptibility


Latency

RION most often develops:

Several months to several years after treatment

A common interval is approximately:

1–3 years

but cases may occur earlier or substantially later.

A very long latency does not completely exclude RION.


Laterality

Disease may be:

  • Unilateral
  • Sequentially bilateral
  • Bilateral simultaneously

If the chiasm is involved, both eyes may be affected through:

  • Chiasmal field loss
  • Bilateral optic nerve dysfunction


Risk Factors

Important risk factors include:

  • High radiation dose to the optic apparatus
  • Large dose per fraction
  • Stereotactic/high-dose focal treatment near optic nerve or chiasm
  • Re-irradiation
  • Concurrent or prior chemotherapy
  • Diabetes mellitus
  • Hypertension
  • Preexisting optic nerve compression
  • Other vascular risk factors


Radiation Dose and Risk

For conventional fractionated radiotherapy, the risk of RION rises substantially when the optic nerve or chiasm receives doses above approximately:

50–55 Gy

particularly when:

  • Fraction size exceeds approximately 1.8–2 Gy
  • Large segments of the optic pathway are irradiated

Modern radiation planning generally attempts to keep maximum optic nerve/chiasm dose below established organ-at-risk constraints whenever tumor control allows.


Stereotactic Radiosurgery

The optic nerve and chiasm are particularly sensitive to:

High single-fraction doses

Therefore single-fraction radiosurgery immediately adjacent to a functioning optic apparatus requires strict dose limitation.

Fractionated stereotactic radiotherapy may be preferred when a lesion lies very close to:

  • Optic nerve
  • Chiasm

because fractionation reduces the risk of delayed radiation injury.


Pathophysiology

RION is believed to result from a combination of:

  • Radiation-induced vascular injury
  • Endothelial damage
  • Capillary occlusion
  • Ischemia
  • Demyelination
  • Direct glial and axonal injury


Vascular Injury

Radiation damages small blood vessels through:

  • Endothelial proliferation
  • Fibrinoid necrosis
  • Obliterative endarteritis
  • Capillary closure

The result is:

Chronic ischemia of the optic nerve


Parenchymal Injury

Radiation may also directly damage:

  • Oligodendrocytes
  • Astrocytes
  • Myelin
  • Axons

leading to:

  • Demyelination
  • Necrosis
  • Axonal loss

The final pathology is therefore both:

Vascular and neural.


Clinical Presentation

The classic symptom is:

Painless visual loss

which may be:

  • Sudden
  • Subacute
  • Rapidly progressive over days to weeks

Vision loss is often severe.


Visual Acuity

Visual acuity may decline to:

  • 20/200 or worse
  • Counting fingers
  • Hand motions
  • No light perception in severe cases

Visual prognosis is generally poor once substantial injury is established.


Color Vision

Patients commonly have:

Marked dyschromatopsia

consistent with optic nerve dysfunction.


Pupillary Findings

If involvement is unilateral or asymmetric:

Relative afferent pupillary defect (RAPD)

is expected.

Bilateral symmetric disease may produce no obvious RAPD.


Visual Fields

Field defects depend on the location of injury.

Optic Nerve

Possible defects include:

  • Central scotoma
  • Cecocentral scotoma
  • Arcuate defect
  • Altitudinal defect
  • Diffuse depression

Optic Chiasm

May produce:

  • Bitemporal hemianopic defects

Optic Tract

May produce:

  • Contralateral homonymous visual field loss


Optic Disc Appearance

At onset, the optic disc may appear:

  • Normal
  • Mildly swollen
  • Pale if there was prior compressive damage

Anterior optic nerve involvement may produce:

Disc edema

but many cases are retrobulbar and initially have a normal-appearing disc.


Optic Atrophy

Over subsequent weeks:

Optic disc pallor develops

because of irreversible axonal loss.

This may be accompanied by:

  • RNFL thinning
  • Ganglion cell loss


Radiation Retinopathy

RION may coexist with:

Radiation retinopathy

especially when the globe was within the radiation field.

Look for:

  • Microaneurysms
  • Cotton-wool spots
  • Retinal hemorrhages
  • Macular edema
  • Capillary nonperfusion
  • Neovascularization

Concurrent retinal disease may contribute to visual loss.


Diagnosis

RION is principally a:

Diagnosis of clinical context + characteristic imaging + exclusion of recurrent tumor and other causes

There is no single laboratory test that confirms it.


History

Obtain detailed information about:

  • Original tumor
  • Radiation field
  • Total radiation dose
  • Fraction size
  • Radiation modality
  • Date of treatment
  • Re-irradiation
  • Chemotherapy
  • Prior visual function

Radiation treatment records are extremely useful if available.


MRI – Investigation of Choice

Obtain:

MRI of the brain and orbits with and without contrast

with:

  • Thin orbital sections
  • Fat-suppressed postcontrast imaging
  • Dedicated evaluation of optic nerves and chiasm


MRI Findings

Characteristic findings may include:

  • Focal or segmental enhancement of the affected optic nerve
  • Chiasmal enhancement
  • T2 hyperintensity
  • Mild nerve enlargement in some cases

Enhancement may involve only a short segment and can be missed if imaging is not optimized.


Important MRI Principle

Enhancement of an irradiated optic nerve is:

Not specific for RION

because similar enhancement can occur with:

  • Tumor infiltration
  • Optic neuritis
  • Sarcoidosis
  • Infection
  • Perineuritis

Therefore imaging must be interpreted in the clinical context.


Excluding Tumor Recurrence

One of the most important goals of imaging is to exclude:

  • Recurrent tumor
  • Progressive tumor
  • New compressive lesion
  • Radiation-induced secondary neoplasm

Serial comparison with previous MRI is particularly valuable.


OCT

Optical coherence tomography is useful for documenting structural injury.

Assess:

  • Peripapillary RNFL
  • Macular GCIPL/GCC

Early disease may show:

  • RNFL thickening if disc edema is present

Later disease typically shows:

  • RNFL thinning
  • Ganglion cell loss


Ganglion Cell Analysis

Macular GCIPL/GCC may reveal:

Early retrograde axonal degeneration

and can be useful for:

  • Baseline documentation
  • Monitoring progression
  • Correlating structural loss with visual fields


Visual Fields

Automated perimetry should be performed whenever visual function permits.

It helps:

  • Localize the lesion
  • Document severity
  • Monitor progression


Fluorescein Angiography

FA is not routinely required for isolated RION but is useful when evaluating:

  • Concurrent radiation retinopathy
  • Macular ischemia
  • Retinal vascular leakage


Laboratory Evaluation

Laboratory testing is directed by the differential diagnosis rather than RION itself.

Consider testing for:

  • Inflammatory disease
  • Infection
  • Giant cell arteritis in appropriate older patients
  • Nutritional/toxic causes

when the clinical picture is atypical.


Lumbar Puncture

CSF examination may be considered when there is concern for:

  • Meningeal carcinomatosis
  • Malignant infiltration
  • Inflammatory optic neuropathy
  • Infection

It is not routinely required for classic RION.


Differential Diagnosis

Important differentials include:

  • Recurrent or progressive tumor
  • Compressive optic neuropathy
  • Tumor infiltration of optic nerve
  • Meningeal carcinomatosis
  • Optic neuritis
  • Anterior ischemic optic neuropathy
  • Posterior ischemic optic neuropathy
  • Radiation retinopathy
  • Sarcoidosis
  • Optic perineuritis
  • Toxic/nutritional optic neuropathy
  • Paraneoplastic optic neuropathy
  • Radiation-induced secondary tumor


RION vs Recurrent Tumor

RION

Usually:

  • Delayed after radiotherapy
  • Relatively abrupt visual decline
  • Segmental optic pathway enhancement
  • No progressively enlarging mass

Recurrent Tumor

More likely:

  • Progressive mass on serial imaging
  • Increasing compression
  • Associated cranial neuropathies
  • Progressive orbital or neurologic signs

The distinction may occasionally require:

  • Serial MRI
  • Multidisciplinary neuroradiology review


RION vs Optic Neuritis

RION

  • History of radiation
  • Usually older or tumor-treated population
  • Often profound vision loss
  • Usually little or no pain
  • Poor recovery

Typical Optic Neuritis

  • Often younger patient
  • Pain with eye movement common
  • Demyelinating context
  • Greater likelihood of spontaneous recovery


RION vs NAION

NAION typically has:

  • Acute painless visual loss
  • Disc edema at onset
  • Altitudinal field defect
  • Crowded fellow optic disc

RION may have:

  • Normal disc at onset
  • Retrobulbar segmental enhancement
  • Prior radiation exposure


Treatment

There is currently:

No treatment of consistently proven efficacy for established RION.

This remains one of the most important clinical realities.


Corticosteroids

Systemic corticosteroids have been used empirically.

However:

There is no convincing evidence that corticosteroids reliably restore vision in RION.

They may be considered if:

  • Inflammatory optic neuropathy remains in the differential

but should not be presented as established treatment for radiation injury.


Hyperbaric Oxygen Therapy

Hyperbaric oxygen has been used because of the hypothesis that increasing tissue oxygenation may improve ischemic injury.

Potential benefit appears most plausible when initiated:

Very early after visual loss

before irreversible optic nerve infarction develops.

However:

  • Evidence is limited
  • Results are inconsistent
  • Controlled data are lacking

Therefore HBO remains:

Unproven and controversial

rather than standard therapy.


Anti-VEGF Therapy

Intravitreal or systemic anti-VEGF therapy has been reported in small series and case reports.

A theoretical rationale is reduction of:

  • Vascular permeability
  • Radiation-associated microvascular leakage

However:

Anti-VEGF is not established therapy for isolated RION.

It is much better established for:

  • Radiation maculopathy
  • Radiation retinopathy


Bevacizumab

Some small reports have described visual stabilization or improvement with bevacizumab, particularly in anterior radiation optic neuropathy with associated disc edema.

Evidence remains insufficient for routine recommendation.


Anticoagulation

Anticoagulants and antiplatelet drugs have been tried based on the vascular hypothesis.

There is:

No established evidence of benefit

for routine use solely for RION.


Pentoxifylline and Vitamin E

These agents have been studied for other radiation-induced tissue injuries.

Their role in RION remains:

Unproven.


Surgical Treatment

There is no surgical treatment for the radiation injury itself.

Surgery may be required only when imaging reveals another treatable cause such as:

  • Recurrent compressive tumor
  • Radiation-induced mass


Prevention

Because treatment is unreliable:

Prevention is the most important strategy.


Radiation Planning

Preventive measures include:

  • Respecting optic nerve/chiasm dose constraints
  • Minimizing fraction size
  • Using conformal planning
  • IMRT
  • Proton therapy in selected cases
  • Fractionated stereotactic techniques when close to optic pathways
  • Avoiding unnecessary re-irradiation


Multidisciplinary Planning

Treatment planning near the optic apparatus should involve:

  • Radiation oncology
  • Neurosurgery
  • Neuro-ophthalmology when appropriate

The goal is to balance:

Tumor control against risk of irreversible visual pathway injury.


Follow-Up After Radiation Near the Optic Pathways

Patients should be educated to report:

  • New blurred vision
  • Color desaturation
  • Visual field loss
  • Sudden monocular or binocular visual change

promptly.

Clinical surveillance may include:

  • Visual acuity
  • Color vision
  • Pupillary testing
  • Visual fields
  • OCT

when the optic apparatus received significant radiation exposure.


Prognosis

Visual prognosis after established RION is generally:

Poor

because the injury represents structural ischemic and radiotoxic damage.

Many affected eyes are left with:

  • Severe visual impairment
  • Permanent field loss
  • Optic atrophy


Bilateral Disease

If both optic nerves or the chiasm are affected, patients may develop:

  • Severe bilateral visual impairment
  • Legal blindness
  • Functional dependence

Early low-vision rehabilitation is important.


Low-Vision Rehabilitation

Patients with permanent bilateral impairment should be referred for:

  • Low-vision evaluation
  • Magnification
  • Electronic visual aids
  • Orientation and mobility training
  • Occupational rehabilitation
  • Blind-services support when appropriate


Complications

The principal complications are:

  • Permanent optic atrophy
  • Severe visual field loss
  • Profound unilateral visual loss
  • Bilateral blindness
  • Associated radiation retinopathy
  • Loss of independence in severe bilateral cases


Ophthalmology Pearls

  • Radiation-induced optic neuropathy is a delayed, usually severe optic neuropathy occurring after radiation exposure to the optic nerve, chiasm, or nearby structures.
  • Typical presentation is painless, sudden or rapidly progressive visual loss months to years after radiation therapy.
  • Risk rises with increasing total dose, fraction size, re-irradiation, and proximity of the optic apparatus to the radiation field.
  • Conventional fractionated doses above approximately 50–55 Gy to the optic nerve/chiasm substantially increase risk, although no dose is absolutely risk-free.
  • The mechanism involves both radiation-induced microvascular ischemia and direct neural/glial injury.
  • MRI with thin-section, fat-suppressed postcontrast orbital imaging is the key investigation.
  • RION commonly produces segmental enhancement of the affected optic nerve or chiasm, but enhancement is not specific.
  • The most important competing diagnosis is recurrent or progressive tumor, which must be excluded before attributing visual loss to radiation.
  • The optic disc may be normal initially; optic atrophy develops later.
  • OCT typically demonstrates progressive RNFL and GCIPL/GCC loss after the acute injury.
  • There is no treatment with consistently proven visual benefit once RION is established.
  • Hyperbaric oxygen has occasionally been attempted very early but remains unproven and controversial.
  • Corticosteroids, anticoagulation, anti-VEGF, pentoxifylline, and vitamin E have been reported, but none is established standard therapy for isolated RION.
  • Anti-VEGF has a much clearer role in radiation retinopathy/maculopathy than in optic neuropathy.
  • Because treatment is unreliable, the key strategy is prevention through careful radiation dose planning and optic pathway constraints.
  • Severe bilateral visual loss warrants early low-vision rehabilitation and blind-services support.


Clinical Importance New visual loss in a patient with previous radiation near the optic pathways should prompt urgent evaluation for:  Radiation-induced optic neuropathy Recurrent/compressive tumor Tumor infiltration Optic neuritis Ischemic optic neuropathy Meningeal carcinomatosis Radiation retinopathy  The diagnosis should not be assumed solely because of a history of radiotherapy.

Epidemiology RION is uncommon with modern radiation planning but remains a serious delayed complication. Risk is strongly related to:  Total radiation dose Dose per fraction Volume of optic nerve/chiasm irradiated Radiation technique Patient-specific vascular susceptibility

Latency RION most often develops: Several months to several years after treatment A common interval is approximately: 1–3 years but cases may occur earlier or substantially later. A very long latency does not completely exclude RION.

Laterality Disease may be:  Unilateral Sequentially bilateral Bilateral simultaneously  If the chiasm is involved, both eyes may be affected through:  Chiasmal field loss Bilateral optic nerve dysfunction

Risk Factors Important risk factors include:  High radiation dose to the optic apparatus Large dose per fraction Stereotactic/high-dose focal treatment near optic nerve or chiasm Re-irradiation Concurrent or prior chemotherapy Diabetes mellitus Hypertension Preexisting optic nerve compression Other vascular risk factors

Radiation Dose and Risk For conventional fractionated radiotherapy, the risk of RION rises substantially when the optic nerve or chiasm receives doses above approximately: 50–55 Gy particularly when:  Fraction size exceeds approximately 1.8–2 Gy Large segments of the optic pathway are irradiated  Modern radiation planning generally attempts to keep maximum optic nerve/chiasm dose below established organ-at-risk constraints whenever tumor control allows.

Stereotactic Radiosurgery The optic nerve and chiasm are particularly sensitive to: High single-fraction doses Therefore single-fraction radiosurgery immediately adjacent to a functioning optic apparatus requires strict dose limitation. Fractionated stereotactic radiotherapy may be preferred when a lesion lies very close to:  Optic nerve Chiasm  because fractionation reduces the risk of delayed radiation injury.

Pathophysiology RION is believed to result from a combination of:  Radiation-induced vascular injury Endothelial damage Capillary occlusion Ischemia Demyelination Direct glial and axonal injury

Vascular Injury Radiation damages small blood vessels through:  Endothelial proliferation Fibrinoid necrosis Obliterative endarteritis Capillary closure  The result is: Chronic ischemia of the optic nerve

Parenchymal Injury Radiation may also directly damage:  Oligodendrocytes Astrocytes Myelin Axons  leading to:  Demyelination Necrosis Axonal loss  The final pathology is therefore both: Vascular and neural.

Clinical Presentation The classic symptom is: Painless visual loss which may be:  Sudden Subacute Rapidly progressive over days to weeks  Vision loss is often severe.

Visual Acuity Visual acuity may decline to:  20/200 or worse Counting fingers Hand motions No light perception in severe cases  Visual prognosis is generally poor once substantial injury is established.

Color Vision Patients commonly have: Marked dyschromatopsia consistent with optic nerve dysfunction.

Pupillary Findings If involvement is unilateral or asymmetric: Relative afferent pupillary defect (RAPD) is expected. Bilateral symmetric disease may produce no obvious RAPD.

Visual Fields Field defects depend on the location of injury. Optic Nerve Possible defects include:  Central scotoma Cecocentral scotoma Arcuate defect Altitudinal defect Diffuse depression  Optic Chiasm May produce:  Bitemporal hemianopic defects  Optic Tract May produce:  Contralateral homonymous visual field loss

Optic Disc Appearance At onset, the optic disc may appear:  Normal Mildly swollen Pale if there was prior compressive damage  Anterior optic nerve involvement may produce: Disc edema but many cases are retrobulbar and initially have a normal-appearing disc.

Optic Atrophy Over subsequent weeks: Optic disc pallor develops because of irreversible axonal loss. This may be accompanied by:  RNFL thinning Ganglion cell loss

Radiation Retinopathy RION may coexist with: Radiation retinopathy especially when the globe was within the radiation field. Look for:  Microaneurysms Cotton-wool spots Retinal hemorrhages Macular edema Capillary nonperfusion Neovascularization  Concurrent retinal disease may contribute to visual loss.

Diagnosis RION is principally a: Diagnosis of clinical context + characteristic imaging + exclusion of recurrent tumor and other causes There is no single laboratory test that confirms it.

History Obtain detailed information about:  Original tumor Radiation field Total radiation dose Fraction size Radiation modality Date of treatment Re-irradiation Chemotherapy Prior visual function  Radiation treatment records are extremely useful if available.

MRI – Investigation of Choice Obtain: MRI of the brain and orbits with and without contrast with:  Thin orbital sections Fat-suppressed postcontrast imaging Dedicated evaluation of optic nerves and chiasm

MRI Findings Characteristic findings may include:  Focal or segmental enhancement of the affected optic nerve Chiasmal enhancement T2 hyperintensity Mild nerve enlargement in some cases  Enhancement may involve only a short segment and can be missed if imaging is not optimized.

Important MRI Principle Enhancement of an irradiated optic nerve is: Not specific for RION because similar enhancement can occur with:  Tumor infiltration Optic neuritis Sarcoidosis Infection Perineuritis  Therefore imaging must be interpreted in the clinical context.

Excluding Tumor Recurrence One of the most important goals of imaging is to exclude:  Recurrent tumor Progressive tumor New compressive lesion Radiation-induced secondary neoplasm  Serial comparison with previous MRI is particularly valuable.

OCT Optical coherence tomography is useful for documenting structural injury. Assess:  Peripapillary RNFL Macular GCIPL/GCC  Early disease may show:  RNFL thickening if disc edema is present  Later disease typically shows:  RNFL thinning Ganglion cell loss

Ganglion Cell Analysis Macular GCIPL/GCC may reveal: Early retrograde axonal degeneration and can be useful for:  Baseline documentation Monitoring progression Correlating structural loss with visual fields

Visual Fields Automated perimetry should be performed whenever visual function permits. It helps:  Localize the lesion Document severity Monitor progression

Fluorescein Angiography FA is not routinely required for isolated RION but is useful when evaluating:  Concurrent radiation retinopathy Macular ischemia Retinal vascular leakage

Laboratory Evaluation Laboratory testing is directed by the differential diagnosis rather than RION itself. Consider testing for:  Inflammatory disease Infection Giant cell arteritis in appropriate older patients Nutritional/toxic causes  when the clinical picture is atypical.

Lumbar Puncture CSF examination may be considered when there is concern for:  Meningeal carcinomatosis Malignant infiltration Inflammatory optic neuropathy Infection  It is not routinely required for classic RION.

Differential Diagnosis Important differentials include:  Recurrent or progressive tumor Compressive optic neuropathy Tumor infiltration of optic nerve Meningeal carcinomatosis Optic neuritis Anterior ischemic optic neuropathy Posterior ischemic optic neuropathy Radiation retinopathy Sarcoidosis Optic perineuritis Toxic/nutritional optic neuropathy Paraneoplastic optic neuropathy Radiation-induced secondary tumor

RION vs Recurrent Tumor RION Usually:  Delayed after radiotherapy Relatively abrupt visual decline Segmental optic pathway enhancement No progressively enlarging mass  Recurrent Tumor More likely:  Progressive mass on serial imaging Increasing compression Associated cranial neuropathies Progressive orbital or neurologic signs  The distinction may occasionally require:  Serial MRI Multidisciplinary neuroradiology review

RION vs Optic Neuritis RION  History of radiation Usually older or tumor-treated population Often profound vision loss Usually little or no pain Poor recovery  Typical Optic Neuritis  Often younger patient Pain with eye movement common Demyelinating context Greater likelihood of spontaneous recovery

RION vs NAION NAION typically has:  Acute painless visual loss Disc edema at onset Altitudinal field defect Crowded fellow optic disc  RION may have:  Normal disc at onset Retrobulbar segmental enhancement Prior radiation exposure

Treatment There is currently: No treatment of consistently proven efficacy for established RION. This remains one of the most important clinical realities.

Corticosteroids Systemic corticosteroids have been used empirically. However: There is no convincing evidence that corticosteroids reliably restore vision in RION. They may be considered if:  Inflammatory optic neuropathy remains in the differential  but should not be presented as established treatment for radiation injury.

Hyperbaric Oxygen Therapy Hyperbaric oxygen has been used because of the hypothesis that increasing tissue oxygenation may improve ischemic injury. Potential benefit appears most plausible when initiated: Very early after visual loss before irreversible optic nerve infarction develops. However:  Evidence is limited Results are inconsistent Controlled data are lacking  Therefore HBO remains: Unproven and controversial rather than standard therapy.

Anti-VEGF Therapy Intravitreal or systemic anti-VEGF therapy has been reported in small series and case reports. A theoretical rationale is reduction of:  Vascular permeability Radiation-associated microvascular leakage  However: Anti-VEGF is not established therapy for isolated RION. It is much better established for:  Radiation maculopathy Radiation retinopathy

Bevacizumab Some small reports have described visual stabilization or improvement with bevacizumab, particularly in anterior radiation optic neuropathy with associated disc edema. Evidence remains insufficient for routine recommendation.

Anticoagulation Anticoagulants and antiplatelet drugs have been tried based on the vascular hypothesis. There is: No established evidence of benefit for routine use solely for RION.

Pentoxifylline and Vitamin E These agents have been studied for other radiation-induced tissue injuries. Their role in RION remains: Unproven.

Surgical Treatment There is no surgical treatment for the radiation injury itself. Surgery may be required only when imaging reveals another treatable cause such as:  Recurrent compressive tumor Radiation-induced mass

Prevention Because treatment is unreliable: Prevention is the most important strategy.

Radiation Planning Preventive measures include:  Respecting optic nerve/chiasm dose constraints Minimizing fraction size Using conformal planning IMRT Proton therapy in selected cases Fractionated stereotactic techniques when close to optic pathways Avoiding unnecessary re-irradiation

Multidisciplinary Planning Treatment planning near the optic apparatus should involve:  Radiation oncology Neurosurgery Neuro-ophthalmology when appropriate  The goal is to balance: Tumor control against risk of irreversible visual pathway injury.

Follow-Up After Radiation Near the Optic Pathways Patients should be educated to report:  New blurred vision Color desaturation Visual field loss Sudden monocular or binocular visual change  promptly. Clinical surveillance may include:  Visual acuity Color vision Pupillary testing Visual fields OCT  when the optic apparatus received significant radiation exposure.

Prognosis Visual prognosis after established RION is generally: Poor because the injury represents structural ischemic and radiotoxic damage. Many affected eyes are left with:  Severe visual impairment Permanent field loss Optic atrophy

Bilateral Disease If both optic nerves or the chiasm are affected, patients may develop:  Severe bilateral visual impairment Legal blindness Functional dependence  Early low-vision rehabilitation is important.

Low-Vision Rehabilitation Patients with permanent bilateral impairment should be referred for:  Low-vision evaluation Magnification Electronic visual aids Orientation and mobility training Occupational rehabilitation Blind-services support when appropriate

Complications The principal complications are:  Permanent optic atrophy Severe visual field loss Profound unilateral visual loss Bilateral blindness Associated radiation retinopathy Loss of independence in severe bilateral cases

Ophthalmology Pearls  Radiation-induced optic neuropathy is a delayed, usually severe optic neuropathy occurring after radiation exposure to the optic nerve, chiasm, or nearby structures. Typical presentation is painless, sudden or rapidly progressive visual loss months to years after radiation therapy. Risk rises with increasing total dose, fraction size, re-irradiation, and proximity of the optic apparatus to the radiation field. Conventional fractionated doses above approximately 50–55 Gy to the optic nerve/chiasm substantially increase risk, although no dose is absolutely risk-free. The mechanism involves both radiation-induced microvascular ischemia and direct neural/glial injury. MRI with thin-section, fat-suppressed postcontrast orbital imaging is the key investigation. RION commonly produces segmental enhancement of the affected optic nerve or chiasm, but enhancement is not specific. The most important competing diagnosis is recurrent or progressive tumor, which must be excluded before attributing visual loss to radiation. The optic disc may be normal initially; optic atrophy develops later. OCT typically demonstrates progressive RNFL and GCIPL/GCC loss after the acute injury. There is no treatment with consistently proven visual benefit once RION is established. Hyperbaric oxygen has occasionally been attempted very early but remains unproven and controversial. Corticosteroids, anticoagulation, anti-VEGF, pentoxifylline, and vitamin E have been reported, but none is established standard therapy for isolated RION. Anti-VEGF has a much clearer role in radiation retinopathy/maculopathy than in optic neuropathy. Because treatment is unreliable, the key strategy is prevention through careful radiation dose planning and optic pathway constraints. Severe bilateral visual loss warrants early low-vision rehabilitation and blind-services support.

Image description
Published on

Ophthalmology – Radiation Keratopathy

Basics

Description

Radiation keratopathy refers to corneal injury caused by electromagnetic radiation and encompasses two clinically different entities:

  • Ultraviolet photokeratitis — an acute epithelial injury after excessive UV exposure
  • Ionizing radiation keratopathy — acute or delayed corneal and ocular-surface damage following therapeutic radiation such as external-beam radiotherapy or ocular brachytherapy

Radiation injury may affect:

  • Epithelium
  • Limbal stem cells
  • Stroma
  • Corneal nerves
  • Endothelium
  • Conjunctiva
  • Lacrimal and meibomian glands

The result can range from transient punctate epithelial keratitis to:

  • Persistent epithelial defects
  • Neurotrophic keratopathy
  • Limbal stem-cell deficiency
  • Stromal ulceration
  • Corneal vascularization
  • Scarring
  • Thinning
  • Perforation


Key Clinical Distinction

UV Photokeratitis

Usually:

  • Acute
  • Bilateral
  • Very painful
  • Delayed several hours after exposure
  • Self-limited

Typical examples:

  • Welding arc injury
  • Snow blindness
  • Tanning-bed exposure
  • High-altitude reflected sunlight

Therapeutic Radiation Keratopathy

Usually:

  • Delayed
  • Chronic or progressive
  • Related to radiation dose and field
  • Frequently accompanied by dry eye, neurotrophic disease, or limbal damage

The long-term prognosis is therefore very different between the two.


Radiation Types

Ultraviolet Radiation

The cornea absorbs much of the shorter-wavelength UV reaching the eye, particularly:

  • UV-B
  • UV-C

Excess exposure causes epithelial phototoxicity.


Ionizing Radiation

Therapeutic radiation includes:

  • External-beam radiotherapy
  • Intensity-modulated radiotherapy
  • Proton-beam therapy
  • Stereotactic techniques
  • Plaque brachytherapy

Corneal injury depends on:

  • Total dose
  • Dose per fraction
  • Volume irradiated
  • Location of treatment field
  • Degree of ocular shielding
  • Preexisting ocular-surface disease


Epidemiology

Radiation keratopathy is uncommon overall.

Photokeratitis is seen particularly in:

  • Welders
  • Outdoor workers
  • High-altitude exposure
  • Snow or water reflection
  • Unprotected artificial UV exposure

Chronic radiation keratopathy is mainly encountered after treatment for:

  • Orbital tumors
  • Eyelid tumors
  • Sinonasal tumors
  • Head and neck malignancies
  • Intracranial tumors near the orbit
  • Intraocular tumors


Risk Factors

Important risk factors include:

  • High cumulative corneal or limbal radiation dose
  • Large fraction size
  • Direct exposure of anterior segment
  • Inadequate shielding
  • Preexisting dry eye
  • Reduced corneal sensation
  • Exposure keratopathy
  • Prior ocular surgery
  • Diabetes
  • Poor eyelid closure
  • Cranial nerve V dysfunction
  • Cranial nerve VII dysfunction
  • Previous ocular surface disease


UV-Specific Risk Factors

These include:

  • Welding without protective shield
  • High-altitude sunlight
  • Snow reflection
  • Water reflection
  • Tanning lamps
  • Germicidal UV lamps
  • Arc lamps


Prevention

UV Injury

Preventive measures include:

  • UV-blocking protective eyewear
  • Welding masks with appropriate filters
  • Wraparound sunglasses
  • Snow goggles
  • Avoiding direct viewing of UV sources


Radiation Therapy Planning

Prevention of chronic radiation keratopathy should begin before treatment.

Important strategies include:

  • Corneal shielding where technically feasible
  • Lacrimal-gland sparing
  • Limbal sparing
  • Modern conformal treatment planning
  • Reduction of unnecessary anterior-segment radiation dose
  • Multidisciplinary planning with radiation oncology


Pathophysiology

Ionizing radiation produces:

DNA damage + reactive oxygen species + impaired cellular replication

Rapidly dividing tissues are particularly vulnerable.

The corneal epithelium depends on continuous renewal from:

Limbal epithelial stem cells

Therefore significant radiation injury to the limbus can lead to:

Limbal stem-cell deficiency

and chronic failure of epithelial regeneration.


Epithelial Injury

Radiation may cause:

  • Reduced epithelial mitosis
  • Abnormal epithelial adhesion
  • Increased apoptosis
  • Delayed wound healing

Clinical consequences include:

  • Superficial punctate keratitis
  • Recurrent epithelial breakdown
  • Persistent epithelial defect


Limbal Stem-Cell Injury

Damage to limbal stem cells can cause:

  • Persistent epithelial defects
  • Conjunctivalization of cornea
  • Superficial neovascularization
  • Recurrent epithelial breakdown
  • Chronic inflammation

Severe cases progress to:

Limbal stem-cell deficiency (LSCD).


Stromal Injury

Radiation can damage:

  • Keratocytes
  • Stromal collagen
  • Limbal vasculature

leading to:

  • Stromal haze
  • Scarring
  • Sterile ulceration
  • Stromal thinning
  • Rare perforation


Endothelial Injury

At sufficiently high doses, the corneal endothelium may be affected.

Consequences include:

  • Endothelial cell loss
  • Stromal edema
  • Epithelial edema
  • Chronic corneal decompensation


Ocular Surface Injury

Radiation may also damage:

  • Lacrimal gland
  • Meibomian glands
  • Conjunctival goblet cells

This produces severe:

Aqueous-deficient and evaporative dry eye

which substantially worsens corneal healing.


Neurotrophic Keratopathy

Damage to:

  • Trigeminal sensory innervation
  • Corneal nerves

may reduce corneal sensation.

The result can be:

Neurotrophic keratopathy

with surprisingly little pain despite severe epithelial disease.


Exposure Keratopathy

Radiation involving:

  • Facial nerve
  • Eyelids
  • Orbital tissues

may cause poor lid closure and exposure.

Thus many patients develop combined:

Radiation + neurotrophic + exposure keratopathy

rather than isolated direct corneal toxicity.


UV Photokeratitis Pathophysiology

Excess UV radiation damages corneal epithelial DNA and generates reactive oxygen species.

Because epithelial injury develops after a latent period, symptoms often begin:

6–12 hours after exposure

rather than immediately.


Clinical Presentation – Photokeratitis

Typical symptoms are:

  • Severe bilateral eye pain
  • Foreign-body sensation
  • Photophobia
  • Tearing
  • Blepharospasm
  • Redness
  • Blurred vision

The delayed onset after welding is classic.


Slit-Lamp Findings – Photokeratitis

Typical findings include:

  • Diffuse punctate epithelial erosions
  • Confluent fluorescein staining
  • Conjunctival injection
  • Mild lid edema
  • Occasionally mild anterior chamber inflammation

The pattern is usually:

Bilateral and symmetric

if both eyes were exposed.


Clinical Presentation – Therapeutic Radiation Keratopathy

Symptoms may begin:

  • During treatment
  • Weeks afterward
  • Months or years later

Possible symptoms include:

  • Dryness
  • Foreign-body sensation
  • Burning
  • Photophobia
  • Redness
  • Fluctuating vision
  • Persistent blurred vision
  • Recurrent epithelial pain

Severe neurotrophic disease may produce surprisingly little pain.


Examination

Assess:

  • Visual acuity
  • Eyelid closure
  • Blink
  • Tear film
  • Corneal sensation
  • Fluorescein staining
  • Corneal thickness
  • Corneal vascularization
  • Limbal integrity
  • Anterior chamber inflammation


Corneal Sensation

Testing corneal sensation is particularly important when there is:

  • Persistent epithelial defect
  • Previous orbital radiation
  • Trigeminal dysfunction

Reduced sensation suggests:

Neurotrophic keratopathy

and significantly changes management.


Early Corneal Findings

Early radiation injury may include:

  • Superficial punctate keratitis
  • Epithelial irregularity
  • Filamentary keratitis
  • Mild stromal edema


Persistent Epithelial Defect

A nonhealing epithelial defect is concerning for:

  • Neurotrophic keratopathy
  • Severe dry eye
  • Limbal stem-cell deficiency
  • Infection
  • Exposure

It requires more aggressive treatment than uncomplicated photokeratitis.


Advanced Findings

Severe chronic radiation injury may produce:

  • Corneal neovascularization
  • Conjunctivalization
  • Stromal scarring
  • Lipid deposition
  • Stromal thinning
  • Keratinization
  • Corneal ulceration
  • Perforation


Limbal Stem-Cell Deficiency

Clinical findings include:

  • Loss of normal limbal palisades
  • Persistent epithelial irregularity
  • Whorl-like epitheliopathy
  • Conjunctival epithelial migration over cornea
  • Superficial vascularization
  • Recurrent epithelial defects


Diagnostic Testing

Radiation keratopathy is primarily a:

Clinical diagnosis

based on:

  • Exposure history
  • Timing
  • Characteristic ocular surface findings


History

Important questions include:

  • Type of radiation exposure
  • Total radiation dose
  • Fractionation schedule
  • Treatment field
  • Use of ocular shielding
  • Timing of symptoms
  • Previous ocular surface disease
  • Prior surgery
  • Cranial nerve dysfunction

For UV injury, ask specifically about:

  • Welding
  • Snow
  • High altitude
  • Tanning bed
  • UV lamp exposure


Fluorescein Staining

Fluorescein is essential for detecting:

  • Punctate epithelial erosions
  • Epithelial defects
  • Corneal ulceration

The size of any persistent defect should be documented serially.


Anterior Segment Photography

Photography is useful for documenting:

  • Epithelial defect size
  • Vascularization
  • Scarring
  • Thinning
  • Limbal disease


Pachymetry

Pachymetry can be useful when monitoring:

  • Corneal edema
  • Progressive stromal thinning

Serial measurements may help identify impending melt.


Anterior Segment OCT

AS-OCT may help quantify:

  • Stromal thinning
  • Epithelial defects
  • Corneal scarring
  • Descemet/endothelial changes

especially when structural progression is suspected.


Corneal Cultures

Culture is not required for uncomplicated radiation injury.

Perform corneal scraping/culture when there is concern for:

Infectious keratitis

such as:

  • Stromal infiltrate
  • Suppuration
  • Rapid progression
  • Significant anterior chamber reaction
  • Contact lens-associated epithelial defect


Differential Diagnosis

Important differentials include:

  • Exposure keratopathy
  • Neurotrophic keratopathy
  • Severe dry eye disease
  • Toxic keratopathy
  • Infectious keratitis
  • Herpes simplex keratitis
  • Recurrent corneal erosion
  • Limbal stem-cell deficiency from another cause
  • Chemical injury
  • Contact lens overwear
  • Graft-versus-host disease


Photokeratitis vs Infectious Keratitis

Photokeratitis

Usually:

  • Bilateral
  • Diffuse punctate epithelial disease
  • Clear exposure history
  • No focal stromal infiltrate
  • Rapid spontaneous recovery

Infectious Keratitis

More often:

  • Unilateral
  • Focal epithelial defect
  • Stromal infiltrate
  • Purulent discharge or anterior chamber reaction

Infection must be excluded before assuming severe focal disease is purely radiation-related.


Treatment – UV Photokeratitis

Most uncomplicated cases heal rapidly.

Management includes:

  • Preservative-free artificial tears
  • Lubricating ointment
  • Oral analgesics
  • Cold compresses
  • Cycloplegic in selected patients with severe photophobia


Topical Antibiotics in Photokeratitis

Routine prophylactic antibiotics are not mandatory for every mild photokeratitis case.

An antibiotic ointment may be considered when there is:

  • Large epithelial defect
  • Significant epithelial breakdown
  • Concern for secondary infection


Topical Anesthetic Warning

Topical anesthetic drops may be useful during examination but should generally:

Not be prescribed for unsupervised repeated home use

because prolonged use can cause:

  • Severe epithelial toxicity
  • Delayed healing
  • Corneal ulceration
  • Melt


Eye Patching

Routine pressure patching is:

Not generally recommended

for uncomplicated photokeratitis or corneal epithelial defects.

It may:

  • Impair monitoring
  • Increase microbial risk
  • Provide little benefit


Bandage Contact Lens

A bandage contact lens may be considered in selected cases with:

  • Significant epithelial defect
  • Severe pain
  • Recurrent epithelial breakdown

but requires:

  • Infection surveillance
  • Appropriate antimicrobial coverage in higher-risk cases
  • Close follow-up


Prognosis of Photokeratitis

The prognosis is usually:

Excellent

Symptoms often improve markedly within:

24–48 hours

and epithelial healing is usually complete within approximately:

24–72 hours

if exposure does not recur.


Treatment – Chronic Radiation Keratopathy

Management depends on the dominant mechanism:

  • Tear deficiency
  • Exposure
  • Neurotrophic disease
  • LSCD
  • Stromal ulceration
  • Endothelial dysfunction


Lubrication

The foundation of therapy is:

Frequent preservative-free lubrication

using:

  • Artificial tears
  • Gel
  • Ointment

Avoid chronic exposure to:

  • Preservatives
  • Toxic topical medications

when possible.


Tear Conservation

Consider:

  • Punctal plugs
  • Punctal cautery

when significant aqueous-deficient dry eye contributes and inflammation is controlled.


Meibomian Gland Dysfunction

If present, treat with:

  • Warm compresses
  • Lid hygiene
  • Appropriate anti-inflammatory therapy

Radiation-related meibomian damage may be chronic and difficult to reverse.


Autologous Serum Tears

For persistent epithelial disease or severe ocular surface failure, consider:

Autologous serum tears

or other blood-derived tear products.

These provide:

  • Growth factors
  • Epitheliotrophic proteins
  • Improved epithelial support


Neurotrophic Keratopathy Treatment

Management may include:

  • Preservative-free lubrication
  • Serum tears
  • Bandage contact lens
  • Scleral lens
  • Amniotic membrane
  • Temporary tarsorrhaphy

In appropriate cases:

Cenegermin

may be considered for neurotrophic keratitis.


Cenegermin

Cenegermin is recombinant human nerve growth factor.

It may improve healing in:

  • Persistent neurotrophic epithelial defects
  • Neurotrophic corneal ulcers

Its usefulness depends on whether the dominant mechanism is genuinely neurotrophic.


Scleral Lenses

A scleral lens may provide:

  • Continuous fluid reservoir
  • Mechanical protection
  • Improved vision

in selected patients with:

  • Severe dry eye
  • Neurotrophic keratopathy
  • Irregular corneal surface

It requires specialist fitting and infection surveillance.


Amniotic Membrane

Amniotic membrane transplantation can promote epithelial healing and reduce inflammation.

It is particularly useful for:

  • Persistent epithelial defects
  • Sterile ulceration
  • Neurotrophic keratopathy
  • Severe ocular surface inflammation


Tarsorrhaphy

Temporary or permanent tarsorrhaphy is highly effective when epithelial failure is driven by:

  • Exposure
  • Neurotrophic disease
  • Severe tear deficiency

It reduces:

  • Evaporation
  • Mechanical trauma

and promotes healing.


Conjunctival Flap

A conjunctival flap may be considered in:

  • Refractory nonhealing ulcer
  • Severe neurotrophic cornea
  • Impending perforation

particularly when visual rehabilitation is not the immediate priority.


Corneal Thinning

If stromal thinning develops, management may include:

  • Intensive lubrication
  • Discontinuation of toxic medications
  • Antibiotics if infection suspected
  • Doxycycline in selected sterile melts
  • Vitamin C in selected cases
  • Amniotic membrane

The exact approach depends on etiology.


Corneal Perforation

Urgent options include:

  • Tissue adhesive
  • Bandage contact lens
  • Amniotic membrane
  • Tectonic patch graft
  • Lamellar or penetrating keratoplasty

depending on:

  • Size
  • Location
  • Cause
  • Ocular surface status


Limbal Stem-Cell Deficiency

Management may include:

  • Aggressive ocular surface optimization
  • Preservative avoidance
  • Serum tears
  • Scleral lenses
  • Amniotic membrane

Definitive reconstruction may involve:

Limbal stem-cell transplantation

in selected severe cases.


Limbal Stem-Cell Transplantation

Options depend on laterality and available donor tissue and may include:

  • Autologous limbal transplantation
  • Living-related allogeneic tissue
  • Cultivated epithelial transplantation

Allogeneic techniques require:

  • Systemic immunosuppression

and should be performed in specialized ocular-surface centers.


Corneal Transplantation

Keratoplasty may be required for:

  • Dense central scar
  • Severe stromal thinning
  • Perforation
  • Endothelial decompensation

However:

Corneal transplantation performs poorly if severe dry eye, neurotrophic disease, exposure, or LSCD has not first been controlled.

Ocular surface rehabilitation comes first whenever possible.


Topical Corticosteroids

Topical corticosteroids may be useful for:

  • Significant sterile inflammation
  • Post-radiation inflammatory ocular surface disease

but should be used cautiously.

Do not use corticosteroid monotherapy when:

  • Infection is possible
  • Significant epithelial ulceration has not been adequately assessed

Monitor for:

  • IOP elevation
  • Delayed epithelial healing
  • Infection


Referral

Urgent corneal specialist evaluation is warranted for:

  • Persistent epithelial defect
  • Corneal infiltrate
  • Progressive stromal thinning
  • Corneal perforation
  • Significant LSCD
  • Severe neurotrophic disease
  • Progressive vascularization or scarring


Follow-Up

Acute UV Injury

Reassessment is appropriate within approximately:

24–48 hours

if:

  • Symptoms are severe
  • Defect is extensive
  • Diagnosis is uncertain
  • Healing is incomplete

Straightforward cases often resolve rapidly.


Chronic Radiation Injury

Patients who have received substantial periocular radiation require long-term surveillance for:

  • Dry eye
  • Neurotrophic keratopathy
  • Persistent epithelial defects
  • LSCD
  • Corneal edema
  • Stromal thinning
  • Cataract
  • Radiation retinopathy
  • Radiation optic neuropathy

Late complications may appear:

Months to years after treatment.


Prognosis

Prognosis depends strongly on the type of radiation exposure.

Photokeratitis

Usually:

Excellent

with complete epithelial recovery.

Chronic Therapeutic Radiation Keratopathy

Variable and influenced by:

  • Radiation dose
  • Limbal involvement
  • Lacrimal gland damage
  • Corneal innervation
  • Eyelid function
  • Development of infection
  • Presence of LSCD

Severe chronic disease may be:

Progressive and vision-threatening.


Complications

Potential complications include:

  • Persistent epithelial defect
  • Neurotrophic keratopathy
  • Limbal stem-cell deficiency
  • Severe dry eye
  • Filamentary keratitis
  • Corneal ulceration
  • Infectious keratitis
  • Stromal thinning
  • Corneal neovascularization
  • Scarring
  • Lipid keratopathy
  • Corneal perforation
  • Endothelial decompensation
  • Secondary visual loss


Ophthalmology Pearls

  • Radiation keratopathy includes both acute UV photokeratitis and chronic corneal injury from therapeutic ionizing radiation; these are clinically distinct entities.
  • Photokeratitis classically causes severe bilateral pain, photophobia, tearing, and diffuse punctate epithelial erosions beginning about 6–12 hours after UV exposure.
  • Common UV causes include welding arcs, snow reflection, tanning beds, and high-altitude sunlight.
  • Uncomplicated photokeratitis usually heals within 24–72 hours with lubrication and analgesia.
  • Do not prescribe topical anesthetics for repeated unsupervised home use because of potentially severe corneal toxicity.
  • Routine pressure patching is not recommended for uncomplicated photokeratitis.
  • Chronic therapeutic radiation injury can damage not only the cornea but also the limbus, corneal nerves, lacrimal gland, meibomian glands, and conjunctival goblet cells.
  • Persistent epithelial defects after periocular radiation should prompt evaluation for neurotrophic keratopathy, exposure, severe dry eye, infection, and limbal stem-cell deficiency.
  • Check corneal sensation in any unexplained nonhealing radiation-associated epithelial defect.
  • Frequent preservative-free lubrication is the foundation of chronic treatment.
  • Severe neurotrophic disease may require serum tears, amniotic membrane, scleral lens, tarsorrhaphy, or cenegermin.
  • Radiation-induced LSCD may cause conjunctivalization, superficial vascularization, recurrent epithelial breakdown, and chronic corneal opacity.
  • Corneal transplantation should generally be delayed until the underlying ocular surface, exposure, neurotrophic disease, and LSCD are controlled.
  • Radiation planning with corneal, limbal, and lacrimal-gland sparing whenever feasible is the most effective preventive strategy.
  • Acute UV injury usually has an excellent prognosis, whereas severe therapeutic radiation keratopathy can produce lifelong ocular-surface disease and permanent visual loss.


Image description
Published on

Ophthalmology – Purtscher’s Retinopathy

Basics

Description

Purtscher retinopathy is a rare acute occlusive microangiopathy characterized by sudden visual loss with posterior-pole retinal whitening, classically after severe trauma remote from the eye.

When an identical retinal phenotype occurs without trauma, it is termed:

Purtscher-like retinopathy

Typical fundus findings include:

  • Purtscher flecken
  • Cotton-wool spots
  • Few retinal hemorrhages
  • Posterior-pole predominance
  • Variable optic disc edema

The disease is usually:

  • Bilateral
  • Asymmetric
  • Acute
  • Nonprogressive once the precipitating systemic disorder is controlled


Purtscher vs Purtscher-Like Retinopathy

Purtscher Retinopathy

Traditionally associated with:

  • Severe head trauma
  • Chest compression
  • Long-bone fractures
  • Major multisystem trauma

Purtscher-Like Retinopathy

Similar ocular findings associated with systemic disease such as:

  • Acute pancreatitis
  • Fat embolism syndrome
  • Preeclampsia/HELLP
  • Thrombotic thrombocytopenic purpura
  • Hemolytic uremic syndrome
  • Autoimmune disease
  • Renal failure
  • Amniotic fluid embolism

The retinal appearance is essentially the same.


Epidemiology

Purtscher retinopathy is:

Very rare

and true incidence is uncertain.

Because many patients are critically ill from their systemic disorder, milder ocular cases may go undiagnosed.


Pathophysiology

The leading mechanism is:

Occlusion of precapillary retinal arterioles and capillaries

causing focal inner retinal ischemia.

Several mechanisms may contribute.


Complement Activation

One important proposed mechanism is:

Complement activation → leukocyte aggregation → microvascular occlusion

This is particularly relevant in:

  • Pancreatitis
  • Severe inflammatory systemic disease


Microembolic Mechanisms

Potential embolic material includes:

  • Fat
  • Leukocyte aggregates
  • Fibrin
  • Platelet aggregates
  • Air in selected traumatic settings

The exact mechanism may vary according to the underlying disorder.


Why Large Retinal Vessels Look Normal

The occlusion typically occurs at the level of:

  • Precapillary arterioles
  • Capillary beds

rather than major retinal arteries.

Therefore:

Visible emboli in large retinal vessels are usually absent.


Associated Conditions

Important associations include:

  • Severe trauma
  • Acute pancreatitis
  • Fat embolism syndrome
  • Preeclampsia
  • HELLP syndrome
  • TTP
  • HUS
  • Systemic lupus erythematosus
  • Scleroderma
  • Dermatomyositis
  • Cryoglobulinemia
  • Chronic renal failure
  • Amniotic fluid embolism
  • Severe systemic inflammatory states


Trauma Associations

Classic traumatic triggers include:

  • Head trauma
  • Chest compression
  • Long-bone fracture
  • Polytrauma

Direct ocular trauma should prompt consideration of:

  • Commotio retinae
  • Traumatic retinal vascular injury

rather than classic Purtscher retinopathy.


Acute Pancreatitis

Acute pancreatitis is one of the best-known causes of Purtscher-like retinopathy.

The proposed mechanism involves:

  • Complement activation
  • Leukocyte aggregation
  • Retinal capillary occlusion

Ocular findings may occasionally precede recognition of severe systemic disease.


Fat Embolism Syndrome

Fat embolism after:

  • Long-bone fracture
  • Orthopedic trauma

may produce:

  • Respiratory distress
  • Neurologic changes
  • Petechial rash
  • Retinal ischemic changes

Purtscher-like retinal findings may overlap with:

Fat embolism retinopathy.


Autoimmune Disease

Purtscher-like changes have been described in:

  • SLE
  • Scleroderma
  • Dermatomyositis

These disorders can independently produce retinal microangiopathy, so clinical context is important.


Clinical Presentation

Typical presentation is:

Acute painless reduction in vision

often developing:

  • Within hours
  • Within 1–2 days

after the precipitating event.


Laterality

Disease is usually:

Bilateral

but may be:

  • Asymmetric
  • Rarely unilateral


Visual Acuity

Vision may range from:

  • Mildly reduced
  • Moderate impairment
  • Profound visual loss

Visual loss depends on involvement of:

  • Foveal capillary circulation
  • Optic nerve
  • Extent of retinal ischemia


Visual Field

Possible field defects include:

  • Central scotoma
  • Paracentral scotoma
  • Relative central depression

depending on macular involvement.


Fundus Findings

Classic findings are concentrated:

Posterior to the equator

especially around the:

  • Optic disc
  • Posterior pole
  • Retinal vascular arcades


Purtscher Flecken

Purtscher flecken are the most characteristic finding.

They appear as:

  • Polygonal
  • White
  • Superficial retinal patches

located between retinal arterioles and venules.

A helpful distinguishing feature is:

A narrow zone of retinal whitening that may spare the immediate vessel border

because the ischemia involves the precapillary bed.


Cotton-Wool Spots

Cotton-wool spots are common and represent:

Focal retinal nerve fiber layer ischemia

They may coexist with Purtscher flecken.


Retinal Hemorrhages

Hemorrhages are usually:

  • Few
  • Small
  • Superficial or intraretinal

Extensive hemorrhage should prompt consideration of another diagnosis.


Optic Disc Findings

Possible findings include:

  • Mild disc edema
  • Peripapillary whitening
  • Later optic disc pallor

Severe optic nerve involvement is associated with poorer visual prognosis.


Late Fundus Changes

As acute retinal whitening resolves, later findings may include:

  • Optic atrophy
  • Retinal arterial attenuation
  • RPE mottling
  • Inner retinal thinning
  • RNFL loss


Diagnosis

Diagnosis is primarily:

Clinical

and depends on:

  • Characteristic fundus appearance
  • Compatible systemic or traumatic trigger
  • Exclusion of other ischemic and inflammatory retinal disorders


Proposed Diagnostic Criteria

A commonly used framework supports the diagnosis when several of the following are present:

  • Purtscher flecken
  • Few retinal hemorrhages
  • Cotton-wool spots confined largely to posterior pole
  • Plausible precipitating systemic or traumatic event
  • Compatible ancillary investigations

No single finding is completely pathognomonic.


Optical Coherence Tomography

OCT is very useful for documenting acute and chronic structural changes.

Acute Phase

May show:

  • Inner retinal hyperreflectivity
  • RNFL thickening
  • Ganglion cell/inner plexiform edema
  • Middle retinal ischemic changes


PAMM-Like Changes

Some eyes demonstrate changes resembling:

Paracentral acute middle maculopathy (PAMM)

with hyperreflectivity involving:

  • Inner nuclear layer
  • Middle retina

reflecting ischemia of the deep/intermediate retinal capillary plexuses.


Chronic OCT Changes

Later OCT may show:

  • Inner retinal thinning
  • RNFL loss
  • Ganglion cell loss
  • Foveal structural damage

These correlate with permanent visual deficit.


OCT Angiography

OCTA may demonstrate:

  • Reduced capillary density
  • Superficial plexus nonperfusion
  • Deep plexus nonperfusion

It is useful for showing retinal microvascular ischemia without dye injection.


Fluorescein Angiography

FA may demonstrate:

  • Capillary nonperfusion
  • Delayed arteriolar filling
  • Vascular leakage
  • Late staining of ischemic areas

Findings vary according to disease severity.


Fundus Photography

Photography is useful for:

  • Baseline documentation
  • Following resolution of retinal whitening
  • Comparing hemorrhage and cotton-wool spot burden


Fundus Autofluorescence

FAF is not essential but may show:

  • Secondary RPE abnormalities

during later stages.


Laboratory Evaluation

There is no laboratory test that diagnoses Purtscher retinopathy itself.

Testing should instead be directed toward identifying the:

Underlying systemic cause

when not already known.


Systemic Workup

Depending on clinical context, consider:

  • CBC
  • Platelet count
  • Renal function
  • Liver function
  • Coagulation profile
  • Lipase/amylase
  • Hemolysis studies
  • Autoimmune testing

The exact workup should be driven by:

  • Trauma history
  • Systemic symptoms
  • Pregnancy status
  • Medical context


Differential Diagnosis

Important differentials include:

  • Central retinal artery occlusion
  • Branch retinal artery occlusion
  • Commotio retinae
  • Fat embolism retinopathy
  • Hypertensive retinopathy
  • Severe preeclampsia/HELLP retinopathy
  • TTP/HUS retinopathy
  • Lupus retinopathy
  • HIV retinopathy
  • Interferon retinopathy
  • Retinal vein occlusion
  • Valsalva retinopathy
  • Terson syndrome
  • Abusive head trauma in infants/children


Purtscher Retinopathy vs CRAO

Purtscher Retinopathy

  • Usually bilateral
  • Patchy polygonal retinal whitening
  • Cotton-wool spots
  • Few hemorrhages
  • Systemic/traumatic trigger

CRAO

  • Usually unilateral
  • Diffuse retinal whitening
  • Cherry-red spot
  • Marked arterial attenuation
  • Often abrupt profound vision loss


Purtscher Retinopathy vs Commotio Retinae

Purtscher

  • Remote body trauma possible
  • Usually bilateral
  • Posterior microvascular ischemia
  • Purtscher flecken

Commotio Retinae

  • Direct ocular trauma
  • Outer retinal photoreceptor injury
  • Gray-white retinal opacity at site of impact
  • Usually unilateral


Purtscher vs Valsalva Retinopathy

Valsalva retinopathy produces:

  • Preretinal/subhyaloid hemorrhage
  • Sudden painless central visual loss

without the characteristic:

  • Purtscher flecken
  • Cotton-wool spot pattern


Purtscher vs Terson Syndrome

Terson syndrome occurs with:

  • Subarachnoid hemorrhage
  • Intracranial hemorrhage
  • Severe acute elevation of intracranial pressure

and typically causes:

  • Vitreous hemorrhage
  • Preretinal hemorrhage
  • Intraretinal hemorrhage

rather than a primarily ischemic white-retina phenotype.


Treatment

Ocular Treatment

There is:

No proven sight-restoring ocular treatment

for Purtscher or Purtscher-like retinopathy.

Management is primarily:

  • Observation
  • Documentation
  • Treatment of the systemic precipitating disorder


Systemic Treatment

Treat the underlying cause aggressively.

Examples include management of:

  • Acute pancreatitis
  • Major trauma
  • TTP/HUS
  • Preeclampsia/HELLP
  • Autoimmune disease
  • Renal failure
  • Fat embolism syndrome

This may prevent further systemic and retinal injury.


Corticosteroids

High-dose corticosteroids have been reported in case series and case reports.

However:

There is no convincing evidence that corticosteroids improve final visual outcome in routine Purtscher retinopathy.

They should not be used solely for the retinal findings unless indicated for the:

Underlying systemic disease.


Anti-VEGF

Anti-VEGF therapy has:

No established role in uncomplicated Purtscher retinopathy.

It may be considered only if a separate VEGF-mediated complication develops.


Laser Treatment

Retinal laser has:

No routine role

because the disease is primarily an acute microvascular ischemic process.


Vitrectomy

Vitrectomy is not a treatment for the retinal ischemia itself.

It may be considered only for an unrelated or secondary surgical indication such as:

  • Nonclearing vitreous hemorrhage

which is uncommon in classic disease.


Follow-Up

Initial follow-up depends on:

  • Severity of visual loss
  • Activity of systemic disease
  • Extent of retinal ischemia

Repeat examination may include:

  • Visual acuity
  • Fundus photography
  • OCT
  • OCTA
  • FA in selected cases


Resolution

Purtscher flecken and cotton-wool spots often fade over:

Weeks to months

but structural retinal damage may remain.


Prognosis

Visual prognosis is:

Variable

Spontaneous improvement is common, particularly when:

  • Initial visual acuity is relatively preserved
  • Foveal ischemia is limited
  • Optic nerve involvement is absent
  • Retinal whitening resolves quickly


Poor Prognostic Features

Features associated with worse visual outcome include:

  • Severe initial visual loss
  • Persistent retinal whitening
  • Extensive capillary nonperfusion
  • Foveal involvement
  • Optic disc swelling followed by atrophy
  • Significant inner retinal thinning


Long-Term Visual Outcome

Some patients recover:

  • Several lines of visual acuity
  • Near-normal vision

while others retain:

  • Central scotoma
  • Reduced acuity
  • Contrast loss
  • Permanent visual field defects


Complications

Potential sequelae include:

  • Optic atrophy
  • Inner retinal atrophy
  • RNFL thinning
  • Permanent scotoma
  • Persistent central visual loss
  • Retinal arterial attenuation
  • RPE abnormalities


Patient Education

Patients should understand that:

  • The retinal process is usually acute rather than continuously progressive
  • Vision may improve spontaneously over weeks to months
  • Final recovery depends on the degree of retinal and optic nerve ischemia
  • Management of the associated systemic illness is essential


Ophthalmology Pearls

  • Purtscher retinopathy is an acute occlusive retinal microangiopathy classically following severe trauma remote from the eye.
  • The identical retinal phenotype associated with systemic disease is called Purtscher-like retinopathy.
  • Major nontraumatic associations include acute pancreatitis, TTP/HUS, preeclampsia/HELLP, autoimmune disease, renal failure, and fat embolism syndrome.
  • The characteristic lesion is the Purtscher flecken: polygonal patches of posterior retinal whitening related to precapillary arteriolar occlusion.
  • Cotton-wool spots are common, while retinal hemorrhages are usually few rather than extensive.
  • Disease is usually bilateral but asymmetric and causes acute painless visual loss.
  • The leading mechanism is precapillary microvascular occlusion, potentially involving complement activation, leukocyte aggregation, and microemboli.
  • OCT acutely shows inner/middle retinal hyperreflectivity and edema, with later inner retinal and RNFL thinning.
  • OCTA and FA can demonstrate capillary nonperfusion.
  • There is no proven ocular treatment that reliably restores vision; management focuses on treating the underlying systemic disorder.
  • Systemic corticosteroids have been reported but have not demonstrated clear evidence of benefit for the retinal disease itself.
  • Purtscher retinopathy should be distinguished from CRAO, commotio retinae, Terson syndrome, Valsalva retinopathy, and fat embolism retinopathy.
  • Visual recovery is variable but spontaneous improvement is common; poor prognosis is associated with extensive foveal ischemia, persistent whitening, optic nerve involvement, and subsequent retinal atrophy.
  • The disease is generally acute and self-limited rather than chronically progressive, although permanent ischemic damage may remain.


Image description
Published on

Ophthalmology – Pupillary Block Glaucoma

Basics

Description

Pupillary block is the most common mechanism of primary angle closure.

It occurs when aqueous humor encounters increased resistance while passing:

Posterior chamber → through pupil → anterior chamber

The resulting pressure differential pushes the peripheral iris anteriorly, producing:

Iris bombe → iridotrabecular contact → angle closure → elevated IOP

If prolonged or recurrent, this can lead to:

  • Peripheral anterior synechiae (PAS)
  • Chronic angle closure
  • Glaucomatous optic neuropathy
  • Permanent visual loss


Key Clinical Concept

Pupillary block is a:

Mechanism of angle closure

rather than a single disease entity.

It may occur as:

  • Acute primary angle closure
  • Intermittent angle closure
  • Chronic primary angle closure
  • Secondary pupillary block

The definitive treatment for a significant pupillary-block component is usually:

Laser peripheral iridotomy (LPI)

which creates an alternative route for aqueous from the posterior to anterior chamber.


Modern Primary Angle-Closure Classification

It is useful to distinguish:

Primary Angle-Closure Suspect (PACS)

  • Iridotrabecular contact/occludable angle
  • No PAS
  • No elevated IOP attributable to angle closure
  • No glaucomatous optic neuropathy

Primary Angle Closure (PAC)

Angle closure with evidence such as:

  • PAS
  • Elevated IOP

but:

  • No glaucomatous optic neuropathy

Primary Angle-Closure Glaucoma (PACG)

PAC plus:

Glaucomatous optic nerve and/or visual field damage


Epidemiology

Primary angle-closure disease is more common in:

  • East and Southeast Asian populations
  • Inuit populations
  • Older adults
  • Women

It is less common in many European-derived populations.

Risk rises substantially with age because the crystalline lens:

  • Thickens
  • Moves anteriorly
  • Crowds the anterior segment


Risk Factors

Important risk factors include:

  • Increasing age
  • Female sex
  • Asian or Inuit ancestry
  • Hyperopia
  • Short axial length
  • Shallow anterior chamber
  • Thick or anteriorly positioned lens
  • Small corneal diameter
  • Family history
  • Plateau iris configuration
  • Nanophthalmos


Lens-Related Predisposition

The crystalline lens plays a major role in angle closure.

With age it becomes:

  • Thicker
  • More anteriorly positioned

This narrows the space between:

  • Iris
  • Lens
  • Cornea

and increases resistance to aqueous movement through the pupil.


Genetics

Primary angle-closure disease has significant:

Heritability

and first-degree relatives have increased risk.

The genetics are:

  • Polygenic
  • Complex
  • Influenced by ocular biometric traits

Routine genetic testing is not clinically useful.


Pathophysiology

Normally, aqueous humor flows:

Ciliary body → posterior chamber → pupil → anterior chamber → trabecular meshwork

In relative pupillary block:

  • Iris contacts the anterior lens more tightly
  • Resistance to aqueous movement through the pupil rises
  • Posterior chamber pressure exceeds anterior chamber pressure
  • Peripheral iris bows forward

This produces:

Iris bombe


Iris Bombe

Iris bombe is anterior convexity of the iris caused by:

Posterior chamber pressure exceeding anterior chamber pressure

The peripheral iris then contacts:

  • Trabecular meshwork
  • Peripheral cornea in severe cases

causing acute or chronic closure of the drainage angle.


Appositional vs Synechial Closure

Appositional Closure

The iris contacts the trabecular meshwork but:

  • Can still be mechanically separated

This may reverse with:

  • Indentation
  • Resolution of pupillary block
  • LPI

Synechial Closure

Prolonged contact causes:

Peripheral anterior synechiae

which represent permanent adhesions between iris and angle structures.


Peripheral Anterior Synechiae

PAS can lead to:

  • Persistent angle closure
  • Chronic IOP elevation
  • Reduced response to LPI alone

Greater PAS burden generally predicts:

Greater likelihood of persistent glaucoma after LPI.


Acute Primary Angle Closure

An acute attack occurs when the angle suddenly closes extensively, causing rapid IOP elevation.

Typical symptoms include:

  • Severe ocular pain
  • Red eye
  • Blurred vision
  • Halos around lights
  • Frontal headache
  • Nausea
  • Vomiting

This is an:

Ophthalmic emergency


Precipitating Factors

Acute angle closure may be precipitated by pupillary dilation from:

  • Darkness
  • Emotional stress
  • Pharmacologic mydriasis
  • Anticholinergic medications
  • Sympathomimetic medications

The pupil is often most vulnerable in a:

Mid-dilated position

because iridolenticular contact and peripheral iris crowding increase.


Medication-Associated Angle Closure

Drugs that may trigger pupillary-block angle closure in anatomically narrow eyes include:

  • Anticholinergics
  • Sympathomimetics
  • Some inhaled anticholinergics
  • Some antidepressants through pupillary dilation


Important Modern Distinction – Topiramate

Topiramate-associated angle closure is generally caused by:

Ciliochoroidal effusion with forward rotation of the ciliary body

not pupillary block.

Typical features include:

  • Bilateral acute myopic shift
  • Bilateral shallow chambers
  • Angle closure

Treatment involves:

  • Stopping the causative medication
  • Cycloplegia
  • IOP lowering
  • Steroids in selected cases

and:

LPI is usually ineffective because the mechanism is not pupillary block.


Secondary Pupillary Block

Pupillary block can also result from:

  • 360° posterior synechiae (seclusio pupillae)
  • Uveitis
  • Intumescent cataract
  • Spherophakia
  • Lens subluxation
  • Aphakia with vitreous block
  • Pseudophakic pupillary block
  • Silicone oil
  • Gas tamponade in selected circumstances


Uveitic Pupillary Block

Inflammation can produce:

Posterior synechiae

If synechiae become circumferential:

Seclusio pupillae → iris bombe → secondary angle closure

Management may require:

  • Intensive topical corticosteroids
  • Cycloplegia
  • LPI or surgical iridectomy


Lens Subluxation and Spherophakia

A small spherical or anteriorly displaced lens can:

  • Increase iridolenticular contact
  • Produce pupillary block
  • Cause angle closure

Lens extraction may ultimately be required.


Clinical History

Ask about:

  • Eye pain
  • Halos
  • Blurred vision
  • Intermittent attacks in dim lighting
  • Headache
  • Nausea/vomiting
  • Previous similar episodes
  • Family history of angle closure
  • Hyperopia
  • Recent dilation
  • New medications
  • Prior uveitis
  • Cataract
  • Ocular surgery


Intermittent Angle Closure

Before a full acute attack, patients may report recurrent episodes of:

  • Blurred vision
  • Colored halos
  • Brow ache
  • Mild headache

especially in:

  • Darkness
  • Evening
  • Stress

Symptoms may resolve spontaneously as the pupil constricts.


Examination in Acute Angle Closure

Typical findings include:

  • Conjunctival/ciliary injection
  • Corneal edema
  • Very shallow peripheral anterior chamber
  • Markedly elevated IOP
  • Mid-dilated poorly reactive pupil
  • Closed angle
  • Possible anterior chamber cells
  • Glaukomflecken after severe/prolonged attack


Corneal Edema

Marked IOP elevation causes endothelial dysfunction and:

Microcystic corneal edema

This may:

  • Reduce visual acuity
  • Produce halos
  • Obscure gonioscopy
  • Make LPI difficult


Pupil

The pupil is often:

  • Mid-dilated
  • Sluggish
  • Poorly reactive

because severe IOP elevation causes:

Iris sphincter ischemia


Glaukomflecken

Glaukomflecken are small anterior subcapsular lens opacities caused by acute lens epithelial ischemic injury after a severe IOP spike.

They suggest:

Previous acute angle closure

and may remain permanently visible.


Gonioscopy

Gonioscopy is essential in the diagnosis of angle-closure disease.

Assess:

  • Degree of angle narrowing
  • Iridotrabecular contact
  • PAS
  • Pigmentation
  • Plateau iris configuration
  • Other secondary mechanisms


Indentation Gonioscopy

Indentation gonioscopy helps distinguish:

Appositional closure from PAS

If the angle opens with indentation:

  • Closure is predominantly appositional

If it remains closed:

  • PAS or another fixed structural mechanism is likely


Fellow Eye Examination

The fellow eye should be examined carefully because it often has similar:

  • Biometry
  • Angle anatomy
  • Predisposition to acute closure

The fellow eye may require:

Prophylactic LPI if it remains anatomically occludable.


Intraocular Pressure

IOP during acute primary angle closure may become extremely high, often:

40–70 mmHg or higher

but the exact pressure varies.

Chronic PACG may have:

  • Persistently elevated IOP
  • Intermittent elevation
  • Normal IOP between attacks


Optic Nerve Examination

After the acute attack is controlled, assess:

  • Cup-to-disc ratio
  • Rim thinning
  • RNFL loss
  • Disc hemorrhage

because the patient may already have:

Chronic glaucomatous damage.


Visual Fields

Obtain automated perimetry after:

  • Cornea clears
  • IOP stabilizes
  • Acute symptoms resolve

to assess for:

  • Arcuate defects
  • Nasal step
  • Advanced constriction


OCT

OCT may assess:

  • RNFL
  • GCIPL/GCC
  • Glaucomatous optic neuropathy

Anterior segment OCT can also demonstrate:

  • Angle width
  • Iris configuration
  • Lens-related crowding


Ultrasound Biomicroscopy

UBM is particularly useful when the mechanism is uncertain.

It can demonstrate:

  • Plateau iris
  • Ciliary body anatomy
  • Lens position
  • Ciliary body cysts
  • Supraciliary effusion
  • Anterior rotation of ciliary body


Provocative Testing

Historical tests include:

  • Dark-room prone testing
  • Pharmacologic dilation testing

These have limited diagnostic accuracy and are:

Not routinely recommended

because modern:

  • Gonioscopy
  • AS-OCT
  • UBM

provide safer and more useful anatomic information.


Differential Diagnosis

Important alternatives include:

  • Plateau iris syndrome
  • Phacomorphic glaucoma
  • Neovascular angle closure
  • Uveitic glaucoma
  • Aqueous misdirection
  • Topiramate/sulfonamide-induced ciliochoroidal effusion
  • Lens subluxation
  • Choroidal effusion
  • Suprachoroidal hemorrhage
  • Posterior segment mass


Pupillary Block vs Plateau Iris

Pupillary Block

  • Iris bombe
  • Increased iridolenticular resistance
  • Usually relieved by LPI

Plateau Iris

  • Relatively flat central iris
  • Anteriorly positioned ciliary processes
  • Peripheral iris rises abruptly
  • Angle may remain occludable despite patent LPI


Pupillary Block vs Phacomorphic Glaucoma

Phacomorphic glaucoma involves:

  • Intumescent/thickened lens
  • Shallow central and peripheral chamber
  • Lens crowding plus pupillary block

Definitive treatment is:

Cataract extraction

after acute IOP control.


Pupillary Block vs Aqueous Misdirection

Aqueous misdirection usually causes:

  • Uniformly shallow or flat central and peripheral chamber
  • Often postoperative setting
  • Patent iridotomy

The iris configuration is different from classic iris bombe.


Acute Treatment Goals

Management of acute primary angle closure has three goals:

  1. Rapidly lower IOP
  2. Reduce inflammation and symptoms
  3. Eliminate pupillary block definitively


Initial Medical Therapy

Common acute treatment includes:

  • Topical beta-blocker
  • Topical alpha-2 agonist
  • Topical carbonic anhydrase inhibitor
  • Systemic acetazolamide

A typical adult acetazolamide loading dose is often:

500 mg

unless contraindicated.


Hyperosmotic Therapy

If IOP remains very high or the attack is severe, consider:

  • IV mannitol
  • Oral glycerol in selected patients

Hyperosmotic agents reduce vitreous volume and help:

  • Deepen the anterior chamber
  • Lower IOP

Use carefully in patients with:

  • Heart failure
  • Renal impairment
  • Significant volume-status problems


Topical Steroids

Topical corticosteroids are useful because acute angle closure produces:

Significant anterior segment inflammation

They help reduce:

  • Cells/flare
  • Pain
  • Synechial formation


Pilocarpine

Pilocarpine can constrict the pupil and pull the peripheral iris away from the angle.

However:

Do not rely on pilocarpine while IOP is extremely high.

At very high IOP:

  • Iris sphincter becomes ischemic
  • Pilocarpine may be ineffective

It is typically used after IOP begins to fall.


Important Pilocarpine Exceptions

Pilocarpine may be inappropriate or harmful in angle closure caused by:

  • Topiramate/ciliochoroidal effusion
  • Aqueous misdirection
  • Certain lens-induced mechanisms

because further anterior movement or ciliary-body contraction can worsen crowding.


Analgesia and Antiemetics

Patients often require:

  • Analgesics
  • Antiemetics

because nausea and vomiting can be severe.


Anterior Chamber Paracentesis

Anterior chamber paracentesis can produce:

Rapid IOP reduction

and may be considered by an experienced ophthalmologist when:

  • IOP is dangerously high
  • Medical therapy is inadequate
  • Rapid corneal clearing is needed

It is an:

Adjunct, not a substitute for definitive treatment.


Corneal Indentation

Gentle indentation of the central cornea may sometimes temporarily:

  • Force aqueous toward the angle
  • Open appositional closure
  • Reduce IOP

This is a short-term maneuver only.


Definitive Treatment – Laser Peripheral Iridotomy

LPI is the definitive treatment for pupillary block.

The iridotomy creates a direct channel between:

  • Posterior chamber
  • Anterior chamber

which equalizes pressure and flattens iris bombe.


Timing of LPI

LPI should be performed once:

  • IOP is sufficiently controlled
  • Cornea is clear enough
  • Inflammation permits safe laser treatment


Iridotomy Site

LPI is usually placed:

  • Superiorly or superotemporally

under the upper lid when possible.

Modern placement is individualized to:

  • Iris crypts
  • Lid position
  • Laser visibility


Nd:YAG and Argon Laser

Iridotomy may be performed with:

  • Nd:YAG laser
  • Sequential argon + Nd:YAG in thick/dark irides

depending on:

  • Iris pigmentation
  • Thickness
  • Surgeon preference


Fellow-Eye LPI

After an acute primary angle-closure attack in one eye, the fellow eye is at substantial risk.

If the fellow eye has a narrow/occludable angle:

Prophylactic LPI is generally recommended.


LPI Complications

Potential complications include:

  • Transient IOP spike
  • Anterior uveitis
  • Hyphema
  • Corneal endothelial injury
  • Dysphotopsia
  • Closure of iridotomy
  • Rare lens injury


Persistent Narrow Angle After LPI

A patent LPI does not guarantee that the angle becomes fully open.

Persistent narrowing may indicate:

  • Plateau iris
  • Large/thick lens
  • PAS
  • Anteriorly positioned ciliary body
  • Other secondary mechanism


Laser Peripheral Iridoplasty

Argon laser peripheral iridoplasty (ALPI) contracts the peripheral iris and pulls it away from the trabecular meshwork.

It can be useful when:

  • Acute closure persists
  • LPI cannot initially be performed
  • Plateau iris contributes
  • Corneal edema makes iridotomy difficult

ALPI is usually:

Adjunctive rather than definitive for true pupillary block.


Surgical Iridectomy

Surgical peripheral iridectomy is considered when:

  • Laser iridotomy cannot be performed
  • Iridotomy repeatedly closes
  • Significant anatomic limitations exist


Lens Extraction

Modern management increasingly recognizes the role of the lens.

Lens extraction:

  • Deepens the anterior chamber
  • Widens the angle
  • Reduces iridolenticular contact
  • Removes an important component of pupillary block


Cataract Extraction

Cataract extraction is especially appropriate when:

  • Visually significant cataract is present
  • Lens crowding is prominent
  • Angle remains narrow after LPI
  • IOP remains difficult to control
  • Recurrent closure occurs


Clear Lens Extraction

In selected patients with established PAC/PACG, clear lens extraction may be considered even without visually significant cataract.

The EAGLE trial supported early lens extraction in selected patients aged ≥50 with:

  • Primary angle closure with substantially elevated IOP
  • Or PACG

It should not be interpreted as recommending clear-lens extraction for every PACS patient.


Goniosynechialysis

In selected eyes with relatively recent PAS, cataract extraction may be combined with:

Goniosynechialysis

to mechanically strip PAS from the trabecular meshwork.

Benefit depends on:

  • Duration of PAS
  • Extent of closure
  • Residual trabecular function


Persistent Glaucoma After LPI

If IOP remains elevated after the pupillary-block component has been relieved, treat according to the remaining mechanism.

Options include:

  • Topical medications
  • Lens extraction
  • Goniosynechialysis in selected cases
  • Trabeculectomy
  • Glaucoma drainage device
  • Other glaucoma surgery


Chronic Angle-Closure Glaucoma

Patients may require a relatively low target IOP because of:

  • Existing optic nerve damage
  • Extensive PAS
  • Reduced trabecular outflow

LPI alone may not adequately control established PACG.


Family Screening

First-degree relatives have increased risk of:

  • Narrow angles
  • PAC/PACG

They should have comprehensive eye examination including:

Gonioscopy when appropriate.


Follow-Up

After an acute attack or LPI, follow-up should assess:

  • IOP
  • Iridotomy patency
  • Gonioscopy
  • PAS
  • Angle width
  • Optic nerve
  • OCT
  • Visual fields


Serial Gonioscopy

Even after successful LPI:

The angle can continue to narrow over time.

Reasons include:

  • Lens growth
  • Plateau iris
  • Progressive PAS

Therefore serial gonioscopy remains important.


Prognosis

Prognosis depends on:

  • Duration of acute IOP elevation
  • Peak IOP
  • Extent of PAS
  • Preexisting optic nerve damage
  • Speed of treatment
  • Residual angle function

An acute attack treated rapidly can recover excellent vision.

Prolonged untreated attacks may produce:

  • Optic nerve injury
  • Iris atrophy
  • Corneal endothelial damage
  • Lens changes
  • Permanent glaucoma


Complications

Potential complications include:

  • Glaucomatous optic neuropathy
  • Permanent visual field loss
  • PAS
  • Chronic angle closure
  • Optic atrophy
  • Corneal endothelial damage
  • Iris sphincter atrophy
  • Glaukomflecken
  • Central retinal vascular occlusion in severe cases


Ophthalmology Pearls

  • Pupillary block is the most common mechanism of primary angle closure.
  • The sequence is resistance to aqueous flow through the pupil → posterior chamber pressure rises → iris bombe → iridotrabecular contact → IOP elevation.
  • Acute primary angle closure classically causes pain, red eye, blurred vision/halos, headache, nausea, corneal edema, high IOP, and a mid-dilated poorly reactive pupil.
  • Indentation gonioscopy is essential for distinguishing reversible appositional closure from permanent PAS.
  • Laser peripheral iridotomy is definitive treatment for the pupillary-block component because it equalizes anterior and posterior chamber pressure.
  • During an acute attack, first lower IOP with aqueous suppressants ± acetazolamide ± hyperosmotic therapy, control inflammation, then perform LPI when feasible.
  • Pilocarpine is often ineffective at extremely high IOP because of iris sphincter ischemia; use it after pressure begins to fall.
  • A patent LPI does not guarantee a permanently open angle; persistent narrowing suggests plateau iris, lens crowding, PAS, or another mechanism.
  • ALPI is a useful adjunct, especially when LPI cannot initially be performed or plateau iris contributes.
  • The fellow eye after an acute primary angle-closure attack is high risk; if occludable, prophylactic LPI is generally recommended.
  • Lens extraction increasingly plays an important role because it deepens the chamber and widens the angle.
  • The EAGLE trial supports clear-lens extraction in selected established PAC/PACG patients, but not routine lens extraction for every asymptomatic PACS eye.
  • Topiramate-induced angle closure is not pupillary block; it results from ciliochoroidal effusion, so LPI is generally ineffective.
  • Even after successful LPI, continue serial gonioscopy, IOP monitoring, optic nerve/OCT assessment, and visual fields because PAS and chronic angle closure can still progress.


Image description
Published on

Ophthalmology – Congenital Ptosis

Basics

Description

Congenital ptosis is drooping of the upper eyelid that is present at birth or develops within the first year of life.

The most common form is:

Simple congenital myogenic ptosis due to levator palpebrae superioris dysgenesis

It may be:

  • Unilateral
  • Bilateral
  • Mild to complete
  • Isolated or syndromic

The major clinical concern is not cosmetic appearance but preservation of visual development by preventing:

  • Amblyopia
  • Significant astigmatism
  • Anisometropia
  • Strabismus
  • Visual-axis obstruction
  • Persistent abnormal head posture


Pathophysiology

In simple congenital ptosis, the levator muscle is developmentally abnormal.

Normal skeletal muscle fibers are variably replaced by:

  • Fibrous tissue
  • Adipose tissue

This produces:

  • Reduced levator contractility
  • Reduced relaxation in downgaze

The result is the classic combination of:

Ptosis in primary gaze + lid lag in downgaze


Epidemiology

Congenital ptosis is uncommon, but exact prevalence varies among populations.

Most cases are:

  • Sporadic
  • Idiopathic

Familial cases occur.


Genetics

The genetics of isolated congenital ptosis are heterogeneous.

Some familial forms demonstrate:

  • Autosomal dominant inheritance
  • X-linked inheritance
  • Other chromosomal associations

Routine genetic testing is not required for isolated simple congenital ptosis.

Genetic evaluation is more useful when:

  • Ptosis is bilateral
  • Other congenital anomalies are present
  • There is a strong family history
  • A defined syndrome is suspected


Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome

BPES is an important syndromic cause of congenital ptosis.

It is associated with pathogenic variants in:

FOXL2

and usually follows an:

Autosomal dominant

inheritance pattern.


BPES Features

The classic findings are:

  • Bilateral ptosis
  • Blepharophimosis
  • Epicanthus inversus
  • Telecanthus

Some affected females also develop:

Primary ovarian insufficiency

depending on the BPES subtype.


Other Syndromic Associations

Congenital ptosis may occur with:

  • Congenital fibrosis of the extraocular muscles
  • Craniofacial syndromes
  • Myotonic disorders
  • Mitochondrial disease
  • Chromosomal syndromes

Systemic evaluation is appropriate when other developmental abnormalities are present.


Clinical Presentation

The eyelid position may range from:

  • Subtle asymmetry
  • Partial pupillary coverage
  • Complete visual-axis obstruction

Parents may notice:

  • Drooping eyelid
  • Chin-up posture
  • Brow elevation
  • Forehead wrinkling
  • Eye closure asymmetry
  • Strabismus


Amblyopia

Amblyopia is one of the most important complications.

It may result from:

  • Visual-axis occlusion
  • Induced astigmatism
  • Anisometropia
  • Associated strabismus

An important point:

Refractive error and strabismus are common causes of amblyopia in congenital ptosis, even when the pupil is not completely covered.


Refractive Error

Congenital ptosis may be associated with:

  • Astigmatism
  • Anisometropia
  • Myopia
  • Hyperopia

The pressure and altered contour of a ptotic lid may contribute to:

Corneal astigmatism

Therefore all children require:

Cycloplegic refraction


Abnormal Head Posture

Children with bilateral severe ptosis may compensate with:

Chin elevation

This allows them to see beneath the drooping eyelids.

Persistent chin-up posture is itself an indication to consider surgery.


Frontalis Recruitment

Children often compensate by:

  • Elevating the eyebrows
  • Contracting the frontalis muscle

This may partially mask the severity of ptosis.

The brow should therefore be stabilized during formal measurement.


History

Ask about:

  • Present since birth?
  • Stable or progressive?
  • Unilateral or bilateral?
  • Does it fluctuate?
  • Worse when tired?
  • Jaw movement change the eyelid?
  • Abnormal head posture?
  • Sleep with the eye partly open?
  • Family history?
  • Birth trauma?
  • Other congenital abnormalities?

Old photographs are useful for documenting:

  • Chronicity
  • Symmetry
  • Head posture
  • Variability


Fluctuating Ptosis

True simple congenital ptosis is generally:

Stable rather than fluctuating

Marked variability should raise suspicion for:

  • Myasthenia gravis
  • Intermittent neurogenic disease
  • Mechanical factors


Examination

A complete pediatric ophthalmic examination should assess:

  • Visual acuity
  • Cycloplegic refraction
  • Ocular alignment
  • Ocular motility
  • Pupils
  • Eyelid measurements
  • Cornea
  • Anterior segment
  • Fundus


Margin Reflex Distance 1

MRD1 is the distance from the corneal light reflex to the upper eyelid margin in primary gaze.

It helps quantify:

  • Ptosis severity
  • Symmetry

A normal MRD1 is generally approximately:

4–5 mm

in adults, though pediatric interpretation should consider age and cooperation.


Palpebral Fissure Height

Measure the vertical distance between:

  • Upper lid margin
  • Lower lid margin

in primary gaze.

Compare both eyes.


Levator Function

This is the most important surgical measurement.

To measure:

  1. Stabilize the brow to eliminate frontalis action.
  2. Ask the patient to look from maximum downgaze to maximum upgaze.
  3. Measure upper-lid excursion.

Approximate interpretation:

  • Good: ≥12 mm
  • Fair: 5–11 mm
  • Poor: ≤4 mm


Congenital Ptosis Examination Pattern

Classic simple congenital ptosis shows:

  • Poor levator function
  • Weak or absent lid crease
  • Lid lag in downgaze
  • Possible lagophthalmos
  • Frontalis overaction
  • Chin-up posture in severe bilateral cases


Lid Crease

The upper eyelid crease is often:

  • Weak
  • Poorly formed
  • Absent

because the abnormal levator has reduced attachment and function.

This contrasts with aponeurotic ptosis, which often has:

Good levator function with a high lid crease.


Lid Lag in Downgaze

This is a classic congenital ptosis feature.

Because the dysgenic levator does not relax normally, the affected eyelid remains relatively elevated in downgaze.

Thus the ptotic lid may appear:

Higher than expected in downgaze

compared with the normal side.


Bell Phenomenon

Always assess:

Bell phenomenon

before ptosis surgery.

Poor Bell phenomenon increases the risk of:

  • Exposure keratopathy
  • Corneal ulceration

after postoperative eyelid elevation.


Lagophthalmos

Assess:

  • Voluntary closure
  • Forced closure
  • Sleep-related lagophthalmos when history suggests it

Children with congenital ptosis may already have incomplete closure, and surgery can worsen it.


Corneal Examination

Look for:

  • Exposure
  • Punctate epithelial erosions
  • Scarring
  • Reduced tear-film protection

especially when:

  • Bell phenomenon is poor
  • Lagophthalmos is present


Pupillary Examination

Pupils are essential in distinguishing congenital ptosis from neurogenic causes.

Miosis

Consider:

Horner syndrome

Mydriasis

Consider:

CN III palsy

especially if accompanied by ophthalmoplegia.


Ocular Motility

Assess all ductions and versions.

Motility abnormalities suggest diagnoses other than isolated levator dysgenesis.

Important possibilities include:

  • CN III palsy
  • Monocular elevation deficiency
  • Congenital fibrosis of extraocular muscles
  • Marcus Gunn jaw-winking
  • Other congenital cranial dysinnervation disorders


Monocular Elevation Deficiency

The older term:

Double elevator palsy

is now more often termed:

Monocular elevation deficiency

The affected eye has limited elevation in:

  • Abduction
  • Adduction

and may appear ptotic because of:

  • True ptosis
  • Hypotropia-related pseudoptosis
  • Both


Marcus Gunn Jaw-Winking Syndrome

Marcus Gunn jaw-winking is a congenital cranial dysinnervation disorder characterized by:

Elevation or retraction of the ptotic upper lid during jaw movement

Triggers may include:

  • Sucking
  • Chewing
  • Opening the mouth
  • Moving the jaw laterally


Marcus Gunn Mechanism

It results from aberrant innervation between:

  • Trigeminal motor pathways
  • Levator palpebrae superioris

It is usually:

  • Unilateral
  • Associated with congenital ptosis


Examination for Jaw-Winking

Observe the eyelid while the child:

  • Sucks from a bottle
  • Chews
  • Opens the mouth
  • Moves the jaw side to side

This is easily missed if not specifically tested.


Treatment of Jaw-Winking

Mild jaw-winking may simply be observed.

Significant socially or functionally troublesome synkinesis may require:

  • Levator weakening/excision
  • Frontalis suspension

Surgical strategy is individualized according to:

  • Degree of jaw wink
  • Ptosis severity
  • Symmetry


Horner Syndrome

Congenital Horner syndrome may produce:

  • Mild ptosis
  • Miosis
  • Lower-lid “reverse ptosis”
  • Iris heterochromia

The affected iris may appear:

Lighter

when sympathetic disruption occurs early in life.


Congenital Horner Workup

Congenital Horner syndrome requires evaluation based on:

  • Timing
  • Birth trauma
  • Neurologic examination
  • Acquired vs clearly congenital onset

If the cause is uncertain, investigation for lesions along the sympathetic pathway may be needed.


Third Nerve Palsy

Congenital or acquired CN III dysfunction may cause:

  • Ptosis
  • Ophthalmoplegia
  • Exotropia/hypotropia
  • Possible pupil abnormality

A ptotic child with abnormal motility should not automatically be diagnosed with simple congenital ptosis.


Congenital Fibrosis of the Extraocular Muscles

CFEOM is a congenital cranial dysinnervation disorder characterized by:

  • Restrictive ophthalmoplegia
  • Abnormal eye position
  • Ptosis
  • Compensatory head posture

Genetic causes include several genes affecting cranial motor neuron development.


Myasthenia Gravis

Rarely, childhood myasthenia may mimic congenital ptosis.

Features favoring myasthenia include:

  • Fluctuating ptosis
  • Fatigability
  • Variable diplopia
  • Orbicularis weakness
  • Normal pupils

Testing may include:

  • AChR antibodies
  • Ice-pack test
  • Electrophysiology


Mechanical Ptosis

Always evert and inspect the lid when an atypical mass is suspected.

Potential causes include:

  • Dermoid
  • Neurofibroma
  • Hemangioma
  • Chalazion
  • Other eyelid/orbital tumors

Imaging may be required if:

  • Mass effect
  • Proptosis
  • Globe displacement

is present.


Pseudoptosis

Apparent congenital ptosis may result from:

  • Microphthalmos
  • Enophthalmos
  • Hypotropia
  • Contralateral lid retraction
  • Brow asymmetry

These should be distinguished from true levator dysfunction.


Diagnostic Testing

Simple congenital ptosis usually requires:

No laboratory testing or imaging

The diagnosis is clinical.


When Imaging Is Indicated

Consider MRI or CT when there is:

  • Abnormal ocular motility
  • CN III palsy
  • Suspected Horner syndrome
  • Orbital mass
  • Proptosis
  • Rapid progression
  • Neurologic abnormalities
  • Atypical presentation

MRI is generally preferred when evaluating:

  • Brain
  • Cranial nerves
  • Soft-tissue orbital pathology


Genetic Testing

Consider genetic evaluation when there is suspicion for:

  • BPES
  • CFEOM
  • Syndromic craniofacial disease
  • Multiple affected family members


Differential Diagnosis

Important differentials include:

  • Simple congenital myogenic ptosis
  • Marcus Gunn jaw-winking syndrome
  • Horner syndrome
  • CN III palsy
  • Monocular elevation deficiency
  • CFEOM
  • Mechanical ptosis
  • Birth-trauma-related ptosis
  • Myasthenia gravis
  • CPEO
  • Myotonic dystrophy
  • Microphthalmos
  • Enophthalmos
  • Hypotropia-related pseudoptosis
  • BPES


Treatment Principles

The priorities are:

  1. Prevent amblyopia
  2. Correct refractive error
  3. Treat strabismus when indicated
  4. Correct significant abnormal head posture
  5. Improve eyelid position and symmetry

Cosmesis is important but comes after preservation of visual development.


Refractive Correction

Treat:

  • Astigmatism
  • Anisometropia
  • Hyperopia
  • Myopia

with appropriate spectacles or contact lenses.

Cycloplegic refraction should be repeated periodically throughout childhood.


Amblyopia Treatment

Treatment may include:

  • Spectacle correction
  • Patching
  • Atropine penalization in selected children

Amblyopia therapy should begin promptly when indicated and should not be delayed solely until after ptosis surgery.


Observation

Observation is appropriate for mild congenital ptosis when there is:

  • Clear visual axis
  • No amblyopia
  • No significant refractive error
  • No strabismus-related concern
  • No abnormal head posture

These children still require:

Long-term visual surveillance.


Indications for Early Surgery

Early surgery is indicated when there is:

  • Visual-axis obstruction
  • Amblyopia or high risk of amblyopia
  • Significant induced astigmatism
  • Persistent chin-up posture
  • Severe bilateral ptosis affecting visual development

In these circumstances:

Do not delay surgery for cosmetic-age considerations.


Timing When Vision Is Not Threatened

If vision develops normally and there is no significant head posture, surgery can often be deferred until approximately:

3–5 years of age

This allows:

  • More reliable measurements
  • Better tissue size
  • Improved postoperative assessment

Timing should be individualized.


Surgical Choice

The operation is determined primarily by:

Levator function


Poor Levator Function

When levator function is approximately:

≤4 mm

the preferred procedure is generally:

Frontalis suspension / frontalis sling


Frontalis Sling

The eyelid is connected to the frontalis muscle so that:

Brow elevation raises the eyelid

This is especially useful for:

  • Severe simple congenital ptosis
  • Poor levator function
  • Selected neuromuscular disorders


Sling Materials

Options include:

  • Autologous fascia lata
  • Silicone rod
  • Other synthetic materials

Autologous fascia lata is durable but may be impractical in very young children because insufficient fascia is available.

Silicone is useful because it is:

  • Adjustable
  • Reversible
  • Commonly used in younger children


Fair or Good Levator Function

If levator function is adequate, options include:

  • Levator resection
  • Levator advancement

The amount of resection depends on:

  • Ptosis severity
  • Levator function
  • Desired eyelid height


Müller Muscle Procedures

Posterior Müller muscle–conjunctival procedures are less commonly the primary operation for classic severe congenital myogenic ptosis because:

  • Levator function is often abnormal

They may be useful in carefully selected mild cases with:

  • Good levator function
  • Good phenylephrine response


Surgical Goals

Goals are:

  • Clear visual axis
  • Appropriate lid height
  • Good contour
  • Acceptable symmetry
  • Preservation of corneal protection

Perfect symmetry in:

  • Primary gaze
  • Upgaze
  • Downgaze

is often impossible because the dysgenic levator does not behave normally.


Postoperative Lagophthalmos

Some degree of lagophthalmos is common after congenital ptosis surgery.

This is particularly expected after:

  • Frontalis sling
  • Large levator resection

The key is whether the cornea remains:

Adequately protected.


Postoperative Lubrication

Management may include:

  • Preservative-free tears
  • Lubricating ointment
  • Nighttime ointment
  • Temporary taping in selected cases

especially when lagophthalmos is significant.


Exposure Keratopathy

Risk is greater with:

  • Poor Bell phenomenon
  • Reduced corneal sensation
  • Aggressive correction
  • Preexisting dry eye
  • Severe bilateral surgery

Monitor carefully for:

  • Punctate epitheliopathy
  • Persistent epithelial defect
  • Corneal ulceration


Hering’s Law

In asymmetric bilateral ptosis, increased central levator drive may elevate the less ptotic eyelid.

After correcting one eyelid:

The fellow eyelid may fall

revealing previously masked bilateral ptosis.

This should be assessed before surgery.


Strabismus

Strabismus is relatively common in congenital ptosis.

Management depends on:

  • Visual axis
  • Head posture
  • Ocular alignment
  • Type of motility disorder

In some patients:

Strabismus surgery is performed before ptosis surgery

because changing ocular alignment can alter apparent eyelid position.


Follow-Up

Children require regular follow-up throughout visual development.

Monitor:

  • Visual acuity
  • Cycloplegic refraction
  • Amblyopia
  • Ocular alignment
  • MRD1
  • Levator function
  • Chin-up posture
  • Corneal exposure
  • Recurrence


Frequency

Follow-up is individualized.

Infants and young children at amblyopia risk require:

Closer and more frequent surveillance

than older children with stable mild ptosis.


Recurrence

Ptosis may recur because of:

  • Growth
  • Sling stretching
  • Material degradation
  • Progressive tissue changes

Repeat surgery may occasionally be necessary.


Surgical Complications

Potential complications include:

  • Undercorrection
  • Overcorrection
  • Eyelid asymmetry
  • Abnormal contour
  • Lagophthalmos
  • Exposure keratopathy
  • Infection
  • Granuloma
  • Sling extrusion
  • Recurrence


Frontalis Sling Infection

Synthetic sling material can rarely cause:

  • Infection
  • Granuloma
  • Extrusion

Management may require:

  • Antibiotics
  • Drainage
  • Partial or complete sling removal


Prognosis

With appropriate surveillance and treatment:

Visual prognosis is generally excellent.

The most important preventable cause of poor vision is:

Amblyopia

rather than the lid abnormality itself.


Ophthalmology Pearls

  • Simple congenital ptosis is usually caused by levator dysgenesis with fibrofatty replacement of normal muscle.
  • The classic examination is poor levator function + weak lid crease + lid lag in downgaze.
  • The major threat is amblyopia, which can arise from visual-axis obstruction, astigmatism, anisometropia, or associated strabismus.
  • Every child with congenital ptosis requires cycloplegic refraction and amblyopia surveillance, even if the pupil is not completely covered.
  • A chin-up posture suggests functionally significant ptosis and may itself justify surgery.
  • Always examine pupils and ocular motility to exclude Horner syndrome, CN III palsy, and congenital cranial dysinnervation disorders.
  • Marcus Gunn jaw-winking causes lid elevation with jaw movement and should be specifically tested during chewing or sucking.
  • The historical term double elevator palsy is now more commonly called monocular elevation deficiency.
  • BPES is associated with FOXL2 and features bilateral ptosis, blepharophimosis, epicanthus inversus, and telecanthus.
  • Simple congenital ptosis usually requires no laboratory testing or neuroimaging unless neurologic, motility, orbital, or syndromic findings are present.
  • Surgery should be performed early if the visual axis is obstructed, amblyopia risk is high, or a significant chin-up posture is present.
  • When visual development is not threatened, surgery can often be deferred until approximately 3–5 years of age.
  • Poor levator function (≈4 mm or less) → frontalis sling is the classic surgical principle.
  • Fair/good levator function → levator resection or advancement is usually preferred.
  • Check Bell phenomenon and corneal exposure risk before surgery.
  • Some postoperative lagophthalmos is expected, particularly after frontalis suspension; the critical issue is maintaining corneal protection.
  • Congenital ptosis requires follow-up throughout childhood because refractive error, amblyopia, strabismus, and recurrence can evolve over time.


Image description
Published on

Ophthalmology – Ptosis


Basics


Description


Ptosis (blepharoptosis) is abnormal drooping of the upper eyelid caused by dysfunction of the eyelid-elevating apparatus.


It may be:


  • Congenital
  • Acquired
  • Unilateral or bilateral


Ptosis can cause:


  • Superior visual field loss
  • Reduced central vision if severe
  • Astigmatism
  • Abnormal head posture
  • Amblyopia in children


The key clinical task is to determine:


Is the ptosis aponeurotic, myogenic, neurogenic, mechanical, traumatic, or pseudoptosis?


⸻


Eyelid Elevators


The upper eyelid is elevated primarily by:


Levator Palpebrae Superioris


  • Innervated by CN III
  • Provides most upper eyelid elevation


Müller Muscle


  • Sympathetically innervated
  • Contributes approximately 1–2 mm of elevation


Frontalis Muscle


  • Innervated by CN VII
  • Can compensate by elevating the eyebrow


⸻


Classification


The major categories are:


  • Aponeurotic
  • Myogenic
  • Neurogenic
  • Mechanical
  • Traumatic
  • Congenital developmental
  • Pseudoptosis


⸻


Aponeurotic Ptosis


Aponeurotic/involutional ptosis is the most common acquired form in adults.


It results from:


  • Stretching
  • Thinning
  • Dehiscence
  • Disinsertion


of the levator aponeurosis.


⸻


Risk Factors for Aponeurotic Ptosis


Associations include:


  • Aging
  • Previous intraocular surgery
  • Long-term contact lens wear
  • Chronic eye rubbing
  • Repeated eyelid manipulation
  • Trauma


⸻


Typical Aponeurotic Examination


Classic findings include:


  • Mild–moderate ptosis
  • Good levator function
  • High or absent upper lid crease
  • Deep superior sulcus
  • Lid lag may be absent
  • Ptosis may appear more pronounced in downgaze


⸻


Congenital Ptosis


Most simple congenital ptosis results from:


Levator muscle dysgenesis


with replacement of normal muscle by:


  • Fibrous tissue
  • Fatty tissue


This causes both:


  • Reduced elevation
  • Reduced relaxation


⸻


Congenital Examination


Typical findings include:


  • Ptosis present from birth or infancy
  • Poor levator function
  • Weak or absent eyelid crease
  • Lid lag in downgaze
  • Possible lagophthalmos
  • Compensatory brow elevation
  • Chin-up head posture


⸻


Pediatric Importance


Congenital ptosis can cause amblyopia through:


  • Visual-axis occlusion
  • Induced astigmatism
  • Anisometropia
  • Associated strabismus


Every child with ptosis requires:


  • Cycloplegic refraction
  • Amblyopia assessment
  • Strabismus examination
  • Visual-axis assessment


⸻


Timing of Congenital Ptosis Surgery


If the eyelid obstructs the visual axis or produces significant abnormal head posture:


Early surgery may be necessary to prevent amblyopia.


If there is no amblyopia risk, surgery can often be delayed until:


  • Later preschool years


when measurements and postoperative cooperation are easier.


⸻


Myogenic Ptosis


Myogenic ptosis results from intrinsic dysfunction of the levator or related skeletal muscle.


Causes include:


  • Myasthenia gravis
  • Chronic progressive external ophthalmoplegia
  • Oculopharyngeal muscular dystrophy
  • Myotonic dystrophy
  • Other mitochondrial or muscular disorders


⸻


Myasthenia Gravis


Myasthenia is an essential cause of:


Variable or fluctuating ptosis


Typical features include:


  • Ptosis worsens with fatigue
  • Improvement after rest
  • Variable diplopia
  • Orbicularis weakness
  • Cogan lid twitch
  • Enhancement of ptosis
  • Pupils remain normal


⸻


Myasthenia Pearl


A pupil abnormality should make isolated ocular myasthenia:


Much less likely


because the autonomic pupil is typically spared.


⸻


Ice-Pack Test


An ice-pack test may support ocular myasthenia.


After several minutes of cooling the eyelid:


  • Improvement in ptosis of approximately 2 mm or more


supports the diagnosis.


It is:


  • Simple
  • Noninvasive
  • Particularly useful in ptosis-predominant disease


⸻


Laboratory Testing for Myasthenia


Consider:


  • AChR antibodies
  • MuSK antibodies in selected seronegative generalized cases
  • Other antibody testing depending on clinical context


Electrophysiology may include:


  • Repetitive nerve stimulation
  • Single-fiber EMG, which is highly sensitive


⸻


Important Modern Correction – Edrophonium


The historical:


Edrophonium (Tensilon) test


is now rarely used because:


  • Availability is limited
  • Cardiac/cholinergic adverse effects are possible
  • Safer diagnostic alternatives exist


⸻


Chronic Progressive External Ophthalmoplegia


CPEO typically causes:


  • Slowly progressive bilateral ptosis
  • Symmetric ophthalmoplegia
  • Little diplopia despite marked motility restriction


because progression is gradual and symmetric.


It is often associated with:


Mitochondrial disease.


⸻


Oculopharyngeal Muscular Dystrophy


Typically presents in later adulthood with:


  • Bilateral ptosis
  • Dysphagia


Family history may be present.


⸻


Myotonic Dystrophy


May produce:


  • Bilateral ptosis
  • Orbicularis weakness
  • Ophthalmoplegia
  • Christmas-tree cataract
  • Systemic myotonia


⸻


Neurogenic Ptosis


Major causes include:


  • Third cranial nerve palsy
  • Horner syndrome
  • Rare central neurologic disease


These are especially important in acute ptosis.


⸻


Third Nerve Palsy


CN III innervates:


  • Levator palpebrae
  • Superior rectus
  • Inferior rectus
  • Medial rectus
  • Inferior oblique
  • Parasympathetic pupillary fibers


⸻


Classic Third Nerve Palsy


Findings may include:


  • Marked or complete ptosis
  • Eye positioned “down and out”
  • Adduction deficit
  • Elevation deficit
  • Depression deficit
  • Diplopia
  • Possible dilated pupil


⸻


Pupil-Involving Third Nerve Palsy


An acute third nerve palsy with:


  • Mydriasis
  • Pain
  • Partial ophthalmoplegia


must raise concern for:


Posterior communicating artery aneurysm


and requires urgent vascular imaging.


⸻


Modern Imaging Principle for Third Nerve Palsy


Because aneurysms can occasionally present atypically:


Acute acquired third nerve palsy generally warrants urgent neurovascular imaging, particularly if:


  • Pupil is involved
  • Palsy is partial
  • Severe headache/pain is present
  • Patient is young
  • Pattern is atypical


Preferred studies include:


  • CTA
  • MRA


with catheter angiography reserved for selected cases.


⸻


Horner Syndrome


Horner syndrome results from interruption of the sympathetic pathway.


Classic findings include:


  • Mild upper eyelid ptosis
  • Miosis
  • Lower eyelid elevation (“reverse ptosis”)
  • Apparent enophthalmos
  • Possible facial anhidrosis depending on lesion location


⸻


Horner Ptosis


Because Müller muscle contributes only a small amount of lid elevation, Horner ptosis is usually:


Mild


rather than complete.


⸻


Congenital Horner Syndrome


Congenital or long-standing early childhood Horner syndrome may produce:


Iris heterochromia


with the affected iris appearing lighter.


⸻


Painful Horner Syndrome


Acute Horner syndrome associated with:


  • Ipsilateral neck pain
  • Facial pain
  • Headache


should be considered:


Internal carotid artery dissection until proven otherwise.


Urgent:


  • CTA head/neck
  • MRA head/neck


is indicated.


⸻


Pharmacologic Testing for Horner Syndrome


Modern confirmation usually uses:


Apraclonidine


because denervation supersensitivity produces:


  • Dilation of the affected pupil
  • Improvement of mild ptosis


The anisocoria may reverse after testing.


⸻


Important Modern Correction – Cocaine/Hydroxyamphetamine


Older testing used:


  • Cocaine
  • Hydroxyamphetamine


These are now much less commonly used because:


  • Availability is limited
  • Apraclonidine is simpler
  • Localization is increasingly performed with imaging rather than pharmacologic hydroxyamphetamine testing


Use caution with apraclonidine in:


Very young infants


because systemic CNS and cardiovascular adverse effects can occur.


⸻


Marcus Gunn Jaw-Winking Syndrome


This congenital synkinesis causes:


Upper eyelid elevation with jaw movement


such as:


  • Chewing
  • Sucking
  • Moving jaw to opposite side


It results from aberrant innervation between:


  • Trigeminal motor pathways
  • Levator palpebrae


It is often associated with congenital ptosis.


⸻


Blepharophimosis Syndrome


The classic BPES phenotype includes:


  • Bilateral ptosis
  • Blepharophimosis
  • Epicanthus inversus
  • Telecanthus


It is commonly associated with:


FOXL2


mutations and follows an autosomal dominant pattern.


Some forms are associated with:


  • Premature ovarian insufficiency


⸻


Mechanical Ptosis


Mechanical ptosis occurs when excess weight or structural abnormality pulls the lid downward.


Causes include:


  • Eyelid tumor
  • Chalazion
  • Eyelid edema
  • Amyloid deposition
  • Neurofibroma
  • Scar
  • Severe dermatochalasis
  • Giant papillary conjunctivitis


⸻


Traumatic Ptosis


Trauma can damage:


  • Levator muscle
  • Levator aponeurosis
  • CN III
  • Sympathetic fibers


Mechanism may include:


  • Laceration
  • Contusion
  • Orbital injury


⸻


Post-Traumatic Observation


Some blunt-trauma ptosis improves spontaneously as:


  • Edema resolves
  • Nerve function recovers
  • Muscle injury heals


Definitive surgery is often delayed when reasonable, but:


A fixed six-month waiting period is not required in every case.


Repair may be earlier when there is:


  • Clear levator transection
  • Significant laceration
  • Visual-axis obstruction
  • Little expectation of spontaneous recovery


⸻


Reactive Ptosis


Painful ocular disease may produce temporary ptosis from:


  • Reflex orbicularis activation
  • Inflammation
  • Swelling


Examples include:


  • Corneal abrasion
  • Uveitis
  • Orbital inflammation


Treating the underlying disorder usually improves the lid position.


⸻


Pseudoptosis


Not all apparent ptosis represents true upper eyelid elevator dysfunction.


Causes of pseudoptosis include:


  • Dermatochalasis
  • Brow ptosis
  • Contralateral upper lid retraction
  • Enophthalmos
  • Microphthalmos
  • Phthisis bulbi
  • Hypotropia
  • Small or recessed globe


⸻


History


Important questions include:


  • Congenital or acquired?
  • Acute or gradual?
  • Constant or fluctuating?
  • Worse late in day?
  • Associated diplopia?
  • Pupil change?
  • Headache or neck pain?
  • Previous ocular surgery?
  • Trauma?
  • Contact lens wear?
  • Difficulty swallowing or generalized weakness?
  • Family history?


Old photographs are particularly useful for determining:


Chronicity.


⸻


Examination – Core Measurements


A formal ptosis examination should document:


  • MRD1
  • MRD2
  • Palpebral fissure height
  • Levator function
  • Upper lid crease height
  • Brow position
  • Lagophthalmos
  • Bell phenomenon


⸻


Margin Reflex Distance 1


MRD1 is the distance between:


  • Central corneal light reflex
  • Upper eyelid margin


in primary gaze.


Normal MRD1 is approximately:


4–5 mm


although normal values vary.


⸻


Ptosis Severity by MRD1


Approximate clinical description:


  • Mild: ~2 mm droop
  • Moderate: ~3 mm
  • Severe: ≥4 mm or pupil covered


The actual surgical decision depends on:


  • Levator function
  • Etiology
  • Visual function


not simply droop magnitude.


⸻


Levator Function


Measured by:


  • Stabilizing the brow to eliminate frontalis action
  • Measuring upper lid excursion from downgaze to upgaze


Approximate interpretation:


  • Good: ≥12 mm
  • Fair: ~5–11 mm
  • Poor: ≤4 mm


These categories guide surgical choice.


⸻


Lid Crease


A:


High lid crease + good levator function


strongly suggests:


Aponeurotic ptosis.


A weak or absent crease with poor levator function favors:


Congenital myogenic ptosis.


⸻


Brow Examination


Patients may compensate for ptosis by:


  • Elevating eyebrows
  • Wrinkling forehead


The brow should therefore be manually relaxed when evaluating true eyelid position.


⸻


Pupils


Pupil examination is mandatory in:


Any new ptosis.


Look for:


  • Miosis → Horner syndrome
  • Mydriasis → CN III palsy
  • Anisocoria pattern in light vs dark


⸻


Ocular Motility


Assess:


  • Ductions
  • Versions
  • Alignment
  • Diplopia


Ptosis associated with ophthalmoplegia strongly suggests:


  • CN III palsy
  • Myasthenia
  • CPEO
  • Orbital disease


rather than simple aponeurotic ptosis.


⸻


Bell Phenomenon


Assess Bell phenomenon before surgery.


Poor Bell phenomenon increases the risk of:


Postoperative exposure keratopathy


especially after aggressive elevation.


⸻


Corneal Sensation and Ocular Surface


Assess:


  • Tear film
  • Corneal sensation
  • Exposure
  • Dry eye
  • Lagophthalmos


because ptosis correction may worsen:


  • Exposure keratopathy
  • Dry eye symptoms


⸻


Upper Lid Eversion


Evert the upper lid when mechanical disease is possible.


Look for:


  • Foreign body
  • Giant papillary conjunctivitis
  • Mass
  • Scar


⸻


Hering’s Law


Elevation of the upper eyelids is bilaterally linked through central innervation.


In unilateral ptosis, the brain may increase levator drive to both eyes.


After lifting the ptotic lid, the fellow lid may:


Drop


revealing previously masked bilateral ptosis.


This is the:


Hering phenomenon


and is important for surgical planning.


⸻


Phenylephrine Test


Topical phenylephrine stimulates Müller muscle.


Improvement of ptosis can help identify patients who may respond to:


Müller muscle–conjunctival resection (MMCR)


It also helps estimate postoperative eyelid position in selected cases.


⸻


Visual Field Testing


Functional visual fields may document:


  • Superior field loss


from ptosis.


Testing may be performed:


  • With eyelid in natural position
  • With lid taped/elevated


to demonstrate functional improvement.


⸻


Clinical Photography


Standardized external photographs are useful for:


  • Baseline documentation
  • Surgical planning
  • Insurance/functional documentation
  • Postoperative comparison


⸻


Imaging


Imaging is not required for typical chronic aponeurotic or congenital ptosis.


Obtain imaging when the history or examination suggests:


  • Orbital mass
  • Neurologic lesion
  • CN III palsy
  • Horner syndrome
  • Trauma


⸻


Orbital Mass


Consider:


  • CT orbit
  • MRI orbit


when there is:


  • Proptosis
  • Globe displacement
  • Palpable mass
  • Progressive unilateral mechanical ptosis
  • Motility restriction


⸻


Differential Diagnosis


Important differential diagnoses include:


  • Dermatochalasis
  • Brow ptosis
  • Contralateral lid retraction
  • Enophthalmos
  • Hypotropia
  • Microphthalmos
  • Phthisis bulbi
  • Eyelid edema


⸻


Treatment Principles


Treatment depends on:


  • Etiology
  • Severity
  • Visual impairment
  • Levator function
  • Ocular surface status
  • Patient goals


Before surgery:


Treat the underlying neurologic, muscular, inflammatory, or mechanical cause whenever possible.


⸻


Observation


Observation is appropriate for:


  • Mild stable ptosis
  • No visual field impairment
  • No amblyopia risk
  • Acceptable cosmesis


⸻


Medical Treatment – Myasthenia


Treatment may include:


  • Pyridostigmine
  • Corticosteroids
  • Steroid-sparing immunosuppressants
  • IVIG or plasma exchange in selected severe disease
  • Targeted biologic therapy in appropriate generalized disease


Ptosis surgery is usually avoided until ocular myasthenia is:


Stable and medically optimized.


⸻


Acquired Ptosis Medication


In selected adults with acquired ptosis, topical:


Oxymetazoline 0.1%


can temporarily elevate the upper eyelid by stimulating Müller muscle.


It is most useful in:


  • Mild acquired ptosis


It does not correct:


  • Severe levator dysfunction
  • Mechanical ptosis
  • Major neurologic disease


⸻


Eyelid Crutch


A spectacle-mounted eyelid crutch may be considered in patients who:


  • Are poor surgical candidates
  • Have neuromuscular disease
  • Need temporary mechanical elevation


Potential problems include:


  • Dry eye
  • Exposure
  • Discomfort


⸻


Surgical Treatment


Main surgical approaches include:


  • External levator advancement/resection
  • Müller muscle–conjunctival resection
  • Frontalis suspension


Choice depends primarily on:


  • Etiology
  • Levator function
  • Degree of ptosis


⸻


External Levator Advancement


Best suited for:


Aponeurotic ptosis with good levator function


The levator aponeurosis is:


  • Reattached
  • Advanced


onto the tarsal plate.


This is a standard procedure for involutional ptosis.


⸻


Levator Resection


Levator resection may be used in:


  • Congenital ptosis
  • Fair to good levator function


The amount of resection is adjusted according to:


  • Ptosis severity
  • Levator function


⸻


Müller Muscle–Conjunctival Resection


MMCR is particularly useful for:


  • Mild–moderate ptosis
  • Good levator function
  • Good response to phenylephrine


Advantages include:


  • Posterior approach
  • No external skin incision
  • Predictable contour in selected patients


⸻


Fasanella-Servat Procedure


Historical posterior lamellar shortening procedures remain available but are:


Less commonly emphasized than modern MMCR techniques.


⸻


Frontalis Sling


Frontalis suspension is usually used when levator function is:


Poor


especially in:


  • Severe congenital ptosis
  • Selected neuromuscular disorders


The eyelid is linked to the frontalis muscle so brow elevation raises the lid.


⸻


Frontalis Sling Materials


Options include:


  • Autologous fascia lata
  • Silicone rod
  • Other synthetic materials


Selection depends on:


  • Age
  • Etiology
  • Surgeon preference


⸻


Exposure Risk After Surgery


All ptosis surgery carries a risk of:


  • Lagophthalmos
  • Exposure keratopathy


Risk is particularly important with:


  • Poor Bell phenomenon
  • Reduced corneal sensation
  • Severe dry eye
  • CPEO
  • Aggressive frontalis sling


⸻


Postoperative Complications


Potential complications include:


  • Undercorrection
  • Overcorrection
  • Asymmetry
  • Abnormal contour
  • Lagophthalmos
  • Exposure keratopathy
  • Dry eye
  • Infection
  • Hemorrhage
  • Recurrence
  • Need for revision


⸻


Congenital Ptosis Prognosis


Visual prognosis is good when:


  • Amblyopia is prevented
  • Refractive error is corrected
  • Strabismus is treated
  • Visual axis remains clear


Cosmetic symmetry can often be significantly improved but may not be perfect.


⸻


Acquired Aponeurotic Ptosis Prognosis


Surgical prognosis is generally:


Excellent


with appropriate patient selection.


Some patients develop:


  • Recurrent aponeurotic stretching
  • Contralateral ptosis
  • Residual asymmetry


over time.


⸻


Emergency Ptosis Red Flags


Urgent evaluation is required for:


  • Acute ptosis + dilated pupil
  • Acute ptosis + ophthalmoplegia
  • Painful acute Horner syndrome
  • Acute ptosis with severe headache
  • Ptosis with new neurologic deficits
  • Rapidly progressive orbital signs
  • Ptosis with generalized weakness or respiratory symptoms suggesting myasthenic crisis


⸻


Ophthalmology Pearls


  • Ptosis is classified as aponeurotic, myogenic, neurogenic, mechanical, traumatic, congenital, or pseudoptosis.
  • Involutional/aponeurotic ptosis is the most common acquired form and typically shows good levator function with a high lid crease.
  • Simple congenital ptosis usually reflects levator dysgenesis, causing poor levator function and lid lag in downgaze.
  • Children with ptosis must be evaluated for amblyopia, astigmatism, anisometropia, strabismus, and visual-axis occlusion.
  • Always examine pupils and ocular motility in any acute ptosis.
  • Acute CN III palsy, especially with mydriasis, pain, or partial ophthalmoplegia, requires urgent vascular imaging for aneurysm.
  • Painful acute Horner syndrome should be considered carotid dissection until proven otherwise.
  • Horner syndrome produces mild ptosis + miosis, while CN III palsy may produce severe ptosis with a “down-and-out” eye and possible mydriasis.
  • Variable fatigable ptosis with normal pupils suggests myasthenia gravis; the ice-pack test and AChR antibody testing are useful modern investigations.
  • Edrophonium/Tensilon testing is now largely historical.
  • Apraclonidine is the common modern pharmacologic confirmation test for Horner syndrome, although caution is required in infants.
  • Measure MRD1, levator function, lid crease, brow position, Bell phenomenon, and lagophthalmos before planning surgery.
  • A high lid crease with good levator function favors aponeurotic ptosis.
  • Poor levator function generally favors a frontalis sling, whereas aponeurotic ptosis with good function is usually treated with levator advancement.
  • MMCR is useful for selected mild–moderate ptosis with good levator function and a favorable phenylephrine response.
  • Consider Hering’s law: correcting one ptotic lid may reveal previously masked ptosis of the fellow eye.
  • The major postoperative concern is exposure keratopathy, particularly in patients with poor Bell phenomenon or ocular surface disease.


Image description
Published on

Ophthalmology – Pterygium

Basics

Description

A pterygium is a benign, fibrovascular, wing-shaped growth of bulbar conjunctiva that crosses the limbus and extends onto the cornea.

It most commonly arises:

Nasally within the interpalpebral fissure

and grows toward the visual axis.

Although benign, it can impair vision through:

  • Induced astigmatism
  • Tear-film disturbance
  • Corneal flattening/distortion
  • Direct involvement of the visual axis
  • Postoperative recurrence


Clinical Importance

Most pterygia are initially:

Observed

Surgery is considered when there is:

  • Progressive growth toward the visual axis
  • Significant induced astigmatism
  • Reduced vision
  • Recurrent inflammation or irritation
  • Restriction of ocular motility
  • Contact lens intolerance
  • Significant cosmetic concern
  • Suspicion for atypical or neoplastic pathology


Epidemiology

Pterygium is strongly associated with chronic environmental exposure.

It is more common in:

  • Tropical and subtropical regions
  • Populations living near the equator
  • Outdoor workers
  • Individuals with prolonged UV exposure

The classic epidemiologic association is sometimes called:

The “pterygium belt”

roughly within 30–40° latitude of the equator.


Risk Factors

Major risk factors include:

  • Ultraviolet radiation
  • Outdoor occupation
  • Wind
  • Dust
  • Dry environments
  • Chronic ocular surface irritation
  • Increasing cumulative lifetime exposure

Additional influences may include:

  • Genetic susceptibility
  • Ocular surface inflammation


UV Radiation

The strongest environmental risk factor is:

Chronic UV-B exposure

UV light may induce:

  • Oxidative stress
  • Limbal epithelial injury
  • Abnormal fibrovascular proliferation
  • Matrix remodeling


Prevention

Preventive measures include:

  • UV-blocking sunglasses
  • Wraparound eyewear
  • Wide-brimmed hat
  • Protection from excessive wind and dust
  • Ocular surface lubrication in dry environments

These measures may reduce:

  • New lesion development
  • Progression
  • Postoperative recurrence risk


Pathophysiology

Pterygium is not simply a passive “degeneration.”

Modern understanding favors an active proliferative process involving:

  • UV-induced limbal epithelial damage
  • Altered limbal stem-cell function
  • Fibroblast activation
  • Extracellular matrix remodeling
  • Angiogenesis
  • Chronic inflammation

There may also be dysregulation of:

  • Matrix metalloproteinases
  • VEGF
  • Transforming growth factor pathways


Histopathology

Typical findings include:

  • Elastotic degeneration of conjunctival stroma
  • Fibrovascular proliferation
  • Abnormal collagen
  • Chronic inflammatory cells
  • Invasion of superficial cornea

This actinic stromal change is often termed:

Elastotic degeneration


HPV

Human papillomavirus has been detected in some pterygium specimens.

However:

HPV is not considered an established universal cause of pterygium.

Its role remains variable and population-dependent.


Clinical Anatomy

A pterygium has:

  • Head – leading edge on cornea
  • Neck – region crossing the limbus
  • Body – fibrovascular conjunctival portion


Location

Most are:

Nasal

because the nasal interpalpebral limbus receives substantial reflected and peripheral UV exposure.

Less commonly:

  • Temporal pterygium
  • Double-headed nasal and temporal pterygia

A purely temporal or otherwise atypical lesion deserves closer evaluation for alternative pathology.


Symptoms

Patients may report:

  • Redness
  • Foreign-body sensation
  • Burning
  • Irritation
  • Dryness
  • Intermittent inflammation
  • Cosmetic concern
  • Blurred vision
  • Distorted vision


Visual Loss

Vision may decrease because of:

  • Induced astigmatism
  • Irregular astigmatism
  • Tear-film instability
  • Corneal scarring
  • Direct encroachment on the visual axis

Visual distortion can occur well before the lesion reaches the pupillary center.


Induced Astigmatism

Pterygium typically produces:

Corneal flattening along the horizontal meridian

which commonly induces:

With-the-rule astigmatism

Increasing lesion size is associated with increasing:

  • Astigmatism
  • Corneal irregularity


Slit-Lamp Examination

Typical appearance:

  • Triangular fibrovascular tissue
  • Apex directed centrally
  • Body arising from bulbar conjunctiva
  • Extension across the limbus onto cornea

Assess:

  • Size
  • Vascularity
  • Thickness
  • Corneal extension
  • Progression
  • Degree of inflammation
  • Distance from visual axis


Active / Progressive Appearance

A more active pterygium may appear:

  • Thick
  • Fleshy
  • Hyperemic
  • Highly vascular

These lesions are more likely to:

  • Progress
  • Recur after surgery


Stocker Line

A Stocker line is a line of:

Iron deposition in the corneal epithelium just anterior to the pterygium head

It reflects chronicity and tear-film iron deposition.

It should not be interpreted as a reliable marker that the lesion is completely inactive.


Fuchs Islets

Small gray-white spots near the pterygium head may occasionally represent:

Fuchs islets

and are associated with epithelial changes near the advancing edge.


Diagnosis

Diagnosis is usually:

Clinical

based on slit-lamp appearance.

Routine laboratory testing is unnecessary.


Corneal Topography / Tomography

Topography is useful when assessing:

  • Induced astigmatism
  • Irregular corneal shape
  • Surgical timing
  • Preoperative planning

It can demonstrate:

  • Horizontal flattening
  • Asymmetric astigmatism
  • Irregularity extending beyond visible lesion margins


Photography

Serial slit-lamp photography is useful for:

  • Documenting size
  • Monitoring progression
  • Counseling patients


Biopsy / Histopathology

Routine biopsy is not necessary for a classic small pterygium.

However, excised tissue is often submitted for:

Histopathologic examination

especially when the lesion is:

  • Atypical
  • Leukoplakic
  • Nodular
  • Rapidly growing
  • Unusually vascular
  • Temporal
  • Recurrent with unusual morphology

This helps exclude:

Ocular surface squamous neoplasia (OSSN).


Differential Diagnosis

Important differentials include:

  • Pseudopterygium
  • Pinguecula
  • Ocular surface squamous neoplasia
  • Conjunctival intraepithelial neoplasia
  • Squamous cell carcinoma
  • Limbal dermoid
  • Salzmann nodular degeneration
  • Peripheral corneal scar


Pterygium vs Pinguecula

Pinguecula

  • Yellow-white elevated conjunctival lesion
  • Located adjacent to limbus
  • Does not cross onto cornea

Pterygium

  • Fibrovascular growth
  • Crosses the limbus
  • Extends onto cornea


Pterygium vs Pseudopterygium

A pseudopterygium is conjunctival adhesion to the cornea caused by:

  • Trauma
  • Chemical injury
  • Inflammation
  • Peripheral corneal ulceration

Unlike a true pterygium:

  • It can occur at any limbal location
  • It is not necessarily confined to the interpalpebral zone

A probe may sometimes pass beneath portions of the pseudopterygium away from the site of adhesion:

Bowman probe test

though this maneuver is not always necessary.


Pterygium vs OSSN

Features concerning for OSSN include:

  • Gelatinous or leukoplakic surface
  • Feeder vessels
  • Nodularity
  • Rapid growth
  • Atypical temporal location
  • Irregular epithelial thickening

If suspicious:

Do not assume the lesion is a simple pterygium.

Consider:

  • High-resolution anterior segment OCT
  • Excisional/incisional biopsy
  • Histopathology


Medical Treatment

Medical therapy does not remove a pterygium.

Treatment is aimed at:

Symptom control and inflammation reduction.


Lubrication

First-line symptomatic treatment includes:

  • Artificial tears
  • Lubricating ointment
  • Preservative-free preparations when frequent use is needed

These improve:

  • Irritation
  • Tear-film instability
  • Foreign-body sensation


Topical Steroids

A short course of mild topical corticosteroid may be considered for:

  • Acute inflammatory flare
  • Significant hyperemia
  • Irritation

Use should be limited and monitored because of:

  • IOP elevation
  • Cataract
  • Infection risk


Vasoconstrictors

Chronic use of topical vasoconstrictors should generally be:

Avoided

because of:

  • Rebound hyperemia
  • Tachyphylaxis
  • Ocular surface irritation


Surgical Indications

Surgery is indicated when there is:

  • Progressive growth toward visual axis
  • Reduced visual acuity
  • Significant induced astigmatism
  • Irregular astigmatism
  • Recurrent troublesome inflammation
  • Restrictive motility
  • Persistent symptoms despite conservative therapy
  • Cosmetic concern
  • Suspicion for dysplasia or malignancy


Timing of Surgery

Surgery should ideally occur:

Before major central corneal scarring or severe visual-axis involvement develops.

However, proximity to the visual axis alone is not the only criterion.

Increasing:

  • Astigmatism
  • Corneal distortion

may justify surgery before the lesion reaches the center.


Preferred Surgical Technique

For most primary pterygia, the preferred approach is:

Excision with conjunctival autograft

often including limbal conjunctiva.

This provides:

  • Low recurrence
  • Good cosmetic result
  • Restoration of normal conjunctival anatomy


Conjunctival Autograft

The graft is usually obtained from:

  • Superior bulbar conjunctiva

It is placed over the bare scleral defect after excision.

It may be secured with:

  • Sutures
  • Fibrin glue
  • Autologous blood in selected techniques


Fibrin Glue

Potential advantages include:

  • Shorter surgery
  • Less postoperative discomfort
  • Reduced suture-related inflammation

Disadvantages include:

  • Cost
  • Rare graft displacement
  • Potential biologic product concerns depending on preparation


Bare Sclera Technique

Simple excision leaving bare sclera has a:

High recurrence rate

and is generally:

Not recommended as routine primary treatment.


Conjunctival-Limbal Autograft

Including limbal tissue may:

  • Restore limbal barrier function
  • Reduce recurrence

especially in:

  • Young patients
  • Aggressive lesions
  • Recurrent pterygia

Care must be taken not to damage the donor limbus excessively.


Mitomycin C

Mitomycin C (MMC) can reduce recurrence by inhibiting fibroblast proliferation.

It may be used:

  • Intraoperatively
  • Occasionally postoperatively in specialized protocols


MMC Risks

MMC must be used cautiously because complications may include:

  • Scleral thinning
  • Scleral melt
  • Delayed epithelial healing
  • Corneal toxicity
  • Infectious scleritis
  • Secondary glaucoma
  • Severe ocular surface complications

It is generally reserved for:

  • High-risk primary lesions
  • Recurrent pterygia
  • Selected surgical cases


Amniotic Membrane Transplantation

Amniotic membrane may be used when:

  • Conjunctiva must be preserved
  • Defect is large
  • There is significant ocular surface disease
  • Prior surgery limits available conjunctiva

However:

Recurrence is generally higher with amniotic membrane alone than with conjunctival autograft for routine primary pterygium surgery.


Preserving Conjunctiva

Conjunctival preservation may be particularly important in patients who may later need:

  • Trabeculectomy
  • Glaucoma drainage surgery

In such patients, surgical planning should consider future glaucoma needs.


Postoperative Treatment

Typical postoperative therapy includes:

  • Topical antibiotic for a short course
  • Topical corticosteroid with gradual taper
  • Lubrication

The exact steroid duration depends on:

  • Inflammation
  • Healing
  • Recurrence risk
  • Surgical technique


Important Modern Correction – Steroid Duration

A fixed requirement for:

Six months of postoperative topical steroid

is not standard for every patient.

Many patients are treated for:

  • Several weeks
  • Sometimes a few months

with tapering individualized to inflammation and recurrence risk.


Recurrence

Recurrence is the most important postoperative complication.

It usually occurs within:

The first 6–12 months

although later recurrence can occur.


Risk Factors for Recurrence

Higher recurrence risk is associated with:

  • Younger age
  • Fleshy/vascular pterygium
  • Large lesion
  • Recurrent pterygium
  • Persistent postoperative inflammation
  • High UV exposure
  • Bare sclera technique
  • Inadequate fibrovascular tissue removal


Recurrent Pterygium

Recurrent lesions may be:

  • More vascular
  • More fibrotic
  • More adherent
  • More difficult to remove

They may cause:

  • Restrictive strabismus
  • Significant corneal scarring
  • Symblepharon

Management often requires:

  • Extensive scar dissection
  • Conjunctival-limbal autograft
  • MMC
  • Amniotic membrane in selected cases


Postoperative Complications

Potential complications include:

  • Recurrence
  • Graft edema
  • Graft displacement
  • Granuloma
  • Dellen formation
  • Infection
  • Diplopia
  • Scleral thinning
  • Corneal scar
  • Persistent epithelial defect
  • Rare scleral melt


Dellen

A corneal dellen is localized peripheral corneal thinning caused by:

  • Tear-film instability
  • Adjacent elevation

It may occur near:

  • Pterygium
  • Postoperative graft elevation

Treatment includes:

  • Aggressive lubrication
  • Reduction of adjacent inflammation/elevation


Follow-Up

Small stable lesions can generally be followed:

  • Periodically
  • Often annually

Earlier review is appropriate if there is:

  • Documented progression
  • Increasing astigmatism
  • Increasing symptoms
  • Suspicious morphology


Postoperative Follow-Up

Monitor for:

  • Epithelial healing
  • Graft position
  • Infection
  • IOP elevation from steroids
  • Recurrence

Long-term UV protection should be encouraged.


Prognosis

Prognosis is generally:

Excellent

when lesions are small and managed appropriately.

After surgery, visual improvement may result from:

  • Reduced astigmatism
  • Improved corneal regularity

However, longstanding central lesions may leave:

  • Persistent corneal scar
  • Residual irregular astigmatism


Ophthalmology Pearls

  • Pterygium is a benign fibrovascular conjunctival growth that crosses the limbus onto the cornea, usually nasally.
  • The strongest environmental risk factor is chronic UV exposure, especially in tropical climates and outdoor workers.
  • Modern understanding views pterygium as an active UV-related proliferative and inflammatory process, not merely passive degeneration.
  • Visual impairment can occur from induced astigmatism well before the lesion reaches the visual axis.
  • Stocker line is iron deposition just anterior to the pterygium head and does not reliably prove inactivity.
  • A pinguecula does not cross the limbus; a pterygium does.
  • A pseudopterygium follows trauma or inflammation and can occur at any limbal location.
  • Atypical, leukoplakic, nodular, rapidly growing, or temporal lesions should raise concern for OSSN and may require biopsy.
  • Lubricants and short courses of topical steroids can relieve symptoms but do not eliminate the pterygium.
  • Surgery is indicated for progression, visually significant astigmatism, threatened visual axis, persistent symptoms, motility restriction, or significant cosmetic concern.
  • Conjunctival autograft is the preferred technique for most primary pterygia because of its low recurrence rate.
  • The bare sclera technique should generally be avoided because recurrence is high.
  • MMC reduces recurrence but must be used judiciously because of potentially serious complications such as scleral melt.
  • Amniotic membrane is useful when conjunctiva needs to be preserved, but for routine primary pterygium surgery it generally has a higher recurrence rate than conjunctival autograft.
  • Recurrence occurs most commonly during the first postoperative year.
  • A fixed 6-month steroid course is not required for every patient; postoperative anti-inflammatory therapy should be individualized.
  • Continued UV-blocking eyewear and hats are important after surgery to reduce ongoing environmental exposure.


Image description